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Abstract 
Introduction: Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional 
structural deformity of the spine occurring in adolescence with unknown 
etiopathogenesis. The reported prevalence rate is about 4% worldwide. Untreated 
curves could progress and cause significant cosmetic problems and in severe cases 
morbidities and complications such as cardiopulmonary failures. Current 
treatments for scoliosis include observation, bracing and corrective surgery with 
instructments. However, these treatments remain unsatisfactory with the likelihood 
of curve progression with bracing and the associated surgical complications. Thus, 
the understanding on the etiopathogenesis of AIS remains the key for the best remedy. 
Further characterization of the AIS patients in addition to the spinal curvature is 
important in further delineating the etiopathogenesis of AIS. 
One of the well-studied phenotypes of the AIS is the presence of low bone mass. 
Previous studies have reported low bone mass in about 30% of the AIS patients, and 
longitudinal follow-up studies also showed that among them more than 80% would 
have persistent low bone mass after skeletal maturity. From the animal studies, it 
was shown that pinealectomy in avians and rodents could lead to the development of 
scoliosis-like deformity. Some studies have reported the beneficial effect of 
exogenous administered melatonin in the prevention of scoliosis development in 
these pinealectomized models. Genetic association study of the melatonin receptor 
IB gene polymorphism has shown that melatonin receptor IB polymorphism is 
associated with the occurrence of AIS. Other studies have suggested the presence 
of melatonin signaling pathway dysfunction in the osteoblasts of AIS patients. To 
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explain for the above mentioned observations, it is logical to postulate that there 
could be abnormality in the response of osteoblasts toward melatonin in AIS patients. 
With the limited information on the cellular effect of melatonin toward AIS patients, 
the aim of the current series of study were to evaluate the effect of melatonin on 
osteoblasts from AIS patients in term of cell proliferation and cell differentiation. 
Based on the response of the osteoblasts from AIS subjects, AIS subjects were 
further subgrouped for the analysis and correlation with different anthropometric 
measurement and bone mineral status. Results were compared with normal 
controls. 
Methods: First part of the study included clinical assessments of 224 severe AIS 
girls and 120 age and sex matched normal controls. Assessments included 
anthropometric measurements: body weight, height, arm span, body mass index 
(BMI). Bone mineral density (BMD) of both bilateral femoral necks and midshafts 
of non-dominant radius was also assessed by DXA and pQCT, respectively. Second 
part of the study utilized primary osteoblasts isolated from intraoperative bone 
biopsies from 13 AIS girls undergoing corrective spinal surgery and 9 control 
subjects undergoing unrelated trauma surgery. The osteoblasts were cultured in 
vitro and assessed for the effect of melatonin on cell proliferation and differentiation 
by MTT cell viability assay and alkaline phosphatase activity (ALPase), respectively. 
In addition, the expression of melatonin receptors, MTl and MT2, on osteoblasts was 
examined by western blot. After the characterization of the cellular response of the 
osteoblasts to melatonin, the subjects were divided into two subgroups according to 
their response to melatonin in proliferation assay. Detail correlation of the cellular 
response pattern with the anthropometric cross-sectional parameter and bone mineral 
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status were then analyzed and results were then compared between groups and the 
normal controls. 
Results: After adjusting for age, the severe AIS girls showed significantly longer 
arm span and lower body weight, BMI and BMD when compared with healthy 
female controls. The in vitro assays of proliferation on osteoblasts from AIS 
patients (n=l3) demonstrated two different types of responses to melatonin. The 
first group (Group A) (n=3) showed promoting effect, similar to normal controls, on 
cell proliferation with physiological dosage (lOnM) of melatonin, while the second 
group (Group B) (n=10) showed inhibitory effect with lOnM of melatonin. Normal 
controls and group A subjects were also found to have melatonin enhanced osteoblast 
differentiation and increased ALPase activity while those in Group B showed an 
inhibitory effect. In semi-quantification of the two types melatonin receptors (MTl 
and MT2), the osteoblasts samples showed the absence of MTl and MT2 receptors 
inin 4 out of 10 of the osteoblast samples in Group B. These patients had the 
longest arm span and lowest BMD. Among the Group B subjects, those with the 
absence of MT2 receptors were found to have an even longer arm span and higher 
prevalence of family history when compared with the other groups of AIS patients. 
Discussion: This is the first report on the abnormal cellular response of osteoblasts 
in AIS to melatonin. The abnormal responses of osteoblasts may affect the 
phenotypic expression of AIS patients such as abnormal anthropometric 
measurement and bone mineral status. In addition to the suggested abnormality in 
the melatonin signaling pathway in the literatures, the expression of MT2 receptor 
could contribute significantly to the abnormal response of osteoblasts in AIS. The 
vi 
observation of the present study points to the speculation that it is likely the AIS 
subjects consist of a heterogeneous groups of individuals with multifactorial 
etiopathogenesis. The findings of the current series of studies also provide 
important evidences on the role of melatonin in the etiopathogenesis of AIS. 
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a-MEM Alpha-minimal essential medium 
4-P-PDOT 4-phenyl-2-propionamidotetralin 
AA-NAT Arylalkylamine-A^-acetyltransferase 
ACL Anterior cruciate ligaments 
AIS Adolescent idiopathic scoliosis 
ALPase Alkaline phosphatase 
ANOVA One-way analysis of variance 
APS Ammonium persulfate 
BA Bone area 
bALP Bone alkaline phosphatase 
BCIP 5-Bromo-4-chloro-3-indolyl phosphate 
BMC Bone mineral contents 
BMD Bone mineral density 
BMI Body mass index 
BMP Bone morphogenetic protein 
BMU Basic multicellular unit 
BO line Basionopisthion reference line 
CBFA-1 Core binding factor-1 
CO2 Carbon dioxide 
CSA Cross-sectional area 
CT Computed tomography 
Cyclic AMP Cyclic adenosine monophosphate 
DEA Diethanolamine 
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DIx5 Distalless homeobox 5 
DMEM Dulbecco's Modified Eagle Medium 
DNA Deoxyribonucleic acid 
DXA Dual energy x-ray absorptiometry 
ERK Extracellular signal-regulated kinase 
FBS Fetal bovine serum 
FGFs Fibroblast growth factors 
GH Growth hormone 
Gpp(NH)p 5'-Guanylimidodiphosphate 
GTP Guanosine-5'-triphosphate 
HIOMT Hydroxyindole-O- methyltransferase 
IGF-1 Insulin-like growth factor 1 
IGF-IR IGF-1 receptor 
Ihh Indian hedgehog 
IL-6 Interleukin-6 
JAK Janus kinase 
MAPK Mitogen activated protein kinase 
Melatonin N-acetyl-5-methoxytryptamine 
MGP Matrix GLA protein 
MRI Magnetic resonance imaging 
MSC Mesenchymal stem cells 
MTNRIB Melatonin IB receptor 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NBT Nitro blue tetrazolium 
PBS Phosphate buffered saline 
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PGR Polymerase chain reaction 
PINX Pinealectomy 
P13K Phosphatidylinositol 3-kinase 
PNPP p-Nitrophenyl phosphate 
PNS Penici 11 in/neomycin/streptomycin antibiotic cocktail 
pQCT Peripheral quantitative computed tomography 
PTH Parathyroid hormone 
PTHrP PTH-related protein 
QLPSD Quality of life profile for spine deformities 
RANKL Receptor activator ofNF-kappaB ligand 
RIPA Radioimmunoprecipitation assay 
RFLP Restriction fragment length polymorphism 
RT-PCR Real-time polymerase chain reaction 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
SNP Single nucleotide polymorphism 
SPA Single energy photon absorptiometry 
SSEP Somatosensory-evoked potentials 
STAT Signal transducers and activator of transcription 
TEMED Tetramethylethylenediamine 
TBST Tris-buffered saline with Tween-20 
TLSO Thoracolumbosacral orthosis 
TWIST Twist homolog 
xiii 




List of Tables xviii 
List of Figures xx 
Major Conference Presentations xxii 
Publications in Preparation xxiv 
Study Flowchart xxv 
Chapter I Study Background - 1 -
1. Introduction - 2 -
1.1. General Overview of Adolescent Idiopathic Scoliosis (AIS) - 2 -
1.2. Natural History - 3 -
1.3. Current Treatments - 5 -
1.4. Additional Phenotypes Abnormalities - 9 -
1.5. Bone Modeling and Remodeling in Adolescents - 14 -
1.6. Bone Development - 15 -
1.7. Bone (re)modeling by osteoclasts and osteoblasts - 17 -
1.8. Factors Affecting Osteoblasts Regulation - 19 -
1.9. Current Hypothesis on the Etiology of AIS - 2 1 -
1.10. Melatonin -26-
Chapter 2 Hypothesis and Objectives - 47 -
2. Hypothesis and Objectives - 48 -
2.1. Study Hypothesis -48 -
xiv 
2.2. Objectives - 48 -
Chapter 3 Study on the Anthropometric Parameters and Bone Geometry of Girls 
with Severe AIS - 49 -
3.1. Introduction - 50 -
3.2. Methodology - 5 1 -
3.2.1. Recruitment of Subjects - 51 -
3.2.2. Evaluation of Curve Severity of Scoliosis - 52 -
3.2.3. Anthropometric Measurements - 53 -
3.2.4. Measurements ofBMD - 53 -
3.2.5. Data Analysis - 54 -
3.3. Results - 5 5 -
3.3.1. Anthropometry - 5 5 -
3.3.2. BMD of Femoral Neck and Midshaft of Radius - 56 -
3.4. Discussion - 5 7 -
Chapter 4 Response of Osteoblasts to Melatonin in AIS - 69 -
Girls - In vitro Study - 69 -
4.1. Introduction - 7 0 -
4.2. Methodology - 72 -
4.2.1. Subjects Recruitments -12-
4.2.2. Cell Isolation - 7 3 -
4.2.3. Effect of Melatonin on Proliferation and Differentiation of AIS 
Osteoblasts -16-
4.2.4. Data Analysis -19 -
4.3. Results - 80 -
4.3.1. Isolated Osteoblasts from Normal Human and AIS Patients - 80 -
XX 
4.3.2. Effect of Melatonin on Osteoblasts Proliferation - 80 -
4.3.3. Effect of Melatonin on Cell Differentiation - 81 -
4.4. Discussion - 83 -
Chapter 5 Expression of MTl and MT2 receptors in AIS - 101 -
Osteoblasts - 1 0 1 -
5.1. Introduction - 102 -
5.2. Methodology - 1 0 4 -
5.2.1. Osteoblast Samples - 104 -
5.2.2. Protein Expression of Melatonin Receptors in AIS Osteoblasts. - 105 -
5.2.3. Genotyping of MT2 receptors by Restriction Fragment Length 
Polymorphism (RFLP) - 109 -
5.2.4. Clinical Evaluations of the AIS Patients - 110-
5.2.5. Data Analysis - 110 -
5.3. Results -111-
5.3.1. Semi-quantification of Melatonin Receptors in AIS Osteoblasts - 111 -
5.3.2. RFLP - 112-
5.3.3. Functional Response Between the Different AIS Groups - 1 1 2 -
5.3.4. Correlation of the Clinical Phenotypes with the Different AIS 
Subgroups - 114 -
5.4. Discussion - 1 1 5 -
Chapter 6 Summary and Conclusion - 132 -
6.1. Summary and Discussion - 133 -
6.2. Limitations and Further Studies - 136 -
6.3. Conclusion - 138 -
Bibliography - 141 -
XV i 
Appendix I - 185 -
Appendix II - 186 -
Appeddix III - 187 -
Appendix IV - 188 -
Appendix V - 189 -
Appendix VI - 190 -
xvii 
List of Tables 
Table 1.1. Occurrence of scoliosis after pinealectomy. 41 
Table 1.2. Experimental scoliosis in melatonin-deficient C57BL/6J mice 44 
with an intact pineal. 
Table 1.3. Effects of bipedal operation with or without pinealectomy on 45 
the induction of scoliosis in C3H/HeJ and C57BL/6J mice. 
Table 3.1. Age distributions of subjects recruited in the current study 64 
Table 3.2. Multiple regression analysis on the arm span and body mass 65 
index between severe AIS patients and control subjects 
Table 3.3. Multiple regression analysis on the BMD of the bilateral 66 
femoral neck between severe AIS patients and control subjects 
Table 3.4. Multiple regression analysis on the BMD of the midshaft of 67 
radius between severe AIS patients and control subjects under 
16 years old 
Table 3.5. Multiple regression analysis on the BMD of the midshaft of 68 
radius between severe AIS patients and control subjects over 16 
years old 
Table 4.1. Clinical data of patients with AIS 91 
Table 4.2. Clinical data of control patients 92 
Table 5.1. The Genotype of the SNP rs4753426 in the MT2 Gene of the 13 126 
AIS patients. 
Table 5.2 Clinical Characteristics between the Three Groups of AIS 129 
Patients 
xviii 
Table 5.3. Z-Score Comparison on the Anthropometry and BMD Between 130 
the Three Groups of AIS Patients 
Table 5.4. Familial Occurrence in the Three Groups of AIS Patients 131 
Table 6.1. Summary on major characteristics between the 3 groups of AIS 140 
osteoblasts in this study 
xix 
List of Figures 
Figure 1.1. Radiological image of right thoracic idiopathic scoliosis. 36 
Figure 1.2. Illustration of an AIS patient treated with a Milwaukee brace. 37 
Figure 1.3. Radiograph images of AIS patients before and after surgical 38 
correction. 
Figure 1.4. Structure of Melatonin 39 
Figure 1.5. Biosynthesis of Melatonin 40 
Figure 1.6. The occurrence of spinal deformity in rats under different 42 
conditions. 
Figure 1.7. Occurrence of right thoracic scoliosis in a bipedal mouse. 43 
Figure 1.8. Evaluation of melatonin inhibitory effect on adenylyl cyclase 46 
activity in human osteoblasts. 
Figure 4.1. Isolation of human osteoblasts from bone biopsies. 93 
Figure 4.2. Typical microphotograph of normal human osteoblasts isolated 94 
in this study. 
Figure 4.3. Typical microphotograph of human AIS osteoblasts isolated in 95 
this study. 
Figure 4.4. Effect of melatonin on the viable cell numbers of normal 96 
human and AIS osteoblasts. 
Figure 4.5. Effect of melatonin on the ALPase activity of normal human 97 
and AIS osteoblasts. 
Figure 4.6. Distribution on the viable cell numbers of controls and AIS 98 
osteoblasts toward the physiological concentration of 
melatonin (lO'^M). 
XX 
Figure 4.6. Effect of melatonin on the viable cell numbers of normal 99 
human and the two groups of AIS osteoblasts. 
Figure 4.7. Effect of melatonin on ALPase activity in normal human and 100 
the two groups of AIS osteoblasts. 
Figure 5.1. Expression of MT receptors in normal human osteoblasts. 122 
Figure 5.2. Expression of MT receptors in AIS osteoblasts. 123 
Figure 5.3. Semi-quantification of MT receptor levels by Western Blot. 124 
Figure 5.4. The expression of MT2 gene polymorphism in osteoblasts 125 
from AIS patients. 
Figure 5.5. Effect of melatonin on the proliferation of normal human and 3 127 
subgroups of AIS osteoblasts. 
Figure 5.6. Effect of melatonin on ALPase activity in normal human and 128 
the 3 subgroups of AIS osteoblasts. 
xxi 
Major Conference Presentations 
1. Man GCW. Yeung HY, Wang WJ, Lee KM，Ng BKW，Hung WY，Ng TB, Qiu Y， 
Cheng JCY. A Study of the Effect of Melatonin on the Proliferation & 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis, Scoliosis 
Research Society Annual Meeting, September 10-13，2008, Utah, USA 
(Awarded John Moe's Award for best basic science poster) 
[Refer to Appendix I] 
2. Man GCW. Yeung HY, Wang WJ, Lee KM, Ng BKW, Hung WY, Ng TB, Qiu Y, 
Cheng JCY. A Study of the Effect of Melatonin on the Proliferation & 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis, The 
International Meeting on Advanced Spine Techniques, July 8-11山，2008，Hong 
Kong, SAR 
3. Man GCW. Wang WJ, Yeung HY, Ng BKW, Lee KM, Hung WY, Qiu Y，Cheng 
JCY. A Study of the Effect of Melatonin on the Proliferation and Differentiation 
of Osteoblasts in Adolescent Idiopathic Scoliosis, the International Research 
Society of Spinal Deformities, July 9-12山 2008，Liverpool, UK. Pp 
4. Man GCW. Yeung HY, Wang WJ, Lee KM, Ng BKW, Hung WY，Ng TB, Qiu Y， 
Cheng JCY. A Study of the Effect of Melatonin on the Proliferation and 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis, The 
International Congress of Osteoporosis and Bone Research 2008, October 22-25, 
2008，Beijing, China. 
xxii 
5. Man GCW. Yeung HY, Wang WJ, Lee KM, Ng BKW，Hung WY, Ng TB，Qiu Y, 
Cheng JCY. A Study of the Effect of Melatonin on the Proliferation and 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis, the Chinese 
Orthopedics Association 3rd Annual Congress, November 12-16, 2008, Suzhou, 
China. 
6. Man GCW. Yeung HY, Wang WJ, Lee KM, Ng BKW, Hung WY, Ng TB, Qiu 
Y, Cheng JCY. The Abnormal Effect of Melatonin on the Proliferation & 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis. The 
Annual Congress of Hong Kong Orthopedics Association, November 29-30^ *^  
2008, Hong Kong, SAR 
7. Man GCW, Wang WJ, Yeung HY, Lee KM, Ng BKW, Hung WY, Ng TB, Qiu Y， 
Cheng JCY. A Study of the Effect of Melatonin toward the Proliferation and 
Differentiation of Osteoblasts in Adolescent Idiopathic Scoliosis, the Annual 
Meeting of the Orthopedics Research Society, February 22-29, 2009, Las Vegas, 
Nevada, USA. 
xxiii 
Publications in Preparation 
1. The effect of melatonin on the proliferation and differentiation of osteoblasts in 
adolescent idiopathic scoliosis Target Journal: Spine (Manuscript In preparation) 
2. Melatonin receptor expression of osteoblasts in adolescent idiopathic scoliosis 




> Adolescent idiopathic scoliosis is a complex three-dimensional structural 
deformity of the spine occurring most commonly in adolescence with a 
prevalence of 4%. 
> The current treatments, including observation, bracing and surgical correction, 
are not totally satisfactory and are associated with different morbidity and 
complications. The ultimate remedy for progressive AIS patients requires the 
proper understanding of the etiopathogenesis and thus the specific and 
appropriate treatment regime. 
> Genetic factors, abnormal skeletal growth, metabolic dysfunction, 
neurosensory disturbance, and biomechanical stress are the main groups that 
have been postulated to be associated with the etiopathogenesis of AIS. 
> Experimental animal model of pinealectomized chicken and 
melatonin-deficient mice were found to develop similar spinal deformity. 
Previous Studies 
> Melatonin enhances BMD in ovarectomized rats. 
> Melatonin prevents scoliosis development in pinealectomized 
rodents and avians. 
> Dose-dependent concentrations of melatonin promote human 
osteoblasts to proliferation, differentiation and mineralization. 
> Clear evidences of the importance of melatonin on bone remodeling. 
> Existence of melatonin signaling pathway dysfunction in osteoblasts isolated 
from severe AIS patients. 
> Melatonin IB gene polymorphism associated with the occurrence of AIS. 
> Hypothesis: 
Abnormal response of osteoblasts to melatonin is present in girls with AIS. 
Continue on next 
page 
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Objectives 
1. To study the anthropometric parameter and BMD of girls with severe AIS, in 
comparison with healthy female adolescent controls. 
2. To determine the effect of melatonin on proliferation and differentiation of 
osteoblasts isolated from intraoperative bone biopsies of AIS patients. 
3. To detect the expression of melatonin receptors on osteoblasts isolated from 
intraoperative bone biopsies of AIS patients in comaprison with healthy normal 
controls. 
Question 1: 
Is there any systemic abnormality in skeletal growth and BMD in girls with 
severe AIS requiring surgerical treatment? 
Methods: Methods: 
> Cross sectional study > Cross sectional study 
> Anthropometric measurements > BMD measurements of both 
(Height, Weight, Arm span and femoral neck and midshaft of 
Body Mass Index) of severe non-dominant radius. 
AIS girls with age-matched > Dual-energy x-ray absorptiometry 
healthy girls. > Peripheral Quantitative 
Computerized Tomography 
> Severe AIS girls versus Controls. 
i / 
Findings: Findings: 
> Severe AIS girls were lighter > The BMD of both femoral necks 
and leaner than the controls. was significantly lower in severe 
> Severe AIS girls have a AIS subjects. 
significantly lower BMI than > There was no statistical difference 
the control. on the BMD in the midshaft of 
> Arm span was significantly distal radius between severe AIS 
longer in severe AIS girls than girls with controls. 
in normal controls 
Continue on next 
page 
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Implications: Implications: 
> There is systemic abnormality > The presence of generalized low 
in bone growth of severe AIS BMD in severe AIS girls. 
girls. > Possible implication on 
> Disproportionally active abnormality in bone remodeling of 
endochondral ossification in severe AIS girls. 
severe AIS girls. 
> The change in arm span may 
help in monitoring the abnormal 
growth in AIS patients. 
Summary： 
> Abnormality of anthropometric measurements and BMD in severe AIS girls. 
> Possible abnormality in bone formation in AIS girls. 
> Previous reports of melatonin signaling dysfunction in AIS osteoblasts. 
> Is there a relationship between the melatonin dysfunction with the abnormal 
phenotypes observed? 
Question 工 
Is there evidence of abnormal melatonin response in osteoblasts from patients 
with AIS? 
Methods: 
> Isolated osteoblasts from AIS patients, undergoing corrective surgery, and 
confirmed by morphology and presence of alkaline phosphatase. 
> Tested the effect of melatonin on proliferation of AIS osteoblasts by MTT 
viability assay. 
> Tested the effect of melatonin on differentiation of AIS osteoblasts by alkaline 
phosphatase activity. 




> Abnormal response to melatonin in AIS osteoblasts. 
> Two different responses to melatonin occurred in the AIS osteoblasts. 
> On proliferation 
• Group A: Melatonin enhanced proliferation. 
• Group B: Melatonin showed a drop in proliferation. 
> On differentiation 
• Group A: Melatonin enhanced differentiation. 
• Group B: Melatonin showed a drop in differentiation. 
Implications: 
> Abnormality in AIS osteoblasts toward melatonin. 
> This implies possible heterogeneity in the AIS populations in the response 
toward melatonin. 
Summary: 
> Abnormal response to melatonin in osteoblasts isolated from AIS girls. 
> Previous reports of melatonin signaling dysfunction in AIS osteoblasts. 
> Are melatonin receptors present in osteoblasts from the Group B AIS patients? 
> Abnormal response to melatonin in osteoblasts isolated from AIS patients 
Question 3: 
Whether there is abnormality in the expression of melatonin receptors in AIS 
osteoblasts? 
Methods: 
> Isolated osteoblasts from AIS patients undergoing corrective surgery, and 
confirmed by morphology and presence of alkaline phosphatase. 
> Investigated the protein expression of the melatonin receptors in AIS 
osteoblasts by Western Blot. 
> Correlation of the melatonin response to clinical phenotypes. 





> All osteoblast samples, both normal controls and AIS subjects, showed 
positive MTl receptor expression by Western Blot. 
> Normal controls and Group A showed expression of MT2 receptors. 
> Group B showed significantly lower expression of MT2 receptor in selected 
samples of AIS osteoblasts. 
> Further subclassification into Group B2 for those with no observable MT2 
expression by Western blot. 
> By RFLP, all the AIS osteoblasts showed the presence of MT2 gene. 
> Group B2 has generalized longer arm span than Group A and Group B1. 
> Rate of familial history is higher in Group B2 than Group A and Group B1. 
— 
Implications: 
> This further implies heterogeneity in the AIS populations. 
> In the group B, further classification of a subgroup from the lack of observable 
MT2 receptor expression by Western blot. 
> The result could imply that low or absent MT2 receptor might contribute to 
the disproportional endochondral ossification, thus resulting in having longer 
arm span and lower BMI in affected AIS patients. 
> Findings support the classifications on the melatonin signaling pathway 
dysfunction reported by Moreau et al. 
Conclusions: 
> Confirmation of abnormal bone growth in severe AIS girls. 
> Severe AIS girls have a lower BMI and longer arm span than normal controls. 
> Severe AIS girls demonstrated a generalized low BMD when compared with 
healthy normal controls. 
> Based on the response to melatonin and presence of MT2 receptors, the AIS 
osteoblasts can be classified into three subgroups (Group A, Group B1 and 
Group B2). 
Continue on next 
page 
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xx ix 
> Group A osteoblasts showed enhanced proliferation and differentiation with 
the addition of physiological and pharmacological concentrations of 
melatonin. 
> Group B1 osteoblasts showed inhibited proliferation and differentiation with 
the addition of physiological and pharmacological concentrations of 
melatonin. 
> Group B2 osteoblasts showed inhibited proliferation and differentiation to 
melatonin, with relatively low or absent MT2 receptors. 
> Longer arm span and lower BMI observed in Group B2 AIS patients. 





1. Prospective follow-up study on the anthropometry of severe AIS patients with 
long arm span. 
2. Cyclic AMP assessment to be conducted to study the possible association with 
the observed abnormal functional response in the AIS osteoblasts 
3. The material property and microarchitecture of the bone in AIS girls. 
4. Possible bone markers during the growth spurt in AIS girls. 
5. Analysis on the structural changes of the melatonin receptors. 
6. Sub-classified the AIS patients by the abnormal melatonin response to 
correlate with the onset and progression of AIS. 
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Chapter 1 Study Background 
1. Introduction 
1.1. General Overview of Adolescent Idiopathic Scoliosis (AIS) 
Idiopathic scoliosis is the most common consulted pathological deformity of the 
spine. By definition, it is a complex three-dimensional structural lateral deformity 
of the spine with vertebral rotation to an otherwise healthy individual (Figure 1.1). 
It is a lifelong, probably systemic condition of unknown cause. Current clinical 
screeing test diagnosis of scoliosis is based on the forward bending test. If a hump 
is noted, the suspected patient would be sent for an x-ray to confirm the diagnosis. 
The standard method for assessing the curvature is by measuring the Cobb's angle. 
The classification of scoliosis is divided into 3 groups depending on the time of onset: 
1) infantile (age below 3 years old); 2) juvenile (age 5 to 8 years old), and 3) 
adolescent (age 10 years old to skeletal maturity) (James, 1954). According to 
radiographic classification of the curvature's apex region, it can be further described 
as cervical, thoracic, thoracolumbar and lumbar curves. Among the different 
subtypes of idiopathic scoliosis, adolescent idiopathic scoliosis is the most common 
form and accounts for 80% of the scoliosis. 
The occurrence of AIS, using a cut-off point of 10° Cobb or more, can vary from 2 to 
2.5% among different countries and ethnical race (Daruwalla et al, 1985，Kane, 
1977’ Lonstein, 1988，Robin, 1990, Shohat et al, 1988). In Hong Kong, the 
prevalence of AIS is about 4% as reported by the Department of Health. The 
occurrence of scoliosis is similar in males and females with small curves of 10° 
(Rogala et al, 1978). However, the incidence of the AIS patients with clinical 
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significant curve that is with Cobb's angle greater than 20® is significantly higher in 
female than in male (Rogala et al., 1978) This indicates that gender may play a 
vital role toward progression. Similarly, the female to male ratio requiring 
treatment is 7:1, with approximately 0.1% warranting the need for corrective surgery 
(Taylor et al., 2000). Although less than 10% of epidemiological studies truly 
reported that positively screened scoliosis would require any treatment, those in need 
of attention would benefit from a better understanding of the etiology of this disorder 
(Brooks et al, 1975，Bunnell, 1986’ Montgomery and Willner, 1997，Rogala et al, 
1978，Weinstein and Ponseti, 1983). 
1.2. Natural History 
The natural history of AIS plays an important role in helping the clinical 
management and research aiming at understanding the etiopathogenesis (Asher and 
Burton, 2006, Weinstein et al, 2003). Upon skeletal maturity, minor loading with a 
large curve would inevitably be more difficult to prognosticate (Van Goethem et al., 
2007). Previously, Weinstein et al. (1983) reported that 68% of the 133 curves in 
102 patients progressed after skeletal maturity. It was found that curves initially 
less than 30° Cobb generally would not progress and single thoracic curves, between 
50° to 75° Cobb, are more likely to progress (Ascani et al., 1986, Weinstein and 
Ponseti, 1983). In addition, large apical vertebral rotations in single thoracic curves 
have been shown to contribute to curve progression (Weinstein, 1999). For double 
curves, the position of the major curve (lumbar > thoracic) and direction right lumbar 
> left lumbar) could affect the curve progression (Weinstein and Ponseti, 1983). 
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In a 50-year follow up study on untreated scoliosis (Weinstein et al.，2003)， 
Weinstein et al. (2008) demonstrated little physical impairment, other than back pain 
and cosmetic concerns. Likewise, the mortality rate of patients suffering from 
scoliosis is more or less similar to the average adolescents in the population. 
Significant differences only arise from patients carrying a thoracic curve greater than 
80® Cobb angle, which could result in progressive pulmonary failure. Typical 
discomforts reported from scoliotic patients include back pain (Mayo et al., 1994)， 
pulmonary symptoms (Pehrsson et al.’ 1992，Weinstein et al., 1981), low self-esteem 
(Weinstein et al.’ 2003)，and low bone mineral density (BMD) (Burner et al, 1982， 
Cheng and Guo, 1997). 
Based on these findings, AIS would not result in increased mortality rate. However, 
it is still not clear whether AIS is the cause of death reported from cardiopulmonary 
failure in some patients. In a 25 years study, Branthwaite et al (1986) reported that 
11 out of 800 AIS patients attending a chest clinic died from cardiopulmonary failure. 
An eleven-year-old AIS patient, diagnosed with 40 Cobb, died from cardiopulmonary 
failure in adulthood, with a curve progression over 150'' (Branthwaite, 1986). 
However, in another study, respiratory failure only occurred in AIS patients with a 
predicted low vital capacity (< 45%) and a larger scoliotic angle (> 110°) (Pehrsson 
et al, 2001, Pehrsson et al.’ 1992). 
Typical pulmonary symptoms in shortness of breath is commonly associated with 
idiopathic scoliosis (Pehrsson et al.’ 1992, Weinstein et al., 1981). It is more 
common in AIS patients carrying a thoracic curve greater than 80° Cobb or with 
increased vertebral rotation near the thoracic rib cage, though larger double curves 
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may also have similar association (Weinstein et al., 1981). Other than that, the 
prevalence of back pain has been reported occasionally in AIS patients (Mayo et al.’ 
1994，Weinstein et al, 2003). Although pain severity is not related to curve size 
(Mayo et al.’ 1994), curve pattern seems to increase with pain (Weinstein and Ponseti, 
1983). Thoracolumbar curves would generate greater back pain than double curves 
(Ascani et al., 1986). Another major setback in AIS patients is low self esteem 
(Weinstein et al, 2003). This is significantly higher in younger female AIS patients 
with small curves than control (Goldberg et al.’ 1994). Likewise, other health 
impairments, including hypertension (Pehrsson et al., 1992) and neurological 
impairment (Jackson et al., 1983), are seldom reported. 
1.3. Current Treatments 
Current medical treatment for AIS depends on the nature and severity of the spinal 
curve. There are a number of criteria affecting the choice of treatments. The criteria 
include the age of the patient, skeletal maturity, curve types, level of curvature and 
progression status. The main objective of the treatment is to control the curve from 
progression and to minimize the need for surgery with improvement on cosmetic 
appearance. The treatment is divided into 2 categories: non-operative and operative 
treatments. 
1.3.1. Non-operative Treatments 
Non-operative treatment of scoliosis includes observation and bracing. Observation 
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can only be employed for skeletal immature patients with a Cobb's angle less than 20 
degree. Upon reaching skeletal maturation, any curvature less than 40 can still be 
treated by monitoring alone (Tang et al, 2003). Other than that, bracing would be 
recommended by the clinicians (Figure 1.2). Patients are advised to wear braces for 
twenty-two to twenty-four hours a day. The most typical braces used are the 
Milwaukee (Noonan et ai, 1997), Boston (Bunge et al., 2008，Morton et al., 2008)， 
Charleston bending (Gepstein et al., 2002, Price et al.’ 1990)， and 
thoracolumbosacral orthosis (TLSO) (Fernandez-Feliberti et al, 1995, Kahanovitz et 
al., 1984). The Milwaukee brace is for scoliosis patients with apex higher than T8. 
This brace consists of metal rods attached to pads at the hips, rib cage and neck. 
The Charleston bending brace is used at night for flexibility to bend the spine in 
opposite directions. Another type of brace is the underarm TLSO brace, which uses 
rigid plastic to surround the lower rib cage, abdomen and hips for apex under T8. 
Climent and Sanchez (1999) conducted a cross-sectional study to determine the type 
of bracing on self-perceived health status. One hundred and two skeletally 
immature patients with spinal deformities (75% with scoliosis) were subjected to 
different braces (Milwaukee, Boston, Charleston bending and TLSO braces) for 
routine biannual follow-up. The degree on health status was assessed by a specific 
instrument on the Quality of Life Profile for Spine Deformities (QLPSD). 
Milwaukee brace-treated patients showed a significantly higher impairment in the 
quality of life than patients treated with the other 3 braces, in terms of psychosocial 
functioning and back flexibility. In the event of different orthoses with proven 
similar effectiveness in controlling the curvatures, bracing with the lowest impact on 
the quality of life should be recommended. However, controversies still exist with 
respect to the effectiveness of bracing, especially in the different types of bracing, 
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bracing duration, type of curve, severity of curve and long term outcome. 
1.3.2. Operative Treatments 
Surgical correction was first initiated in 1914 (Hibbs，1911). It was used as the last 
resort in spinal curve correction. Before proceeding with corrective surgery, many 
factors in the patient's clinical profile have to be considered. These include the 
curve magnitude, skeletal age, curve characteristic, cosmetic appearance and 
potential risk of curve concerned. Evidently, patient preference is one of the 
important consideration on whether surgery would be performed (Greiner, 2002). 
In general, patients having a thoracic curve with an angle of over 45° Cobb and a 
high potential of progression (Clark, 2008) during adolescence would be advised to 
undergo corrective surgery. Other curve patterns would generate more problems 
due to the risk of lower back pathology and pain into the low lumbar region of the 
spine (Weinstein et al., 1981). The main purpose of corrective surgery is to prevent 
further progression and minimize curve angle, restoration of trunk balance and 
improvement on cosmetic appearance. Pehrsson et al (2001) showed that there 
was improvement in the pulmonary function of surgically-operated AIS patients. In 
the 25-year follow-up, the vital capacity of the pre-operated and operated AIS 
patients increased from 67% to 84%, respectively. The two main principles of 
surgery are: 1) using instrumentation to correct the spinal curvature and improvement 
of balance and 2) maintaining the solid bone fusion at the corrected position to 
prevent further deterioration. Corrective surgery can be achieved through posterior, 
anterior or combined approaches. The type of surgery performed would depend on 
the magnitude and stiffness of the operated curve. With documented solid fusion of 
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the spine usually within six months to one year postoperatively, the patient can then 
resume an active normal lifestyle (Bridwell et al., 1999). 
1.3.3. Complications of Treatments 
In non-operative treatments, monitoring alone can lead to bias among different 
clinicians. Different medical practices and measurements can cause 
misinterpretation of the actual curve angle (Theologis et al, 1997). With regards to 
bracing, some centers have different implications on significantly controlling curve 
progression (Karol, 2001, Milbrandt and Johnston, 2005, Sponseller et al., 2000). 
Although controversies still exist in reducing the need for surgery, promising results 
have been reported in some centers (Rigo, 2003, Weiss, 2003). Results showed a 
reduction in the frequency of surgery to 50%. Similarly, the use of bracing would 
not be effective for a curve greater than 45 degrees and the presence of significant 
thoracic lordosis. Likewise, the stiffness of the bracing might cause discomfort and 
fatigue in some patients (Gabos et al, 2004, Mac-Thiong et al., 2004, Roach, 1999). 
Spinal corrective surgery with instrumentation is a major surgery and can be 
associated with significant morbidity. As a safeguard, a thorough pre-operative 
assessment of blood clotting, radiological curve location, somatosensory 
evoked-potentials and cardiopulmonary function would usually be conducted 
(Hausmann et al., 2003, Lauder, 2007, Winkler et al., 1998). After the surgery, 
postoperative care and recovery would be needed. Most importantly, corrective 
surgery can only correct the cosmetic appearance of the curve. However, 
health-related signs and symptoms of AIS cannot be corrected (Weiss et al, 2008). 
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There are reports of curve reoccurrence and progression in the young patients until 
skeletal maturity is reached (Kesling et al, 2003, Lee and Nachemson, 1997). This 
is known as 'crankshaft phenomena'. Hence, the best way to overcome the problem 
of bracing and surgery would be to find an alternate way to treat scoliosis. In order 
to do so, it would be most essential to have a better understanding of the etiology and 
etiopathogenesis of adolescent idiopathic scoliosis. 
1.4. Additional Phenotypes Abnormalities 
1.4.1. Growth and Development 
Generally, it is recognized that the curve onset and progression in AIS are closely 
related to growth. Many studies have analyzed the anthropometry of both normal 
and AIS girls (Burwell et al., 2006, Goldberg et al, 2006, Shohat et al, 1988, Siu 
King Cheung et al., 2003，Starcevic-Klasan et al, 2008，Ylikoski, 2003). Most of 
these studies showed that AIS patients were taller and more slender than normal 
adolescents (Burwell et al, 2006, Goldberg et al., 2006, Siu King Cheung et al.， 
2003)，while some showed no significant difference (Skogland and Miller, 1981， 
Ylikoski, 2003). In a cohort study with 11 years follow up, Nissinen et al. (2000) 
showed that body height, sitting height and growth of sitting height were higher in 
pre-scoliotic children, however, this was insignificant toward development of AIS. 
Similarly, Cheung at al. (2006) demonstrated that scoliotic girls were significantly 
taller and had longer limbs than normal control after the onset of puberty. 
In order to compare growth between normal and AIS individuals, Zorab et al. (1971) 
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measured the total urinary hydroxyl proline profile excreted from normal and AIS 
children. The increase in urinary concentration would indicate a high turnover of 
bone collagen, corresponding with bone growth and repair. The results 
demonstrated a higher excretory activity in AIS patients over control, which indicate 
either an increase in bone growth or bone remodeling in AIS patients. However, 
Clark et al. (1980) measured the same parameters in 21 AIS patients and found no 
difference between the normal control and AIS patients. Also, fluctuation in growth 
hormone has been mentioned to be a causative factor in the development of AIS. 
Controversial findings have been established from different centers of investigations. 
Willner et al (1976) found a higher basal growth hormone and somatomedin-A in 
serum samples of AIS patients compared with controls. However, other authors 
failed to demonstrate any substantial difference in these two indicators in AIS 
patients and healthy controls (Misol et al., 1971，Spencer and Zorab, 1977). 
Although much of the findings seemed conflicting among different centers, it is a 
fact that AIS patients are generally taller and more slender than normal controls. 
This could indicate a faster growth pattern in AIS patients, whose spine is longer and 
slimmer, and more prone to the development of scoliosis. 
1.4.2. Delay Sexual Maturation 
Characterization of normal puberty in adolescents can be indicated by chronological 
age, height and weight variation, skeletal growth and sexual maturation (Sanders et 
al., 2007). Idiopathic scoliosis progression in adolescence has been closely related 
to patient maturity status (Burwell, 2003， Goldberg et al., 1993). The most 
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commonly used indicators for assessing maturity in scoliosis include Risser signs, 
chronological age and the age at menarche. Although the stage of ossification of 
the iliac apophysis, or Risser sign, is most commonly used for determining skeletal 
maturation in AIS patients, it has been shown to be poorly correlated with the curve 
progression phase (Izumi, 1995). Thus, in choosing the type of indicator, it should 
be easily detected by orthopedic surgeons and correlate significantly with curve 
progression. 
In 1993, Goldberg et al. (1993) conducted a study to compare the pubertal growth 
spurt of Irish AIS girls. The age of menarche in AIS girls was shifted significantly 
0.39 years earlier than the national mean for Irish girls. In terms of addressing 
progression, it was found that the group with early menarche tends to have a stable 
curvature. However, those with a late onset of menarche, at the age of 13.83 years, 
tended to progress. Similarly, other findings also showed similar interpretations of 
early menarche in AIS girls (Ahl et al., 1988), Although there was a significant 
difference in that AIS patients had a taller height at the time of diagnosis, the 
difference between the AIS patients and control disappeared upon maturation. On 
the contrary, Warren et al. (1986) found that ballet dancers with scoliosis had a late 
onset of menarche and were taller than healthy controls. However, this finding was 
criticized the ground that on ballet dancers represented only a minority of the 
scoliotic population (Goldberg et al.’ 1993). Likewise, it is likely that ballet 
dancers would escape from the early screening test to prevent bracing, as it would 
end their dance life. Hence, ballet dancers with AIS would likely be screened with 
a late menarche. Implications of an early onset of menarche matched with the 
clinical observations that AIS girls are taller and slender, yet stronger evidences are 
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still needed for this being an absolute growth disturbance. 
1.4.3. Osteopenia 
Association of osteopenia with AIS was first reported by Wynne-Davies (1968) in 
UK from a family survey. Similar observations were reported by different authors 
(Burner et al, 1982, Cheng and Guo, 1997, Cook et al, 1987a, Thomas et al, 1992, 
Wynne-Davies, 1968). Low bone mineral density was reported in AIS patients 
from different part of the world (Carter and Haynes，1987, Cheng and Guo, 1997， 
Matzen et al., 1984). However, there is no evidence on association with regional or 
ethnical specificity. Current clinical evaluations on BMD include single-energy 
photon absorptiometry (SPA) (Runge et al., 1980, Weinstein et al., 1991)， 
quantitative computed tomography (CT) (Cheng et al, 2006, Yeung et al, 2006) and 
dual-energy x-ray absorptiometry (DXA) (Cheng and Guo, 1997，Hung et al, 2005). 
Cheng et al. (1997，，1999a) have clearly demonstrated the presence of low BMD in 
female AIS patients. In the cross-sectional study, assessment was conducted on the 
lumbar spine and proximal femoral BMD with DXA in 81 AIS girls (Cheng et al., 
1999a). In all the measured regions, the AIS patients were found to have a lower 
BMD between 6.9 - 30.4%. In addition, Cheng et al. (1999a) found that in 33.3% 
and 20.1% of the 71 AIS patients, the proximal femoral BMD was 1 SD and 2 SD 
below age- and sex-matched normal healthy controls, respectively. 
Past indications have shown the reduced BMD of premenopausal female adults with 
a past history of AIS (Cheng and Guo, 1997, Cook et al., 1987c). This suggested 
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that osteopenia might be a persistent problem in AIS patients. Cheng et al. (1999a) 
conducted a follow-up study of the BMD of 14 AIS patients of more than 2 SD 
below the mean normal value. Assessment was carried out by DXA with follow-up 
as long as 3 years longitudinally. Comparing the BMD of the AIS patients at initial 
and follow-up evaluation, the z-score decreased from -2.96 to -3.84. This indicated 
a significant difference in the rate of increase of the femoral neck BMD (1:2) 
between AIS patients and age-matched controls. There is a chance that the lower 
BMD in AIS would persist and manifest possibly into osteoporosis in adulthood. 
Cheng et al. (1997) and Cook et al. (1987b) reported no difference in the proximal 
femoral BMD of the two hips between AIS patients and normal healthy controls. 
This disproved the lower femoral BMD in AIS being secondary to the spinal 
deformity and the asymmetrical mechanical loading of the hips and spine. Likewise, 
a cross sectional, case control study failed to indicate bracing during growth could 
affect the BMD (Snyder et al.’ 2005, Snyder et al, 1995). In addition, Hung et al. 
(2005) conducted a prospective study on 324 AIS female patients with BMD profile 
of the spine and both hips. Longitudinal measurements on BMD were conducted 
on these patients until they reached skeletal maturity or curve progressed greater than 
6®. By using complicated statistics, the prevalence of curve progression could be 
predicted. This demonstrated that the measurement of BMD, at the time of 
diagnosis, may serve as an additional objective measurement in predicting curve 
progression in AIS. 
Intrinsic factors have been known to affect skeletal development and BMD in AIS 
(Krall and Dawson-Hughes, 1993). Sexual maturation has shown a significant 
relationship between early menarche and higher peak bone mass (Slemenda et al, 
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1994). There is speculation that the mechanically weakened spinal column in the 
potential osteopenic patients may be inclined to scoliosis development during the 
rapid growing peri-pubertal period. There is strong evidence that intraskeletal 
mechanisms may participate in the pathogenesis of AIS (Cheng et al., 1999a). 
Further studies on the regulation of endochondral and membranous bone formation 
would be needed to elucidate the etiological role of osteopenia in AIS. 
1.5. Bone Modeling and Remodeling in Adolescents 
The human endoskeleton is made up of rigid bone tissues, which is comprised of 
cortical and trabecular bone. The cortical bone, or compact bone, is a rather dense 
tissue with mass penetration by blood vessels through a network of canaliculi. 
These can be found in the shaft of long bones. While the trabecular bone, or 
cancellous bone, is porous and located near joint surfaces at the end of long bones 
and within the vertebrae. To ensure a healthy metabolism on bone quality, old bone 
from the skeleton would be removed (bone resorption) with new bone being 
generated (bone formation). This process is known as bone remodeling. These 
processes also control the reshaping or replacement of bone during growth and 
following injuries. Imbalance in the regulation on the bone modeling and 
remodelingcan result in different metabolic bone disease such as osteoporosis. 
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1.6. Bone Development 
1.6.1. Endochondral Ossification 
Endochondral ossification, or intracartilaginous ossification, could be defined as one 
of the two processes during fetal development of the mammalian skeletal system in 
which bone tissue is created. This process is necessary for the rudimentary 
formation of long bones (Forriol and Shapiro, 2005)，growth in length of long bones 
(Brighton et al.’ 1973) and healing of bone fractures (Brighton and Hunt, 1986). 
Vertebral growth can also be accounted for by endochondral ossification at the two 
epiphysial growth plates on the upper and lower surfaces of the vertebral body 
(Knutsson, 1966, Roaf，1960). The primary site of ossification begins at the middle 
of diaphysis (shaft) (Martin et al., 1998). Under vascularization, the perichondrium 
becomes the periosteum, which would later differentiate into osteoblasts. During 
this process, there is a rich secretion of collagen and other proteoglycans found 
around the site of ossification. The formed osteoblasts would then secrete osteoid 
against the shaft of the cartilage to become a support for the new bone. 
Hypertrophic chondrocytes would begin to migrate toward the midsection of the 
ossification center, with secretion of alkaline phosphatase. Likewise, the 
hypertrophic chondrocytes would secrete VEGF to induce the sprouting of blood 
vessels in the perichondrium. The newly formed blood vessel would carry the 
hemopoietic cells (which further differentiate into bone marrow cells), 
osteoprogenitor cells (which further differentiate into osteoblasts cells) and other 
cells into the cavity. With the occurrence of apoptosis to the hypertrophic 
chondrocytes, the calcification of the matrix occurred to create a cavity within the 
bones (Sawae et al.，2003). The osteoprogenitor-differentiated osteoblasts would 
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use the calcified matrix as a scaffold to secrete osteoid, which is composed mainly of 
Type 1 collagen, to form the bone trabecula. At the end, osteoblasts would break 
down the spongy bone to form the medullary cavity. During puberty, various 
regulators would interact in endochondral ossification toward growth. These 
factors include growth hormone (GH), insulin-like growth factor 1 (IGF-1), 
parathyroid hormone (PTH) and PTH-related protein (PTHrP) (Van Wyk and Smith, 
1999). Both GH and IGF-1 would account for all the stages of differentiation by 
stimulating the growth plate through the specific receptors (Robson et al, 2002). 
While PTH is intimated involved in the formation and activation of osteoclasts 
(Aubin and Bonnelye, 2000), it potentially stimulates de novo synthesis of IGF-1 in 
osteoblasts (McCarthy et al., 1989). 
1.6.2. Membranous Ossification 
Intramembranous ossification is the other process during fetal development of the 
mammalian skeletal system in which bone tissue is created. Similar to 
endochondral ossification, it is an essential process for healing bone fractures 
(Brighton and Hunt, 1991) and the formation of bones of the skull (Morimoto et al, 
1987). The process can be characterized by mesenchymal cells, in the membrane 
forming osteochondral progenitor cells. They eventually will specialize to become 
osteoblasts cells. The secretion of bone matrix from the osteoblasts would surround 
the nearby collagen fibers to become osteocytes. Then, the process of trabeculae 
formation would develop which then entrap the osteoblasts to form a spongy cell. 
Cells in the spongy area would further specialize into red bone marrow, while the 
cells surrounding the developing bones would become periosteum (Hall and Miyake, 
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1992). Finally, osteoblasts from the periosteum on the bone matrix will produce 
compact bone (Martin et al.’ 1998). Previous studies have identified important 
factors contributing to membranous ossification, including bone-specific 
transcriptional modulator core binding factor-1 (CBFA-l) (Ducy et al.’ 1997)，Indian 
hedgehog (Ihh) (St-Jacques et al, 1999), distalless homeobox 5 (Dlx5) (Acampora et 
al., 1999) and twist homolog (TWIST) (el Ghouzzi et al, 1997). Although these 
various factors have been shown to regulate membranous ossification, the complex 
interaction between bone formations in conjunction to endochondral ossification is 
not fully understood. 
1.7. Bone (re)modeling by osteoclasts and osteoblasts 
The bone modeling and remodeling processes are quite similar at cellular level. 
These are mainly based on the interactions between osteoclasts (bone resorbing cells) 
and osteoblasts (bone forming cells). The remodeling process begins at the 
quiescent bone surfaces with the appearance of large multinucleated osteoclasts 
(Vaananen and Horton, 1995). They would attach to the bone matrix tissue to form 
a ruffled border at the interface between the bone and osteoclasts layer, creating an 
isolated microenvironment. Subsequently, the osteoclast would acidifies the 
microenvironment and dissolves the organic and inorganic matters of the bone matrix 
(Vaananen et al., 2000). This process is known as bone resorption. With the 
resorptive process ceased, osteoblasts would appear in the same surface. 
Osteoblasts are derived from mesenchymal stem cells found in the bone marrow, 
periosteum and soft tissue. They would deposit osteoid to mineralize the surface 
and form new bone, while some of these osteoblasts are encapsulated in the osteoid 
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matrix to differentiate into osteocytes. Remaining osteoblasts continue to 
synthesize bone until they eventually stop and transform into quiescent lining cells 
that completely cover the newly formed bone surface. These lining cells are highly 
interconnected with the osteocytes in the bone matrix through a network of canaliculi 
(Lian and Stein, 2001). 
The close relationship between osteoclasts and osteoblasts in the remodeling process 
has been known as "Basic Multicellular Unit" (BMU) (Frost, 1964). This concept 
indicates that a coupling mechanism must exist between formation and resorption, 
with the mechanism remains uncertain. The organization of the BMU's in cortical 
and trabecular bone differs, but these differences are mainly morphological rather 
than biological. In the cortical bone, the BMU would form a cylindrical canal 
thatgradually burrows through the bone, with the tip (consisting of osteoclasts) 
digging circular tunnels (cutting cone) in the dominant loading direction (Petrtyl et 
al.，1996). This is followed by filling of the tunnel by osteoblasts (closing cone) to 
produce a (secondary) osteon of renewed bone (Parfitt, 1994). With this repeated 
process, about 2% and 5% of cortical bone can be remodeled each year (Parfitt, 
1994). Remodeling process of trabecular bone in contrast, occurs mainly on the 
surface. With much larger surface to volume ratio, this process is intensely more 
active than cortical bone, with the rate up to 10 times higher (Einhorn and Lee, 2001). 
Similarly, osteoclasts would be the first to migrate into the process. Like the 
process in cortical bone, this is quickly followed by bone formation. As the 
trabecular BMU is a half cortical BMU, the resulting structure that is formed is 
called a trabecular osteon or hemi-osteon (Frost, 1986, Kassem et al, 1992). The 
cellular activities of osteoclasts and osteoblasts in modeling are basically similar to 
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those in remodeling. However, in this case formation and resorption are not 
balance, the activities of osteoclasts and osteoblasts can also be completely 
uncoupled thus leading to changes in the micro-architecture of the trabecular bone.. 
Indeed, complete unloading may cause resorption that is not followed by formation 
(Mosekilde, 1990). Nevertheless, bone formation does not necessarily be preceded 
by resorption. It was also observed that the lining cells at the bone surface can 
transform back to bone forming osteoblasts (Chow et al., 1998, Dobnig and Turner, 
1995). 
1.8. Factors Affecting Osteoblasts Regulation 
The process of initiation, differentiation and apoptosis of osteoblasts are affected by 
many systemic hormones and local factors. These include gonadal steroids 
(estrogen and androgens), PTH/PTHrP, bone morphogenetic protein (BMP), and 
fibroblast growth factors (FGFs), that have been widely discussed and reviewed 
(Komori, 2006, Lian et al., 2006，Matsubara et al, 2008, Nishimura et al, 2008, 
Tenta et al” 2006). Other than these, many new confounding regulators are 
continuously discovered. 
1.8.1. Insulin-like Growth Factor T^pe 1 (IGF-1) 
GH can affect bone size and mass through stimulating IGF-1 production in liver and 
bone. GH exerts many of its effects by stimulation of IGF-1 (Sotiropoulos et al., 
2006). IGF-1 is a small polypeptide with homology to pro-insulin that is produced 
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by a number of cell types. IGF-1 signals via the IGF-1 receptor (IGF-IR)，engaging 
extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (P13K) 
pathways through Src homology 2 domain-containing proteins and insulin receptor 
substrates-1 and 2 (Dietrich et al, 2000, LeRoith, 2000). The function of IGF-1 
was shown to induce proliferation of MC3T3 osteoblast-like cells (Merriman et al., 
1990) and is an important survival factor for many mammalian cell types, including 
osteoblasts. In mice, targeted overexpression of IGF-1 accelerates new bone 
formation and increases the rate at which matrix is mineralized (Zhao et al., 2000), 
whereas osteoblast-specific disruption of the IGF-IR causes markedly impaired 
mineral apposition rate and increased mineralization lag time (Zhang et al., 2002). 
However, it has been difficult to precisely define discrete actions of each of these 
factors. 
1.8.2. Interleukin-6 (IL-6) 
This is a multifunctional cytokine that can activate target genes involved with 
proliferation, differentiation and apoptosis in a variety of cells (Kishimoto et al., 
1995). The effect occurs after binding to its transmembrane receptor (IL-6 receptor 
or alpha receptor) and the signal inducer gpl30 (beta receptor). This 
receptor-ligand interaction activates the receptor-bound Janus kinase (JAK). The 
phosphorylation of the tyrosine residues of the cytoplasmic tail of the beta receptor 
by JAK will be followed by recruitment of signal transducers and activator of 
transcription (STAT). Further phosphorylation of STAT would generate the 
formation of STAT-protein dimers that migrate to the nucleus and initiate gene 
transcription. In bone, the production of IL-6 can be found in many types of cells, 
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such as osteoblasts, mononuclear phagocytes, endothelial cells, chondrocytes, 
fibroblasts and lymphocytes (Heymann and Rousselle, 2000, Littlewood et al., 1991). 
An imbalance or over-expression of IL-6 can result to osteoporosis, rheumatoid 
defects and accelerated bone turnover (Ershler and Keller, 2000，Hoyland et al., 
1994). In addition, transgenic mice with over-expression of IL-6 would resulted in 
severe skeletal defects including osteopenia, defective ossification and abnormality 
in the growth plate (De Benedetti et al, 2006). These findings indicate the 
importance of IL-6 as a regulator of bone remodeling and its role toward bone 
homeostasis. However, extensive studies would be needed to better understand the 
mechanism of action, as the relation between osteoblasts and IL-6 remains unknown. 
1.9. Current Hypothesis on the Etiology of AIS 
1.9.1. Abnormalities in Skeletal Development 
Up to date, there is no single explanation for the cause of idiopathic scoliosis. 
Theories on abnormal bone growth and skeletal disproportion have been related to 
the pathogenesis of AIS (Guo et al, 2003). Guo et al (2003) conducted a study to 
demonstrate such observation. It was reported that the AIS girls had longer 
vertebral bodies and shorter pedicle height between T1 and T12 vertebrae when 
compared with normal controls. Moreover, another study (Siu King Cheung et al, 
2003) showed that many differences in anthropometry were revealed in a comparison 
of 598 AIS girls with 307 healthy controls. Such significant differences included 
shorter body height, corrected height, arm span, sitting height and leg height. 
Burwell et al (2006，，2008a, , 2008b, Nicolopoulos et al, 1985) proposed that the 
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difference in AIS is significant based on anthropometric measurements. 
1.9.2. Genetic Factors 
Although specific etiology of AIS remains undefined, the role of hereditary or 
genetic factors in the curvature development is widely accepted (Axenovich et al., 
1999，Chan et al., 2002, Justice et al., 2003, Kesling and Reinker, 1997, Riseborough 
and Wynne-Davies, 1973, Salehi et al., 2002). Clinical observations and 
longitudinal studies have documented a higher incidence of scoliosis occurring 
within families and relatives, as opposed to the general community (Miller, 2007， 
van Rhijn et al, 2001). It has been consistently shown that the occurrence of 
scoliosis is higher in monozygous twins (Kesling and Reinker, 1997, Weiss, 2007) 
and those with reported scoliotic first degree relatives (Czeizel et al., 1978，Miller, 
1999，Riseborough and Wynne-Davies, 1973). Despite the documentation on the 
familial prevalence in AIS, the mode of inheritance remains subjective. In a wide 
variety of population studies, some authors suggested this occurrence is an autosomal 
dominance or sex-linked inheritance. However, other states the inheritance would 
be multifactorial in explaining the wide spectrum of scoliosis occurrence among the 
individuals of affected families. 
In early studies, Wynne-Davies et al. (1968) screened first to third degree relatives of 
114 AIS patients. Their findings indicated a possible dominant or multiple gene 
inheritance for the occurrence of scoliosis. In addition, Robin et al. (1975) showed 
that scoliosis occurred in 15 members of a family for three successive generations. 
Studies associated with twins often showed the presence of idiopathic scoliosis (Carr, 
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1990，McKinley and Leatherman, 1978, Weiss, 2007). In contrast, De George and 
Fisher (1967) conducted a questionnaire study of 1378 AIS patients for determining 
whether there is a predictable mode of inheritance. The study concluded that there 
was not enough evidence on the mode of AIS being inherited. However, this study 
had not examined the X-rays of all the scoliotic family members, who might be 
unaware of having mild scoliosis. In a more recent study, Miller et al. (2006) 
performed a genomic screening and statistical linkage analysis of 202 families with 
at least two individuals diagnosed with idiopathic scoliosis. In the linkage analysis, 
several candidate regions for AIS, with one reported chromosome similar to a 
previous report, was identified (Chan et al., 2002). However, the author failed to 
find any disorder among the structural genes encoding for elastin and type I collagen. 
Hence, previous reports (Sharipov et al, 2006， Zaidman et al.’ 2006) on the 
association between familial AIS and aggrecan gene remained questionable. 
Although the role of genetic factors in the development of AIS is widely accepted, 
the specific mode of inheritance has not been resolved. More recently, analysis on 
sporadic idiopathic scoliosis was conducted in search of a possible candidate gene 
(Cheng et al, 2007， Giampietro et al, 1999). However, difficulties in clinical 
definition and environmental factors increase the variability in the onset of the 
disease. Most importantly, it is clear that a larger patient population would be 
needed to possibly identify the role of genetic factors toward the etiopathogenesis of 
this disorder. 
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1.9.3. Neuromuscular Impairment 
Clear evidences on abnormal somatosensory-evoked potentials (SSEP) (Cheng et al, 
1998a, Harrington, 1977) and tonsilar ectopia from magnetic resonance imaging 
(MRI) (Cheng et al, 1999b, Chu et al., 2007) have been reported. Among the 135 
subjects diagnosed with AIS, it was found that about 4% would develop 
syringomyelia, with a higher incidence in males. Toward low-lying cerebellar 
tonsil, Chu et al. (2007) reported that 42% of the 69 AIS subjects had tonsilar trips 
below the basionopisthion reference line (BO line). Likewise, the regional brain 
volume was significantly different between AIS patients and age-matched control 
(Liu et al., 2008). In this study, 10 out of 22 measured regions were larger in AIS 
patients than control, while the remaining regions were smaller. Similarly, Chu et 
al. (2006) reported spinal cord tethering in severe AIS patients that resulted from the 
immense curvature. This suggested a disproportionate growth between the neural 
system and skeletal development of AIS. These findings provide a possible 
explanation for the poor performance in visual testing and impaired balance reported 
in AIS patients. 
It is a common understanding that stability of the spine depends on the interaction 
between intrinsic factors (bone, facet joints and ligaments) and extrinsic factors 
(muscle force, elasticity of tendons) (Hosman, 2003). Many diseases affecting 
muscles or their functions tend to associate with the occurrence of secondary 
scoliosis deformity (Aprin et al, 1982, Hsu, 1983, James, 1956, Robin, 1972). 
Likewise, muscle imbalance has been associated with the etiology of AIS (Fidler and 
Jowett, 1976, Riddle and Roaf，1955). As far as the 19th century, Adams (1882) 
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conducted a postmortem investigation of AIS patients and found muscle hypertrophy 
at the convex side and atrophy at the concave side of the curvature. This finding 
suggested muscle force could play a role in preventing spinal progression, rather than 
inducing it. Histochemical studies have also been conducted on the paraspinal 
muscle in AIS patients (Cheung et al., 2004). In France, a study demonstrated that 
the middle and deep dermis muscle of AIS was significantly different from normal 
healthy subjects (Echenne et al, 1988). Similarly, Cheng et al. (2001) found a 
lower expression of glycoproteins in the iliac crest biopsies from AIS patients. 
Both studies demonstrated a difference in anatomical structure in AIS patients. In 
another study, Moreau et al. (2008) isolated messenger RNA from paraspinal muscle 
intraoperatively from AIS patients. Expression analysis showed that the left 
restricted genes were more expressed on the right side. This observation can 
explain the prevalence of the right thoracic curve over the left curve. However, to 
an extent, the impaired muscle development is likely a secondary cause of spinal 
deformity, rather than a primary one. 
1.9.4. Hormone Dysfunction 
Many related issues have linked hormone dysfunction with the etiopathogenesis of 
AIS. Hormones studied include growth hormone, leptin and melatonin. A study 
by Wilner et al .(1976) found higher plasma growth hormone and serum 
somatomedin A levels in AIS girls than age-matched controls. The same group 
(Dymling and Willner, 1978) found that treatment of AIS patients with growth 
hormone over a 10-week period would create a higher curve progression and on the 
termination of treatment, curve progression could be deferred. A similar finding on 
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associating growth hormone with AIS patients was conducted by Skoglund and 
Miller (1980). They found a significantly higher growth hormone release 
mechanism in prepubertal girls diagnosed with AIS. On the contrary, a study in 
Sweden (Ahl et al, 1988) did not detect any difference in the growth hormone level 
of AIS girls in pubertal stages 3 and 4 from the matched control. However, 
difference was found between AIS girls at pubertal stage 2 and the control. Qiu et 
al. (2007b) revealed that the growth hormone receptor did not appear to be a 
predisposing gene or disease modifier gene in AIS. These studies raised further 
concerns on whether growth hormone does play a crucial role in the etiology of AIS. 
Another hormone of great interest toward AIS is leptin. A study reported a marked 
decrease in circulating leptin level in AIS girls from a comparison of 120 AIS girls 
with 80 healthy controls (Qiu et al, 2007c). In analyzing the results, leptin was 
positively associated with body weight, BMD, body mass index (BMI) and other 
growth parameters. Similarly, Burwell et al. (2008a) hypothesized that leptin 
would influence the BMI and skeletal maturation in AIS. However, there is still a 
lack of related in-depth studies on the relationship between leptin and the 
etiopathogenesis of AIS. Most recently, melatonin deficiency has been widely 
linked with the occurrence of AIS. Melatonin is a hormone secreted primarily from 
the pineal gland. Further discussion on this hormone would be given in the 
following section. 
1.10. Melatonin 
N-acetyl-5-methoxytryptamine (melatonin) is a hormone secreted primarily from the 
pineal gland. It was first discovered by Aaron Lerner and his colleagues in 1958 
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(Lerner et al., I960). Melatonin (Figure 1.4) is a hormone found in all living 
organisms, including non-mammalian vertebrates, some invertebrates, and in many 
plants (Hardeland and Poeggeler, 2003， Pandi-Perumal et al, 2006). It is 
biosynthesized from biochemical pathway (Figure 1.5). The amino acid tryptophan 
is first converted by tryptophan hydroxylase to 5-hydroxytryptophan. Next, 
5-hydroxytryptophan is further decarboxylated to serotonin. The synthesis of 
melatonin by serotonin is governed by two main rate-limiting enzymes; 
arylalkylamine-A^-acetyltransferase (AA-NAT) and hydroxyindole-O-
methyltransferase (HIOMT), which is mainly produced in the pineal gland (Axelrod 
and Weissbach, 1960， Coon et al.’ 1995). Other organs producing melatonin 
include retina, extraorbital lacrimal gland, Harderian gland, gastrointestinal tract, 
blood platelets and bone marrow cells (Pandi-Perumal et al., 2006). Metabolism of 
melatonin occurs mainly in the liver, in which it is hydrolyzed to 
6-hydroxymelatonin. Then, it is excreted in the urine as 6-sulfatoxymelatonin 
(Lynch et al., 1975). 
The synthesis and release of melatonin by the pineal gland are stimulated by 
darkness and inhibited by light (Lowe et al.’ 2000). Without light, the unpolarized 
photoreceptors release norepinephrine to highly activate a number of adrenergic 
receptors in the pineal gland (Panged et al., 1990). This onset stimulates the 
AA-NAT enzymatic activity to synthesis and release melatonin into the bloodstream, 
by passive diffusion (Pangerl et al, 1990). In addition, light does not cause the 
timing but entrains it (Brzezinski, 1997). The function of light can only modify the 
diurnal cycle for melatonin secretion, or abruptly suppresses the production (Lewy et 
al.’ 1980). The melatonin threshold is between 200-400 lux, while intensity higher 
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than 600 lux would cause maximal inhibition (Mclntyre et al, 1989). However, 
seasonal variations of a longer summer (Lowe et al” 2000) and increase in the age of 
an individual (Lynch et al., 1975) would also cause drastic depression in melatonin 
production. 
In 1994，the cloning of melatonin receptors in mammals was first reported (Reppert 
et al, 1994). In mammals, mainly two types of membrane-bound 
melatonin-binding sites have been identified: MLl (high affinity) and ML2 (low 
affinity) receptors. Activation of MLl receptors is responsible for the inhibition of 
adenylate cyclase activity in target cells (Ebisawa et al, 1994，Turek and Gillette, 
2004). With the use of polymerase chain reaction, two further subtypes of MLl 
receptor were cloned in humans: MTl and MT2 receptors (Reppert et al, 1995, 
Reppert et al., 1994). These two membrane receptors mediate several major actions 
of melatonin. Belonging to the G-protein coupled receptors superfamily, MTl 
receptors activate protein kinase C-b. At the same time, the MT2 receptors would 
inhibit the guanylate cyclase pathway and stimulate protein kinase C (Reppert et al, 
1995, Reppert et al., 1994). In the example of a rodent's brain, the widespread 
occurrence of MTl receptors indicates the majority for melatonin-binding sites. 
Likewise, the lower expressions of MT2 receptors demonstrate a minor action, and 
independence to photoperiodic response (Reppert et al, 1995). This hormone is 
involved in many regulations including embryo development (Chan and Ng，1994a, 
Chan and Ng, 1994b), cardiac monitoring (Ghosh et al.’ 2007), circadian rhythm 
(McArthur et al., 1997，Redman et al, 1983)，sexual maturation (Silman et al., 1979, 
Sizonenko et al., 1985)，aging (Armstrong and Redman, 1991, Sandyk, 1990)，tumor 
malignancy (Hill and Blask, 1988，Lissoni et al., 1994，Panzer, 1997’ Shiu et al., 
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2003, Yang et al., 2007) and bone growth (Ladizesky et al, 2003, Nakade et al, 
1999， Ostrowska et al.’ 2003). In this study, it will focus on the relation of 
melatonin with bone development. 
1.10.1. Melatonin and Bone-reiated Studies 
In the early 90's, melatonin was believed to be associated with bone metabolism. 
Although without any compelling evidence, it was suggested that melatonin might be 
a possible remedy in reducing the rate of osteoporosis in menopausal women 
(Sandyk et al.’ 1992). The idea originated from the observation that osteoporosis 
occurred most rapid at menopause, in which melatonin and other hormones decline 
briskly in level with dramatic decrease in bone turnover rate. Other studies have 
suggested an association of age progression and decreasing level of melatonin (Grad 
and Rozencwaig, 1993, Rozencwaig et al., 1987). In these studies, the use of 
melatonin was proposed as a possible treatment for improving bone health. Some 
studies suggested prescription of melatonin for enhancing bone growth in spinal 
fusion (Abdel-Wanis and Kawahara, 2002). 
In a study related to medication for preventing osteoporosis at the menopausal age, 
Ladizesky et al (2001)used ovariectomized rats to assess the changes in urinary 
deoxypryridinoline, calcium excretion, blood levels of calcium, phosphorous, and 
bone alkaline phosphatase. In addition, they evaluated BMD, BMC and BA of the 
entire skeleton after melatonin treatment (250 |ig/mL) through drinking waters. 
After 30 days, the untreated group showed an increase in urinary deoxypryridinoline 
that was not found in the melatonin-treated group. Serum phosphorous and bone 
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alkaline phosphatase had increased significantly in the melatonin-treated groups at 
15 days after surgery. However, the BMD, bone mineral contents (BMC) and bone 
area (BA) were decreased in both the melatonin-treated group and untreated group 
60 days after surgery. In another study (Ladizesky et al., 2006), male rats were 
treated with melatonin or methylprednisolone, a synthetic glucocorticoid agent, or 
with a combination of the two. After 10 weeks, rats treated with either melatonin or 
methylprednisolone had significantly stimulated BMD, BMC and BA. From these 
studies, it is evident that melatonin can reduce bone resorption and possibly prevent 
bone damage. 
1.10.2. Pinealectomized and Bipedal Scoliotic Animal Model 
In the early 1959, Thillard first reported that the removal of the pineal gland, also 
known as pinealectomy (PINX), can produce scoliosis in chickens (Thillard, 1959). 
As introduced previously, the main secretory product of the pineal gland is melatonin. 
By removing the pineal gland from chicken, they could produce post-operative spinal 
curvature, similar to that in AIS patients. This phenomenon brings forth a 
hypothesis which associates melatonin with the occurrence of AIS. 
However, the occurrence of scoliosis varied widely from PINX alone (Table 1). 
PINX alone was not able to induce scoliotic curvature in rats unlike the avians 
(O'Kelly et al, 1999). This led to the theory that the quadrupedal movements of the 
rats do not create the much needed pressure as the bipedal movements of the chicken. 
Machida et al (1999) decided to confirm this theory. In this study, they created a 
few groups of rats: sham-operated bipedal, PINX quadrupedal, PINX bipedal and 
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PINX with implanted melatonin pellets. Three months after surgery, only PINX 
bipedal rats developed scoliosis similar to that of PINX chicken. Importantly, 
treatment with the melatonin pellet prevented 90% (9/10) of the PINX bipedal rats 
from developing scoliosis. However, Cheung et al. (2005) were not able to show 
the relation between pinealectomized non-human primates and the development of 
scoliosis. In the 29 months post-operative follow-up, 10 out of 18 rhesus monkeys 
have a significant loss in melatonin secretion, while none developed scoliosis. Yet, 
this finding was criticized for the limited area of movement to allow the monkeys to 
move freely or stand upright naturally on inducing the vertebral stress (Reiter et al, 
2007). Nevertheless, these findings do suggest that postural processes and 
melatonin deficiencies are crucial factors in weakening the vertebral column to 
induce scoliosis formation. 
1.10.3. Natural Melatonin Deficient Model, C57BL6J 
Recently, a study with melatonin-deficient mice (C57BL/6J) showed that the lack of 
melatonin in rodent would be associated with the development of scoliosis. It has 
been shown that the C57BL/6J strain mice have a natural melatonin deficiency due to 
the reduce enzymatic rate of melatonin synthesis by the knock-out of the AA-NAT 
gene during initial mating (Ebihara et al., 1986). The mice lack the AA-NAT gene, 
a key enzyme for the production of melatonin from serotonin, exhibiting a depressed 
melatonin level in plasma and pineal gland compared with other inbreed species of 
mice. In addition, numerous studies have shown this mouse to have the lowest 
BMD among the inbred strains of mice (Chen and Kalu, 1999, Dimai et al., 1998, 
Richman et al, 2001，Sheng et al, 1999，Turner et al., 2001). Hence, this makes it 
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an ideal model for assessing the effect of melatonin with bone formation in vivo. 
Machida et al. (2006) attempted to study the relation of melatonin-deficiency and the 
occurrence of scoliosis by utilizing this strain of mouse together with the 
surgically-induced bipedal to assess the rate of development of scoliosis and the 
effect of daily injections of melatonin (8 mg/kg) in reversing scoliosis development. 
After treatment for 5 months, the mice were sacrificed and the spine was examined 
by X-ray and 3D CT. Nearly 100% of the melatonin-deficient bipedal mice (Figure 
1.5) developed spinal deformity, while a quarter of the quadrupedal model naturally 
developed scoliosis (Table 1.2). In both groups of mice, daily melatonin treatment 
prevented scoliosis development. 
In line with the previous study, the same team extended their study with this unique 
mouse (Oyama et al.’ 2006). They removed the forelimbs of these mice, without 
performing PINX, and produced scoliosis at a higher rate (Table 1.3). As the 
control, they removed the forelimbs of another type of mice, C3H/HeJ (a melatonin 
proficient mice), without pinealectomy. The rate of scoliosis occurrence was 
two-fold less than the bipedal C57BL/6J mice. However, once PINX was also 
performed in the bipedal C3H/HeJ mouse, the prevalence of scoliosis rose to 70%. 
The finding demonstrated that spinal malformations would occur in combined 
melatonin deficiency and bipedal amputation. 
1.10.4. Effects of Melatonin in Osteoblasts 
There are very few reports showing the effect of melatonin in osteoblasts in the 
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current literatures (Nakade et al, 1999, Roth et al, 1999, Satomura et al., 2007). 
Roth et al. (1999), were first to report the effect of melatonin toward two rodent 
osteoblastic cell lines (MC3T3-E1 and ROS 17/2.8). The results suggested that 
melatonin may play little or no role in the osteoblasts' proliferation. However, 
melatonin promoted cell differentiation and stimulated mineralization. In contrast, 
Nakade et al. (1999) reported melatonin's ability to enhance proliferation in normal 
human osteoblasts. However, there was no effect on differentiation. Because 
these two findings contradict each other, the effect of melatonin on osteoblasts 
remains controversial. 
In a more complete study, Satomura et al. (2007) demonstrated the dose-dependent 
stimulation of melatonin in proliferation, alkaline phosphatase activity and rate of 
mineralization in normal human osteoblasts. Likewise, the presence of MTl 
expression was confirmed by real-time polymerase chain reaction (RT-PCR) and 
western blotting analysis. Also, the author found a linear correlation with an 
increase in age and decrease in MTl expression. In the same study, intraperitoneal 
injections of melatonin (100 mg/kg/day) were given to a group of mice for 21 days to 
assess bone formation by immunohistology. Interestingly, melatonin was able to 
increase the bone volume and newly formed cortical bone in the femurs of the mice. 
As for osteoblasts are derived from mesenchymal stem cells (MSC), the study (Radio 
et al., 2006) demonstrated an increase in alkaline phosphatase (ALPase) activity after 
melatonin treatment. These observations (Nakade et al., 1999，Radio et al., 2006， 
Roth et al.’ 1999，Satomura et al., 2007) further suggested the enhancement effect of 
melatonin on bone cells. 
- 3 3 -
1.10.5. Melatonin in AIS 
At present, the causes of AIS remain uncertain and are probably multifactorial. 
There is currently no proven prognosis to identify children or adolescents with AIS. 
Current reports targeted associations with the pathogenic attribute (Hung et al, 2005) 
rather than the etiological factors. With the many suggestions concerning the 
etiology of AIS, melatonin may play an essential role in the pathogenesis of 
scoliosis. 
The resemblance in spinal deformity and reduced melatonin level of PINX chicken 
led to the relation of melatonin-deficiency and the occurrence of AIS (Bagnall et al, 
1999, Dubousset and Machida, 2001, Machida et al, 1995，O'Kelly et al., 1999). 
Machida et al (1996) conducted a study to determine any difference in serum 
melatonin level between AIS patients and normal healthy control. Significant 
difference was found in a comparison of progressive AIS patients with control and 
non-progressive AIS patients. However, there was no difference in the serum 
melatonin level between the normal control and non-progressive AIS patients. 
Likewise, other studies on comparing the melatonin level in serum (Bagnall et al, 
1996，Brodner et al., 2000) and urine (Fagan et al, 1998, Hilibrand et al, 1996) 
showed no difference between AIS patients and normal control. However, unlike 
the study of Machida et al (1996), these studies might not show any difference in 
generalizing both progressive and non-progressive AIS patients as one group. Also, 
Bagnall et al. (1996) suggested the difference in melatonin level might be observed 
during the onset of scoliosis. Thus, the data on human melatonin level are 
controversial and melatonin deficiency as a causative factor in the etiology of AIS 
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seemed unsupported. 
In order to speculate the possible relation of melatonin with AIS, there might be a 
dysfunction of the melatonin-signaling pathway in AIS. Moreau et al. (Azeddine et 
al, 2007,，2004) examined osteoblasts from 41 AIS patients and 17 control patients. 
Primary osteoblast cultures were prepared from bone biopsies obtained 
intraoperatively during spine surgeries. Melatonin and 5'-guanylimidodiphosphate 
(Gpp(NH)p), a guanosine-5’-triphosphate (GTP) analogue, were tested in the cells for 
their ability to block cyclic adenosine monophosphate (cyclic AMP) accumulation 
induced by forskolin. In parallel, the results showed that melatonin signaling was 
clearly impaired varying in osteoblasts isolated from AIS patients. A new 
classification of patients with AIS can be divided into three distinct groups, based on 
their responsiveness to melatonin. In addition, the study suggested that the 
abnormalities in Gi protein function could be the cause in the occurrence of AIS. 
It is well-known that the mutation of genes might be implicated in causing a signal 
dysfunction in the melatonin signaling pathway. Qiu et al. (2007a) found that 
melatonin IB receptor (MTNRIB) gene polymorphism was associated with the 
occurrence of AIS (Qiu et al., 2007a). However, there was no association with the 
curve severity. Evidently, melatonin may play a key role in the pathogenesis of 
AIS. Undoubtedly, the diurnal variations in the melatonin level and circadian 
rhythm of melatonin secretion would be important. However, the question remains 
on the causative effect of melatonin in the etiology of AIS being primary or 
secondary. 
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Figure 1.1. Radiological image of right thoracic idiopathic scoliosis. 
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Figure 1.2. Illustration of an AIS patient treated with a Milwaukee brace. 
(Image adopted from Tang SP et allO^I (Tang et al, 2003)) 
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Figure 1.3. Radiograph images of AIS patients before and after surgical 
correction. A) Pre-operative standing posterior view; B) Pre-operative standing 
lateral view; C) Post-operative standing posterior view; D) Post-operative standing 
lateral view. 
(Image adopted from Weinstein et a/. 2008 (2008)) 
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Figure 1.4. Structure of Melatonin 
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Figure 1.5. Biosynthesis of Melatonin. N-acetlytransferase (NAT) and 
hydroxyindole-O-methyletransferase (HIOMT) are key enzymes in the melatonin 
biosynthetic pathway. (Image adopted from Grivas TB et al. 2007 (2007)) 
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Table 1.1. Occurrence of scoliosis after pinealectomy 
Occurrence of Scoliosis Report 
Chickens 100% Machida M et al (1995, , 
1997) 
60-80% Inoh H et al. (2001) 
50-80% Nette F et al (2002) 
50-58% Turgut M et al. (2003) 
Bagnall KM et al. (1999) 
54% Cheung KM et al. (2003) 
Wang X et al. (1998) 
O'Kelly C et al. (1999) 
Bipedal Rats 100% Machida M et al (1999) 
Monkeys 0% Cheung KM et al. (2005) 
Salmons »2Vo Fjelldal PG et al. (2004) 
- 4 1 -

• P H O i 
•圓 
Figure 1.7. Occurrence of right thoracic scoliosis in a bipedal mouse. (Image 
adopted from Machida et al. 2006 (1995)) 
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Table 1.2. Experimental scoliosis in melatonin-deficient C57BL/6J mice with 
an intact pineal gland (Data reported and adopted from Machida M et al. 2006 
(2006)) 
Occurrence of Scoliosis 
No Melatonin Melatonin Treatment 
Treatment (8mg/kg) 
Bipedal C57BL/6J mice 97% (29 out of 30) 0% (0 out of 30) 
Quadrupedal C57BL/6J 25% (5 out of 20) 0% (0 out of 20) 
mice 
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Table 1.3. Effects of bipedal operation with or without pinealectomy on the 
induction of scoliosis in C3H/HeJ and C57BL/6J mice (Data reported and adopted 
from Oyama J et al. 2006 (2006)) 
Occurrence of Scoliosis 
Bipedal Bipedal Bipedal and PINX 
C3H/HeJ mice C57BL/6J mice C3H/HeJ mice 
Single site (%) ^ ^ 
Double site ( % ) N o n e U J ^ 
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Figure 1.8. Evaluation of melatonin inhibitory effect on adenylyl cyclase 
activity in normal human and AIS osteoblasts. The AIS subjects are further 
subgrouped based on their responsiveness toward melatonin; Group 1, Group 2 and 
Group 3. Results are represented mean 士 SEM. (Graph adopted from Azeddine B 
etal. 2007 (2007)) 
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2. Hypothesis and Objectives 
2.1. Study Hypothesis 
Adolescent idiopathic scoliosis is the major type of spinal deformity abnormal in 
bone growth and BMD in adolescent girls. Although different treatments have been 
applied for the girls with different curve severity, they are not satisfactory. This is 
mainly due to the lack of understanding on the etiology of AIS. Among different 
possible causes of AIS, melatonin should play an important role on the 
etiopathogenesis. The recent finding on the melatonin signaling pathway 
dysfunction might suggest the heterogeneity in AIS population. Taken together, it 
is hypothesized that there is an abnormality in the response of osteoblasts from AIS 
girls to melatonin. The aim of this study is to investigate the cellular activity of 
osteoblasts from AIS girls' and it's responses to melatonin. 
2.2. Objectives 
In order to to address the study hypothesis, the following three objectives are: 
1. To study the anthropometric parameter and BMD of girls with severe AIS in 
comparison with healthy female adolescent controls. 
2. To determine the effect of melatonin on proliferation and differentiation of 
osteoblasts isolated from intraoperative bone biopsies of AIS patients. 
3. To detect the expression of melatonin receptors on osteoblasts isolated from 
intraoperative bone biopsies of AIS patients in comparison with healthy normal 
control. 
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Chapter 3 Study on the Anthropometric Parameters and 
Bone Geometry of Girls with Severe AIS 
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3.1. Introduction 
Adolescent idiopathic scoliosis mainly occurs during peri-puberty or at the stage of 
rapid growth spurt of a child prior to skeletal maturation. Idiopathic scoliosis can 
be characterized of having a spinal curvature malformation with vertebral rotation, 
and possibily lordosis. Earlier studies reported that AIS patients have significantly 
longer arm span, taller in height and other body segmental lengths than those of 
healthy controls after the onset of puberty (Burwell et al, 2008b, Cheng et al., 1996, 
Wiliner, 1975). Throughout puberty, a lower body weight and BMI has consistently 
been recorded from AIS girls (Burwell et al., 2008a, Qui et al, 2008, Siu King 
Cheung et al., 2003). In a cross-sectional study, 621 girls with AIS were studied for 
the association of bone mass with anthropometric parameters and bone turnover 
(Cheung et al., 2006). The results showed that the AIS patients have longer and 
taller anthropometric parameters, generalized osteopenia and 38.6% higher bone 
alkaline phosphatase (bALP) than the controls. The study concluded that the 
abnormally faster growth spurt and greater bone turnover of AIS patients might lead 
to bone dimension increments. A MRI study have shown disproportional or 
asynchronous growth of the anterior and posterior thoracic vertebral column in AIS 
patients (Guo et al., 2003). Significant positive correlation between the scoliosis 
severities with the ratio of differential thoracic growth of the column was also found. 
The disproportionate growth of the vertebral body in AIS patients was proposed to be 
contributed mainly by active endochondral ossification, with a relative decrease on 
the circumferential growth through membranous ossification. 
Also, recent studies showed osteopenia occurrence in AIS girls through measurement 
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using DXA (Cheng and Guo, 1997，Cheng et al, 2000，Cheung et al., 2006) and 
peripheral quantitative computed tomography (pQCT) (Cheng et al., 2000). In 
these studies, it was shown that the AIS girls have lower BMD than healthy 
individuals both for the areal BMD and volumetric BMD. Within the AIS clinic in 
Prince of Wales Hospital, approximately 25% of AIS patients followed up were 
classified as osteopenic (Cheng and Guo, 1997，Cheung et al.’ 2006, Lee et al., 
2005b). However, the above studies only focused on a generalized population of 
AIS patients with different severities. Thus, it would be of interest to understand 
whether these abnormalities in anthropometry and BMD could be reflected in a 
group of AIS patients with demonstrable curve progression. This group of severe 
AIS would be defined with curvature of Cobb's angle greater or equal to 40 degrees. 
The objective of the current study was to investigate the anthropometric parameters 
and bone geometry of the severe AIS girls between the ages of 13 to 20 and to 
compare the results with age and sex matched healthy control subjects. Importantly, 
this cross-sectional study would further consolidate the observation of abnormal 
systemic growth and osteopenia in severe AIS girls. 
3.2. Methodology 
3.2.1. Recruitment of Subjects 
3.2.1.1. Patients with Severe Adolescent Idiopathic Scoliosis 
In this study, 224 Chinese girls, between the ages of 13 and 20, with a clinical and 
radiographic diagnosis of severe adolescent idiopathic scoliosis and had a Cobb 
angle of at least 40°, were recruited. Patients diagnosed with disease other than 
idiopathic scoliosis, and those who had scoliosis of congenital, neuromuscular, 
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metabolic etiology, skeletal dyplasia and known endocrine and connective tissue 
abnormalities or have taken medications were excluded from this study. 
3.2.1.2. Normal Control 
In accordance, 160 healthy Chinese adolescents without scoliosis, between the ages 
of 13 and 20，were recruited randomly from the community. The control subjects 
were clinically examined, with forward bending test (Bunnell, 1984), by an 
experienced orthopedics surgeon to confirm the absence of scoliosis. Subjects with 
suspected spinal curvatures were referred to the scoliosis clinic for further 
confirmation. 
3.2.1.3. Patients Consent 
The protocol was approved by the Clinical Research Ethics Committee of the 
University (Appendix II). Informed consents were given by all the subjects and 
their parents prior to their entrance into the study (Appendix III-VI). 
3.2.2. Evaluation of Curve Severity of Scoliosis 
Standard radiography of the spine in the standing position of the corona丨 and sagittal 
planes was used for measuring the curve severity. Patients with Cobb's angle 
greater than 40 degree would be classified as severe AIS. For patients with double 
or triple curves in the spine, the major curve with the greatest angle would be used 
for analysis. 
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3.2.3. Anthropometric Measurements 
Anthropometric measurement of body weight, height, and arm span were conducted 
by using standard methods (Cheng et al., 1996，Cheng et al., 1998b). Subjects wore 
light garment, without shoes, when measuring the body weight on an electronic 
balance (Soechnle, Germany). Accuracy was taken to the closest 0.1 kg. 
Similarly for the height, subjects were measured without shoes by standing upright 
against a wall-mounted stadiometer, with the head positioned in the Frankfort 
horizontal plane and the heel against the stadiometer (Technical Service Unit of the 
University). Accuracy was taken to the closest 0.1 cm. For measurements of arm 
span, the subject's arm was fully stretched horizontally against a wall-mounted tape 
for measurement. Accuracy was taken to the closest 0.1 cm. For scoliotic patients, 
corrected height was computed by adjusting trunk loss using Bjure's formula (log y = 
0.01 Ix - 0.177; where y is the loss trunk height (cm) caused by the spinal deformity, 
and X is the Cobb angle of the primary curve) (Bjure et al.’ 1968). BMI was 
measured by weight (kg) divided by square of arm span (m^). 
3.2.4. Measurements of BMD 
3.2.4.1. Dual-energy X-ray Absorptiometry (DXA) 
DXA (XR-36; Norland Medical Systems, Fort Atkinson, Wisconsin) was used to 
measure the bilateral proximal femoral neck BMD in the anteroposterior position, 
according to the manufacturer's instructions. To maintain an anteroposterior 
position, a foot support was used to maintain a 20® inward rotation of the legs to 
compensate for femoral neck ante vers ion. Measurement of femoral BMD was done 
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with standard techniques described previously (Mazess et al.’ 1991). In this study, 
only the bilateral proximal femoral necks were chosen for BMD evaluations. As 
shown in our previous study (Hung et al.’ 2005)， these sites could 
representadequately the systemic BMD and osteopenia in AIS patients. The 
precision error of the femoral neck was within 0.8%. BMD was determined from 
the measured BMC (g) divided by the detected BA (cm^) (Fuerst et al, 1998). 
3.2.4.2. Peripheral Quantitative Computed Tomography (pQCT) 
The current study focused on the mid-shaft BMD which mainly reflects membranous 
ossification, pQCT (Densiscan 2000, Scanco Medical, Basselsdorf, Switzerland) was 
used to measure volumetric BMD. The long-term reproducibility of 0.3% was 
demonstrated in mixed reports (Ruegsegger, 1994). The radius of the patients was 
positioned in a radiolucent splint anatomically comfortable during the pQCT 
scanning. For the midshaft of radius, the midpoint was marked on the skin and a 
radiolucent marker was placed around the radius at the mid-point. By a projectional 
scout view, the reference line was marked at the radiolucent marker. The 
cross-sectional area and the cortical bone area of midshaft radius were measured with 
a single slice of pQCT image, at a scan resolution of 0.3 mm. Technical details on 
using pQCT for volumetric BMD measurement can be found elsewhere (Cheng and 
Guo, 1997，Cheng et al, 2000). 
3.2.5. Data Analysis 
Multiple regression analysis, with adjustments for confounding variables, was used 
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for the comparison of different anthropometric data and the BMD between the severe 
AIS girls and controls. All data were expressed as the intercepts, regression 
coefficients and standard errors. The alpha value was set to 0.05 to be considered 
statistically significant. SPSS software (version 11; SPSS, Inc., Chicago, IL) was 
used for statistical analysis. 
3.3. Results 
3.3.1. Anthropometry 
A total of 384 adolescents (224 AIS girls and 160 healthy females) were recruited 
into this study (Table 3.1). In Table 3.1, the average age of severe AIS girls (16.3 士 
2.0) was similar to the normal control (16.8 士 2.2) used in this study. The age 
distribution among AIS and control subjects was similar. The average Cobb's angle 
of the recruited severe AIS patients was 55.8° (range between 40° to 100�). 
Table 3.2 shows the age-adjusted measurements of the arm span and body mass 
index between severe AIS girls and normal controls. The multiple regression 
analysis of the BMI in the normal controls showed an intercept at 17.99 kg/m^ with a 
standard error of 0.91 kg/m^. As age increase, the BMI would significantly increase 
(p=0.045) by 1.4 kg/m^ with a standard error of 0.05 kg/m^. However, if it is an 
AIS patient, the BMI would significantly (p<0.001) be lowered than those of the 
control subjects by 1.43 kg/m^ with a standard error of 0.22 kg/m^. While for the 
arm span, the multiple regression analysis in the normal controls showed an intercept 
at 148.23 cm with a standard error of 3.06 cm. As age increase, the arm span would 
significantly increase (p=0.001) by 0.58 cm with a standard error of 0.18 cm. 
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However, if it is an AIS patient, the arm span would be significantly longer (p=0.001) 
than the normal controls by 2.56 cm in average with a standard error of 0.75 cm. 
3.3.2. BMD of Femoral Neck and Midshaft of Radius 
Table 3.3 shows the different measurements of BMD of femoral neck by DXA and 
midshaft radius by pQCT, respectively. Due to the loading of the curvature, the 
femoral neck was grouped according to the dominance and convexity. With 
multiple regression analysis, the intercept of the non-dominant, dominant and convex 
side of femoral neck BMD in the normal control was 0.38 g/cm^ with a standard 
error of 0.05 g/cm^. While for the BMD on the concave side of the femoral neck, 
the intercept was 0.39 g/cm^ with a standard error of 0.05 g/cm^. The BMD of the 
femoral neck regardless of the dominance and convexity of the curve would 
significantly (p<0.01) increase by 0.01 g/cm^ with a standard error of 0.01 g/cm^ as 
age increased. With an increase in body weight, the BMD of these parameters of 
the femoral neck would significantly (p<0.001) increase by 0.01 g/cm^ with a 
standard error of 0.005 g/cm^. However in severe AIS patients, the BMD of the 
non-dominant and dominant side of the femoral neck would significantly (p<0.001) 
be lowered than the normal controls by 0.04 g/cm with a standard error of 0.01 
g/cm^. While for the BMD on convexity of the femoral neck, the severe AIS have a 
lower BMD on the convex and concave side than the control by 0.04 g/cm^ (S.E. 
0.01 g/cm^) and 0.03 g/cm^ (S.E. 0.01 g/cm^), respectively. 
In Table 3.4，measurement on the BMD of the cortical and apparent midshafts of 
radius was assessed by pQCT. The result was divided into 2 age groups to assess 
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for the difference maturity: 1) below 16 years old and 2) equal of older than 16 years 
old. By using multiple regression analysis of the adolescent girls below the age of 
16，the intercept of the cortical BMD was 1.24 g/cm^ with a standard error of 0.07 
g/cm^. With age increase in the normal controls, the cortical BMD of the midshaft 
of radius would significantly increase by 0.02 g/cm^ with a standard error of 0.01 
g/cm^ (pO.OOl). However, there was no significance between the severe AIS 
subjects and normal controls (p=0.948). While for the multiple regression analysis 
on the matured female adolescents, the intercept of the cortical BMD was 1.46 g/cm^ 
with a standard error of 0.03 g/cm^. And when age increases in the matured normal 
subjects, the cortical BMD would further increase by 0.01 g/cm^ with a standard 
error of 0.01 g/cm^ (p<0.001). However, the AIS girls would have a significant 
lower BMD (p二0.05) than the normal controls by 0.01 g/cm^ with a standard error of 
0.01 g/cm^. Similarly for the midshaft apparent BMD of the adolescent girls below 
the age of 16, the intercept of the apparent BMD was 0.87 g/cm^ with a standard 
error of 0.09 g/cm^. However, there was no significant toward the increase in age 
and the presence of scoliosis (p>0.05). While for the multiple regression analysis 
on the matured female adolescents, the intercept of the apparent BMD was 0.94 
g/cm^ with a standard error of 0.05 g/cm^. And when age increases in the matured 
normal subjects, the apparent BMD would further increase by 0.01 g/cm^ with a 
standard error of 0.01 g/cm^ (p=0.01). However, there was no significant difference 
toward the apparent BMD when subjects having scoliosis (p=0.530). 
3.4. Discussion 
By using multiple regression analysis, cross-sectional measurements on 
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anthropometry showed that severe AIS girls had a significantly longer arm span and 
a slender figure, lower BMI when compared with the normal controls. This growth 
anomaly has been clinically observed in previous studies (Nordwall and Willner, 
1975，Willner, 1974，Willner, 1975). In this study, a generalized low bone mass 
were also observed in the measurement of both femoral necks of the severe AIS 
patients by multiple regression analysis. This matches the previous findings of low 
BMD in AIS girls (Cheng et al., 2006, Cheung et al, 2006), and possibly being a 
prognostic factor to assess progression, since all our patients had severe AIS (Hung 
etaL, 2005). 
In anthropometric analysis, the heights of the severe AIS girls and the normal control 
were compared. The measurement could be used to convert to corrected height by 
Bjure's formula (Bjure et al, 1968). Similar study was reported to deduce different 
regression models in measuring the corrected height in AIS patients (Kono et al.’ 
2000). However, the difficulties in measurement of the corrected height have been 
discussed in particular for AIS patients with multiple curves (Kono et al., 2000). 
Previous study showed positive linear correlation between arm span and standing 
height in healthy adolescents (r^ = 0.99) (Cheng et al, 1996). Hence, with this 
present study, due to the presence of different curves types in the AIS girls, it is more 
reliable and feasible to use arm span as a measure of body height. As there was 
minimal effect from the spinal deformity toward arm span, this can minimize the 
inaccurate prediction of the height using the conventional Bjure's formula (Bjure et 
al, 1968) with only the major Cobb's angle. By multiple regression analysis, it was 
shown that age increment would significantly increase the arm span by 0.58 cm, with 
a standard error of 0.18 cm, in a healthy individual (Table 3.2). However, for AIS 
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patient, the arm span would be significantly longer than the normal controls by 2.56 
cm with a standard error of 0.75 cm. This finding was similar to previous reports 
(Cheng et al, 2000，Cheung et al., 2006，Lee et al., 2005a, Siu King Cheung et al, 
2003) on AIS girls having a longer arm span than normal controls. In Lee et aVs 
study (2005b), they compared the anthropometry and BMD of 619 AIS girls, of 
different severities, with 300 healthy controls aged 11-16 years old. It reported that 
the arm span and leg length among the moderate and severe AIS girls were longer 
than the controls. After adjusting for the age，the arm span and leg length was 
significantly correlated with curve severity (p=0.015). Thus，the observed longer 
arm span could reflect the presence of abnormal bone growth in AIS girls with a 
large curvature. 
For the body weight and body mass index, there are mixed results showing that AIS 
patients were similar in weight (Cheng and Guo, 1997，Vetter et al., 1991) or leaner 
than normal healthy individuals (Akhtar et al, 2005, Felsenberg and Boonen, 2005). 
In the present study, the severe AIS girls had a lower BMI than the normal controls 
(Table 3.2). By multiple regression analysis, the severe AIS patients had a 
significantly lower BMI (pO.OOl) than the normal adolescent girls by 1.43 kg/m^ 
with a standard error of 0.22 kg/m . Nevertheless, the present findings agrees with 
previous literatures (Shohat et al.’ 1988, Willner, 1975) that severe AIS girls are 
leaner and likely to be below the normal range of BMI. 
The abnormal growth, demonstrated in the arm span and BMI, might be a reflection 
of disproportional endochondral ossification in the growth plates of long bone and 
endplate in vertebral bodies (Juul, 2001, Smith et al., 1994). In Guo et al. (2003) 
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MRI study, the anterior vertebral bodies of AIS girls were found to be taller and 
leaner when compared with age-matched controls. It also demonstrated the relative 
overgrowth of the anterior column of the spine. The authors hypothesized that the 
abnormality was due to the disproportionate growth between endochondral 
ossification and membranous ossification. The findings coupling with the clinical 
observation that the severe AIS girls are slender and leaner than the normal 
adolescent girls points to a systemic disorder in skeletal growth. 
For the BMD measurements, the severe AIS girls were grouped according to the site 
and convexity of major curve (Table 3.3). BMD Measurement showed lower BMD 
in bilateral sides of the femoral necks of the severe AIS girls when compared with 
the healthy controls. The results of multiple regression analysis showed that the 
BMD of the bilateral femoral necks was significantly related to age, body weight and 
curve severity in the AIS girls. In the severe AIS girls, the BMD on the convex side 
of the femoral neck have a lower mean value than the concave side when compared 
with the normal control. This finding was similar to Hans et al. (1996)，through 
dual-photon x-ray absorptiometry measurments, this study measured the femoral 
BMD to determine whether there is a difference between left and right side and its 
relationship to scoliosis convexity. The result showed that the BMD at the femoral 
neck was lower on the convex side in fifteen female patients with structural lumbar 
scoliosis. Another study on subjects with adult lumbar scoliosis (Rumancik et al.’ 
2005) showed a higher BMD on the concave side of the femoral neck than the 
convex side by DXA measurements. This occurrence was postulated to be due to 
the greater mechanical loading within the osteoporotic bone, less bone formed and 
higher bone loss on the convex side. However, a study pointed out multiple factors 
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could affect these results, including rotation of the spine, compression of the 
vertebrae and biomechanical adaptation within the cancellous or cortical bone tissue 
(Routh et al, 2005). The current study showed significantly lower BMD in both 
femoral necks of the AIS girls than the normal controls. This result agreed with the 
previous reports on the high prevalence of low BMD in a mixed population of AIS 
girls with different severities (Hung et al., 2005, Lee et al., 2003). 
The measured apparent BMD is the mass of mineral in a skeletal region, where not 
all of which is bone. These regions are composed of mineral fashioned into cortical 
bone and trabecular bone within a central medullary cavity containing marrow. The 
BMDs of the cortical and apparent midshafts of radius were measured by pQCT 
(Table 3.4). As this study is focused on the mid-shaft BMD undergoing 
membranous ossification, only the BMD is taken into account, which assumed 
osteoblasts bone formation without cartilagenesis. Thus, the parameters of BMC 
and cross-sectional area (CSA) were not considered. In order to determine whether 
there is a difference due to maturity, the subjects were divided into 2 groups based on 
the age of 16 years old. By using multiple regression models, difference between 
the severe AIS and normal controls were only found after skeletal maturity, an 
observation that could be possibly explained by the more rapid acquisition in BMD 
in the normal controls with its accumulated effects. This observation has no 
apparent contradiction to previous reports on the presence of systemic low BMD in 
AIS girls (Cheng et al, 2000，Cheung et al, 2006). For their studies reported 
findings on systemic low BMD in skeletally-matured AIS girls, but not involving 
immatured AIS girls. However, the difference between the maturations may be due 
to the intrinsic difficulties in accurately estimating the cortical BMD of the midshaft 
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of radius in the younger severe AIS subjects. Previous report (Cooper et al., 2007) 
showed that porosity of the cortical bone might be taken into account when 
measuring the material density. As in the current technology, there is no available 
method to depict the porosity of these pores in vivo, unless the tissue is taken from 
the subject for histology or microCT evaluations (which will form part of another 
series of ongoing studies in the same center). 
These results revealed poor BMD may reflect the presence of poor bone mechanics 
in AIS patients. A recent study (Cheng et al., 2006) revealed that over 86% of 
osteopenic AIS patients had persistently low BMD, at both distal tibia and femoral 
neck regions, at the time of skeletal maturity. The observed osteopenia in AIS girls 
may indicate a strong likelihood of developing osteoporosis at adulthood (1993). 
Osteoporosis is now defined as the micro-architectural deterioration of the bone with 
associated lost in bone mechanical strength. The bone strength is governed not only 
by the micro-architecture, but also the material property (Felsenberg and Boonen, 
2005). The material properties of properly mineralized bone are contributed by a 
combination of stiffness and brittleness, while weakly mineralized bone are mainly 
from brittle fragments (Currey, 1984, Turner, 2002, Zioupos et al, 2000). 
Mechanical property accounts for over 60% of the bone density observed (Bouxsein, 
2003, Carter and Hayes, 1977, Rice et al., 1988). In osteoporosis of the elderly, 
changes in geometry and material properties are the main causes for the loss of bone 
strength (Mosekilde, 1998). 
In previous studies, Cheng et al. (1997) reported that the presence of systemically 
low BMD in AIS patients was independent to severity or curve patterns. Based on 
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our results, the severe AIS girls demonstrated a similar phenomenon of having low 
BMD like those reported of generalized AIS population (Cheng et al.’ 2000，Cook et 
al.’ 1987b, Thomas et al, 1992). Study on histology and histomorphometry of 
cancellous bone from AIS patients (Cheng et al, 2001) also showed lower osteocytes 
count in the trabecular bone characterized with smooth and continuous borders. 
This suggested a possible disturbance of bone remodeling in AIS patients. Bone 
remodeling is the dynamic interaction of activities of osteoblasts and osteoclasts. 
This consists of three main steps: 1) production of extracellular organic matrix 
(osteoid)，2) mineralization of the matrix to form bone and 3) bone remodeling by 
resorption and reformation. Various factors can affect the activity of both 
bone-forming osteoblasts and bone-resorping osteoclasts by modulating the synthesis 
(signaling) of growth factors and cytokines (Cai et al., 2008, Galliera et al., 2008, 
Korf-Klingebiel et al, 2008). 
Recent studies suggested that melatonin has an effect on bone remodeling (Ladizesky 
et al.’ 2003, Ladizesky et al, 2001). An in vitro study showed that melatonin 
increased the proliferation in normal human bone cells and osteoblastic cells to 
increase gene expression of sialoprotein and other bone marker proteins, like alkaline 
phosphatase and osteocalcin in bone cells (Roth et al., 1999), which may promote 
matrix mineralization. Hence, it is logical to speculate that melatonin signaling 
dysfunction and/or abnormal cellular responses to melatonin might account for the 
low BMD and abnormal bone growth observed in AIS patients. 
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Table 3.1. Age distributions of subjects recruited in the current study 
” S e v e r e AIS Subjects (n=224) Normal Controls (n=160) 
Age (yr) No. of Patients % of No. of Patients % of 
Distribution Distribution 
13 21 9.4 % 16 10.0% 
14 29 12.9% 12 7.5 % 
15 25 11.2 % 19 11.9% 
16 45 20.1 % 17 10.6% 
17 45 20.1 % 23 14.4 % 
18 20 8.9 % 32 20.0 % 
19 28 12.5 % 23 14.4% 
20 11 4.9 % 18 11.30/0 
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Table 3.2. Multiple regression analysis on the arm span and body mass index 
between severe AIS patients and control subjects 
Arm span BMI 
(cm) (kg/m') 
R 0.223 0.339 
R squared 0.05 0.115 
Regression sig <0.001 <0.001 
(p value) 
Constant B ^ 148.232 17.99 
S.E. 3.057 0.911 
P value 0.0001 0.045 
Variables 
Age B ^ 0.580 0.107 
S.E. 0.179 0.053 
P value 0.001 0.045 
Severity B ^ 2.566 -1.434 
S.E. 0.748 0.223 
P value 0.001 <0.001 
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Table 3.3. Multiple regression analysis on the BMD of the bilateral femoral neck 
in severe AIS patients and control subjects. 
Non-Dominant Dominant Convex Concave 
FN BMD FN BMD side FN side FN 
(g/cm^) (g/cm^) BMD BMD 
( g W ) (g/cm2) 
R 0.535 0.534 0.537 0 . 5 2 6 “ 
R squared 0.286 0.285 0.288 0.277 
Regression <0.001 <0.001 <0.001 <0.001 
(p value) 
Constant B ^ 0.383 0.387 0.381 0.394 
S.E. 0.049 0.049 0.049 0.049 
P value <0.001 <0.001 <0.001 <0.001 
Variables 
Age B ^ 0.007 0.007 0.007 0.007""“ 
S.E. 0.002 0.002 0.002 0.002 
P value 0.005 0.003 0.004 0.006 
BW B ^ 0.007 0.007 0.007 0 . 0 0 7 “ 
S.E. 0.001 0.001 0.001 0.001 
P value <0.001 <0.001 <0.001 <0.001 
Severity B ^ -0.035 -0.035 -0.036 - 0 . 0 3 3 “ 
S.E. 0.01 0.01 0.01 0.01 
P value <0.001 <0.001 <0.001 <0.001 
FN=Femoral neck; BMD=Bone mineral density 
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Table 3.4. Multiple regression analysis on the BMD on the midshaft of radius in 
severe AIS patients and control subjects under 16 years old. 
Age < 16 years old Cortical BMD (g/cm^) Apparent BMD (g/cm^)""" 
R 0.427 0.126 
R squared 0.182 0.016 
Regression (p-value) <0.001 0.601 
Constant B ^ 1.238 0.874 
S.E. 0.067 0.088 
P value <0.001 <0.001 
Variables 
Age B ^ 0.024 0.009 
S.E. 0.005 0.007 
P value <0.001 0.185 
Severity B ^ 0.000 0.003 
S.E. 0.009 0.011 
P value 0.948 0.794 
BMD=Bone mineral density 
Table 3.5. Multiple regression analysis on the BMD on the midshaft of radius in 
severe AIS patients and control subjects over 16 years old. 
Age > 16 years old Cortical BMD (g/cm^) Apparent BMD (g/cm^)“ 
R 0.365 0.195 
R squared 0.133 0.038 
Regression (p value) <0.001 0.019 
Constant B ^ 1.464 0.941 
S.E. 0.034 0.053 
P value <0.001 <0.001 
Variables 
Age B ^ 0.010 0.006 
S.E. 0.002 0.002 
P value <0.001 0.010 
Severity B ^ -0.010 -0.004 
S.E. 0.005 0.007 
P value 0.050 0.530 
BMD=Bone mineral density 
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Chapter 4 Response of Osteoblasts to Melatonin in AIS 
Girls - In vitro Study 
4.1. Introduction 
In the study presented in detail in Chapter 3，severe AIS girls had been shown to have 
low BMD and abnormal anthropometric parameters including lower BMI and longer 
arm span when compared with normal controls. The results pointed strongly to 
abnormal peri-pubertal bone growth and bone remodeling which matched with a 
number of other related studies (Cheung et al., 2006, Willner, 1975). 
Normal bone matrix consists of a unique composite of living cells embedded within a 
three dimensional, mineralized, honeycomb like structure. The bone remodeling 
process is carried out by three types of cells; osteoblasts, osteoclasts and osteocytes. 
Osteoblasts are responsible for the synthesis of bone matrix, while osteoclasts are 
responsible for the resorption of mineralized bone. Osteocytes are osteoblasts 
entrapped within the lacunae. In order to balance bone formation and resorption in 
healthy individuals, osteoblasts secrete factors that regulate the differentiation of 
osteoclasts. Osteocytes are responsible for secreting factors regulating the activity 
of both osteoblasts (Hartmann, 2006) and osteoclasts (Seeman, 2006). As part of 
the normal bone remodeling process, bone is constantly reabsorbed by osteoclasts 
and replaced by osteoblasts (Ducy, 2000). These interactions are essential for 
maintaining a balance between the rates of bone loss and gain. Disruption in the 
regulated networks can result in rapid bone loss (i.e. osteoporosis) together with 
fragility fractures (Boskey and Posner, 1984，Felsenberg and Boonen, 2005, Parfitt, 
1984). 
It has been reported that melatonin plays a vital role in preventing bone loss in 
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osteoporosis of animal models (Ladizesky et al, 2003, Ladizesky et al, 2001). 
Ladizesky et al. (2003) reported that daily intake of melatonin might prevent the 
bone loss in ovariectomized rats. Other clinical studies have shown that aging 
would decrease melatonin secretion, eventually increasing the risk to develop 
osteoporosis (Sandyk et al., 1992, Witt-Enderby et al., 2006). In addition, previous 
reports have demonstrated that melatonin enhances proliferation (Nakade et al., 1999， 
Satomura et al.’ 2007) and differentiation (Roth et al, 1999，Satomura et al.’ 2007) 
of bone cells. Satomura et al. (2007) showed a dose-dependent response in 
enhancing proliferation, differentiation in human osteoblasts and mineralization of 
bone matrix. 
Studies on the serum melatonin concentrations in AIS girls have been reported 
(Bagnall et al., 1996，Brodner et al, 2000，Fagan et al, 1998, Hilibrand et al.’ 1996’ 
Machida et al., 1996). However, controversies on whether there are differences on 
the melatonin serum concentration between AIS girls, of different severities, and 
healthy controls still prevail. Machida et al. (1996) had shown that AIS patients 
with progressive curves have significantly lower melatonin serum concentrations 
than the controls. Recently, Moreau et al. (2004) found dysfunction of melatonin 
signaling pathway in osteoblasts derived from AIS patients. The osteoblasts from 
AIS patients responded differently to melatonin's inhibitory effect on the 
forskolin-stimulated cyclic AMP. It showed some of the AIS osteoblasts failing to 
inhibit the forskolin-stimulated cyclic AMP, upon the addition of melatonin. The 
AIS patients were subdivided into three groups according to their degree of cellular 
responses toward melatonin on the accumulation of cyclic AMP concentration 
(Moreau et al., 2004). However, the functional characteristic of individual groups 
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has yet to be determined. Moreover from previous genetic association study by Qiu 
et al (2007a), melatonin IB receptor polymorphism was shown to be associated with 
the occurrence of AIS. 
It was hypothesized that there could be abnormal cellular responses of osteoblasts 
from AIS patients to melatonin physiologically. Hence, the objective of the study 
described in this chapter is to determine the effect of melatonin on proliferation and 
differentiation of osteoblasts isolated from AIS patients and to compare the response 
with normal controls. 
4.2. Methodology 
4.2.1. Subjects Recruitments 
From the series of severe AIS patients recruited for the previous study described in 
Chapter 3，only a few subjects were recruited due to the time limitation and 
difficulties in obtaining consent from the patients and their parents. Consents to take 
intraoperative bone biopsy were obtained from 13 patients and their parents who 
subsequently underwent corrective spinal surgery and instrumentation within the 
period of this thesis study (Table 4.2). The inclusion and exclusion criteria and the 
clinical diagnosis of AIS were described in Chapter 3. 
Intraoperative bone biopsies were also obtained from 9 normal control subjects, aged 
between 14 to 28 who were undergoing reconstructive surgery for trauma-related 
condition, from the same hospital during the same period (Table 4.3). The absence 
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of scoliosis, spinal problem and other bone metabolic diseases were confirmed by an 
experienced orthopedic surgeon preoperatively. 
The protocol was approved by the Clinical Research Ethics Committee of the 
University (Appendix II). An informed consent was given in details to all the 
subjects and their parents prior to their recruitment into the study (Appendix III-VI). 
4.2.2. Cell Isolation 
4.2.2.1. Bone Biopsies for Osteoblasts Isolation 
Bone biopsies of iliac crest or facet joint were obtained intraoperatively from the AIS 
girls (Figure 4.1). For the osteoblasts from normal controls, bones biopsies were 
obtained from normal bone of the distal femur during surgery, or unaffected areas for 
the tumor cases. The study protocol was approved by the Clinical Research Ethics 
Committee of the University (Appendix II). Informed consents were obtained from 
all the subjects and their parents prior to collecting any samples for the study 
(Appendix III-VI). 
4.2.2.2. Materials and Reagents 
Phosphate Buffered Saline (PBS) 
The following 1.44 g NaaHPCU (Merck & Co., Darmstadt, Germany), 0.24 g KH2PO4 
(Merck & Co.，Darmstadt, Germany), 8.0 g NaCl (Merck & Co.，Darmstadt, 
Germany) and 0.2 g KCl (Merck & Co., Darmstadt, Germany) were dissolved in 900 
ml distilled water. The pH was adjusted to 7.4 and the final volume was made up to 
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1000 ml with distilled water. Sterilize the solution by autoclave and store at 4°C. 
Alpha-Minimal Essential Medium (a-MEM) 
One pack of aMEM (Invitrogen, Carlsbad, USA), 2.2 g NaHCOs (Riedel-de Haen, 
Seelze, Germany) and 0.1 g D-valine (Sigma, St.Louis, USA) were dissolved in 800 
ml distilled water. The pH adjusted to 7.4 and the final volume was made up to 
1000 ml with distilled water. The solution was passed through a bottle top filter. 
Osteogenic Medium 
Fetal bovine serum (FBS) (10 ml) (Gibco-Invitrogen, Carlsbad, USA) and 
penicillin/neomycin/streptomycin antibiotic cocktail (PNS) (1.0 ml) (Invitrogen, 
Carlsbad, USA) in 89 ml a-MEM were mixed gently to prevent foam formation. 
Then, 1.0 ml 10 mM ascorbic acid (Sigma, St.Louis, USA), 1.0 ml 10 mM 
p-glycophosphate (Sigma, St.Louis, USA) and 0.1 ml 10"^  M dexamethasone (Sigma, 
St.Louis, USA) were added to the solution. The solution was mixed gently and 
stored at 4°C in the dark. 
ALPase Buffer 
The following including 10.2 g MgCb.GHaO (Panreac, Barcelona, Spain), 12.1 g 
Tris-HCl (Sigma, St丄ouis, USA), 5.8 g NaCl (Amresco, Solon, USA) and 1.0 ml 
0.1% Tween-20 (Amresco, Solon, USA) were dissolved in 1000 ml distilled water. 
The solution was mixed gently. 
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ALPase Substrate Buffer 
The solution was freshly prepared by adding 25 |il 5-Bromo-4-chloro-3-indolyl 
phosphate (BCIP) (Promega, Madison, USA) and 50 |il nitro blue tetrazolium (NBT) 
(Promega, Madison, USA) into 4.9 ml ALP buffer. The solution was mixed gently 
and stored in the dark. 
4.2.2.3. Isolation of Osteoblasts from Bone Biopsies 
Bone fragments were first rinsed with plain a-MEM supplemented with 10% PNS to 
prevent possible bacterial contamination. The trabecular bones were cut and 
minced into small pieces with a sharp bone cutter in sterile conditions. Excess 
blood was removed by gentle rinsing in sterile PBS. The fragments were then 
plated onto a 6-well culture plate and incubated for 28 days in basal culture medium 
of a-MEM (Invitrogen, Carlsbad, USA) supplemented with 10% FBS (Invitrogen, 
Carlsbad, USA) and 1% PNS (Invitrogen, Carlsbad, USA). The culture was 
maintained at 37°C in a humidified atmosphere of 5% carbon dioxide (CO2). The 
medium was renewed every 3-4 days. When the osteoblasts reached 80 - 90% 
confluence, the cells were harvested for assessment. A clear illustration of the 
isolation process is shown in Figure 4.1. In confirming the osteoblastic 
characteristic, cells were detected for the presence of ALPase, a bone forming 
marker. In addition, cells passage for more than 3 times were excluded from this 
study. 
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4.2.2.4. Alkaline Phosphatase Enzyme Cytochemistry 
To confirm the osteoblastic characteristic of the isolated cells, their capacity to 
produce ALP was assessed. In brief，the cells were seeded at a density of 7500 cells 
per well in a 6-well plate, and cultured in the presence of osteogenic medium for 3 
days. Thereafter, the cells were fixed in 70% alcohol and washed with ALPase 
buffer. Then, the cells were incubated at 37°C with ALPase substrate buffer for 45 
minutes. The reaction was stopped by adding distilled water. Positive purple 
signal was evaluated under microscope. 
4.2.3. Effect of Melatonin on Proliferation and Differentiation of AIS 
Osteoblasts 
4.2.3.1. Materials and Reagents 
Dulbecco's Modified Eagle Medium (DMEM) 
One pack of DMEM (Invitrogen, Carlsbad, USA), 3.7 g NaHCOs (Riedel-de Haen, 
Seelze, Germany) and 0.1 g D-valine (Sigma, St丄ouis，USA) were dissolved in 
800ml distilled water. The pH adjusted to 7.4 and the final volume made up to 
1000 ml with distilled water. The solution was passed through a bottle top filter and 
stored at 4°C. 
Melatonin 
Melatonin (23.23 mg) (Sigma, St.Louis, USA) was dissolved in 1 ml DMSO (Sigma, 
St.Louis, USA) in the dark and mixed gently. The concentration of the prepared 
solution is O.IM. Serial dilutions were performed to obtain other concentrations. 
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When added into the medium, the final DMSO concentration should not exceed 
0.1%. 
3-(4,5-Dimethvlthiazol-2-vn-2.5-diphenvltetrazolium bromide (MTT) Stock 
Solution 
MTT powder (0.01 g) (Sigma, St.Louis, USA) was dissolved in 2.0 ml autoclaved 
PBS. Stock solution was sterilized by filtering through a 0.22-|xm membrane 
(Millipore, Bedford, USA). The solution was kept away from light and stored at 
-20°C. 
MTT Working Solution 
The solution was freshly prepared by mixing 1.0 ml MTT stock solution in 9.0 ml 
DMEM (Invitrogen, Carlsbad, USA). The solution was mixed gently and kept 
away from light. 
Diethanolamine (PEA) Buffer 
The followings including 0.2 g MgCb.GHaO (Merck & Co.，Darmstadt, Germany), 
0.5 ml 4M HCl (Merck & Co” Darmstadt, Germany) and 0.5 ml diethanolamine 
(Sigma, St.Louis, USA) were mixed in 99 ml distilled water. The solution was 
mixed gently and stored at room temperature. 
ALPase Working Reagents 
Approximately 25 ml of 2-amino-2-methyl-1 -propanol (Reagent A) was mixed in 50 
ml of 4-nitrophenylphosphate (Reagent B). The solution was mixed gently and 
stored at 4°C for a shelf-life of 2 months. Prior to use, the solution was allowed to 
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pre-warm at 37°C for at least 30 minutes. 
4.2.3.2. Cell Viability Assay 
The effect of melatonin on proliferation of the normal human and AIS osteoblasts 
was analyzed by using MTT cell viability assay to measure the total number of 
viable cells before and after 3 days of melatonin treatment, as described by Satomura 
et al. (2007). The assay is dependent on cellular reduction of MTT by 
mitochondrial dehydrogenase present in viable cells to form a red formazan product 
representing the proliferative activity of the cells (Mosmann, 1983). In brief, the 
cells were seeded at a density of 3000 cells per well in 96-well culture plates and 
cultured in a-MEM containing 1% FBS and various concentrations (10" ,^ 10"^  and 
10-4 M) of melatonin for 3 consecutive days, with daily renewal of medium and 
melatonin. At the end of 3 days, the medium was removed and rinsed with sterile 
PBS. The MTT solution was added and incubated for 4 hour at 37°C. Thereafter, 
the MTT solution was carefully removed. The formazan in the cells was released 
with the addition of DMSO and shaken gently at room temperature. The 
absorbance of the amount of formazan formed was measured at 570 nm using a 
microplate reader (Gemini, Osaka, Japan). All measurements were performed in 
quadruplicate. 
4.2.3.3. Alkaline Phosphatase Activity 
The ALPase enzyme activity was determined using p-nitrophenyl phosphate (PNPP) 
as the substrate (Lowry et al., 1954). In brief, cells were plated at a density of 7500 
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cells per well in a 96-well culture plate. The cells were cultured in a-MEM 
containing 10% FBS until confluence. Thereafter, the cells were treated overnight 
with osteogenic medium to induce the ALPase activity of the cells. Afterwards, 
daily treatments with various concentrations (10"^ 10"^  and 10—4 M) of melatonin in 
a-MEM containing 1% FBS was added for 3 consecutive days. At the end of 3 
days, the medium was removed and rinsed with sterile PBS. The cells were then 
lysed with DEA buffer at room temperature. To determine the ALPase activity, the 
pre-warmed PNPP substrate from a commercial kit (Biosystems, Barcelona, Spain) 
was added. The reaction mixture was mixed gently for 5 minutes at room 
temperature. The absorbance due to ALPase activity was measured at 405 nm 
using a microplate reader (Gemini, Osaka, Japan). The level of ALPase activity 
was normalized by the total number of viable cells, determined by MTT assay. All 
measurements were performed in quadruplicate. 
4.2.4. Data Analysis 
All data were expressed as mean 士 S.D. This was taken from the average of the cell 
cultures performed in either triplicate or quadruplicate. Statistical significance of 
the difference from the vehicle controls was analyzed with a two-tailed Student's 
t-test. Statistical significance on the difference between the groups in the same 
melatonin concentrations was determined by one-way analysis of variance 
(ANOVA). The alpha value was set to 0.05 to be considered statistically significant. 
SPSS software (version 11; SPSS, Inc., Chicago, IL) was used for statistical analysis. 
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4.3. Results 
4.3.1. Isolated Osteoblasts from Normal Human and AIS Patients 
The isolated osteoblasts, from normal human (Figure 4.2) and AIS patients (Figure 
4.3)，were fibroblast-like in morphology (Figure 4.2A and Figure 4.3A) and 
exhibited positive ALPase activity (Figure 4.2B and Figure 4.3B). 
4.3.2. Effect of Melatonin on Osteoblasts Proliferation 
In Figure 4.4, the proliferation of the normal human osteoblasts was enhanced in a 
dose-dependent manner when the cells were exposed to a serial concentration of 
melatonin for 3 days. As measured by MTT assay, the percentage of proliferation 
in normal human osteoblasts was enhanced by 6%, 11% and 12% with the serial 
concentration of melatonin (10"^ 10"^  and 10"^  M) when compared with the vehicle, 
respectively. The enhancement was significant at both physiological (10'^ M) 
(p=0.021) and pharmacological dosages of melatonin (10"^  M) (p=0.005), (10'^ M) 
(p=0.004). However, there was no significant overall difference on the proliferation 
of the AIS osteoblasts to melatonin (p>0.05) in comparison with the vehicle. In 
comparing the normal controls with the AIS osteoblasts, the differences in 
proliferation at different melatonin concentrations were statistically significant at 10"^  
M (p=0.014)，10-^M(p=0.008) and (p=0.002). 
The osteoblasts isolated from the AIS patients were divided into two groups basing 
on their response to the physiological dose (lO'^M) of melatonin (Figure 4.6). In 
the first group (Group A, n=3; Figure 4.7), melatonin treatment enhanced the 
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proliferationof osteoblasts, at a trend similar to the normal control, at all 
concentrations (10-9，jq-s ^^^ 10^ M). The enhancement on the proliferation of 
osteoblasts was statistically significant at 10'^  M (p=0.021) when compared with the 
vehicle. However, this enhancement at melatonin concentrations 10"^  M (p=0.109) 
and 10"'^  M (p=0.263) was not statistically significant. The second group (Group B, 
n=lO; Figure 4.7) showed an inhibitory trend on the proliferation of osteoblasts by 
increasing concentrations of melatonin. The inhibition was statistically significant 
at all concentrations of 10"^  (p=0.006)，10'^ (p=0.016) and 10"^  M (p=0.006) when 
compared with the vehicle. 
When compared between the normal controls and Group B (Figure 4.7), there was 
also statistical significant differences in the number of osteoblasts at all melatonin 
concentrations (pO.OOl). In the comparison between Group A and Group B，there 
were significant difference on the effect of melatonin toward the number of 
osteoblasts concentrations of 10"^  (p=0.031) and 10'^  (p<0.001) without an associated 
difference at the melatonin concentrations of 10"'^(p=0.109), which could be related 
to the large standard deviations in Group A. 
4.3.3. Effect of Melatonin on Cell Differentiation 
The rate of ALPase activity was measured as an indicator for the degree of osteoblast 
differentiation, with normalization by MTT cell viability assay. Figure 4.5 shows 
that the ALPase activity of normal human osteoblasts was enhanced in a 
dose-dependent manner when the cells were exposed to a serial concentration of 
melatonin for 3 days. The percentage of ALPase activity was enhanced by 8%, 
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22% and 32% with the serial concentration of melatonin (10"^ 10"^  and 10"^  M), 
respectively. The enhancement was significant (p=0.036) at the highest 
pharmacological dosage of melatonin M) and not at the melatonin 
concentrations of 10"^  M (p=0.103) and 10"^  M (p=0.083) when compared with the 
vehicle. However, there was no significant difference on the ALPase activity of the 
AIS osteoblasts to melatonin (p>0.05) in comparing with the vehicle. In comparing 
the normal controls with the AIS osteoblasts, there was no significant difference in 
ALPase activity following the addition of melatonin (p>0.05). 
Based on classification from cell proliferation study, the osteoblasts isolated from the 
AIS patients were similarly grouped into Group A and B and tested for their cellular 
differentiation in response to various concentrations of melatonin (Figure 4.8). In 
Group A (Figure 4.8)，melatonin treatment promoted ALPase activity, similar to the 
normal control, at all concentrations (10'^ 10"^  and lO ^ M) when compared with the 
vehicle. However, the promotion was not statistically significant at any of the 
melatonin concentrations (p>0.05). While for Group B (Figure 4.8), it showed an 
inhibition on the ALPase activity toward melatonin concentrations of 10'^  and 10"^  M 
when compared with the vehicle. While at the melatonin concentration of 10"^  M, it 
showed the promotion of ALPase activity. However, the enhancement of ALPase 
activity might be affected by the large standard deviation observed in this melatonin 
concentration (10'^ M). None of the ALPase activity response in Group B was 
statistically significant toward melatonin (p>0.05). 
In comparing the normal controls with Group B (Figure 4.8)，there were significant 
differences in ALPase activity at the highest melatonin concentrations (p=0.042) 
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(10"^), but not at the other melatonin concentrations 10"^  M (p=0.079) and 10"^  M 
(p=0.505). No significant difference between the ALPase activity was found 
between Group A and normal controls (p>0.05). In comparing between Group A 
and Group B, there was no significant difference in the ALPase activity following 
the addition of melatonin (p>0.05). 
4.4. Discussion 
In this study, melatonin dose-dependently enhanced proliferation and differentiation 
of normal human osteoblasts (Figure 4.4 and 4.5). However, there was the lack of 
enhancement effects on proliferation and differentiation in the AIS osteoblasts to 
melatonin (Figure 4.4 and 4.5). When compared between the normal controls with 
the AIS osteoblasts, there was significant difference in all concentrations of 
melatonin toward proliferation (p<0.05). Hence, the study further classified the 
AIS osteoblasts into two groups based on the proliferative response toward the 
physiological dose of melatonin (Figure 4.6). Based on this classification, 
osteoblasts from patients with AIS showed heterogeneous response toward melatonin 
on proliferation and differentiation (Figure 4.7 and Figure 4.8). One of the groups 
(Group A) showed enhancement effect of melatonin, while the other group (Group B) 
showed inhibitory effect. Group A behaved similarly to the proliferative trend of 
normal osteoblasts toward melatonin, while Group B showed inhibitory response 
toward melatonin. Significant difference in cellular proliferation was found 
between the normal human osteoblasts and Group B AIS at physiological and 
pharmacological concentrations of melatonin (p<0.001) and also between Group A 
and Group B at the physiological melatonin concentrations (p=0.031). Similar 
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differences were not found when comparing the normal controls with Group A AIS. 
This provides reasonable grounds supporting the functional classification of AIS 
patients into 2 groups of A and B. As proliferation declines before the onset of 
differentiation, it is likely that the abnormal response to melatonin could be seen in 
cellular proliferation first. Using this classification, statistical significance on the 
ALPase activity (p=0.042) was also found between the controls and Group B at the 
highest pharmacological concentrations of melatonin (10.4 M). 
On the effect of melatonin on cellular proliferation, there were three studies mainly 
demonstrated the different effects on bone cells (Nakade et al., 1999，Roth et al, 
1999，Satomura et al., 2007). In the rodent's cell line, MC3T3-EI and ROS 17/2.8， 
melatonin showed minimal suppression of cell proliferation (Roth et al., 1999). 
Nakade et al. (1999) reported that melatonin stimulated proliferation of primary 
human osteoblasts. Similarly, Satomura et al. (2007) showed that melatonin at 
pharmacological doses could enhance proliferation in primary human osteoblasts as 
well. The slight difference in reports might be due to species variation, where the 
latter two reports used human osteoblasts instead of rodent cells. 
In this study, melatonin showed a similar dose-dependent stimulatory effect on the 
normal human osteoblasts (Figure 4.4). While in the AIS osteoblasts, there was no 
significant enhancement on proliferation to melatonin (Figure 4.4). However, when 
it was compared between normal human osteoblasts and the AIS osteoblasts, there 
were significant differences at all concentrations of melatonin. On the contrary, 
determination of the cell viability in the presence of melatonin allowed a functional 
classification of patients with AIS into 2 groups based on their responsiveness 
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toward the physiological concentration of melatonin (Figure 4.6). In Figure 4.7， 
Group A showed the enhancement in proliferation with the addition of melatonin, 
similar to the trend of normal controls. While the other group, Group B 
demonstrated inhibitory response in viable osteoblast counts with the addition of 
melatonin. The response in Group A was similar to that of normal control. This 
might indicate that the etiology of this group of patients might not be affected by 
melatonin pathway dysfunction. In current studies, melatonin showed inhibitory 
effect on proliferation to melatonin in osteosarcoma (Hill and Blask, 1988，Panzer, 
1997，Toma et al, 2007). However, the inhibitory response of melatonin in Group 
B is similar to other studies on suppressing osteoblast proliferation. It was shown 
that by blocking the ERKl/2 pathway inhibitor with antagonists (PD98059), 
melatonin can attenuated the ERKl/2 phosphorylation to significantly reduce the 
proliferation and differentiation in osteoblasts (Dai et al., 2007). In addition, 
antagonist of estrogen receptor had shown to decrease cell proliferation by slowing 
down the osteoblasts maturation (Ogita et al, 2008). Therefore, it is possible that 
these molecular mechanisms might also be involved in the proliferation of the 
primary osteoblasts from the selected group of AIS patients. 
Based on the results, Group A demonstrated an enhancement effect by melatonin on 
both proliferation and differentiation, which was similar to the normal human 
osteoblasts. No significant difference was found between these two groups, 
indicating that the osteoblasts in Group A do not have abnormal response to 
melatonin. Unlike Group A, the osteoblasts in Group B showed a drop in 
proliferation and differentiation toward melatonin. As there was significant 
difference between Group B and Group A, this could imply that the osteoblasts from 
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Group B did have an abnormal response to melatonin. The different responses 
toward melatonin could imply the presence of heterogeneity in the AIS population. 
The ALPase activity in the normal human osteoblasts showed a dose-dependent 
enhancement in response to increased concentrations of melatonin (Figure 4.5). 
This result is similar to the study reported by Satomura et al. (2007) on melatonin 
enhancing differentiation markers and ALPase activity in human osteoblasts. While 
in the osteoblasts from the generalized AIS patients, there was a lack of enhancement 
effect in the ALPase activity toward the addition of melatonin. Likewise, there was 
no significant difference in the ALPase activity between the normal human 
osteoblasts and AIS osteoblasts. This might be due to the complication involved in 
the process of differentiation, which other substances (e.g. estrogen) might be 
interact with melatonin (Radio et al., 2006, Suzuki and Hattori, 2002). Hence, 
when the AIS osteoblasts were subgroup according to that of the proliferation assay, 
two groups of responsiveness were shown again (Figure 4,8). Group A showed 
promoted effect in ALPase activity with the addition of melatonin, similar to the 
trend of normal controls. In Group B, inhibitory effect on ALPase activity was 
found with the increasing concentrations of melatonin. In a study on human 
mesenchymal stems cell (Radio et al., 2006), melatonin was found to enhance 
ALPase activity by 50% relative to osteogenic media alone. However, the 
melatonin-mediated increases in ALPase activity could be blocked by the presence of 
MT2 antagonists. In general, the promotion of osteoblast differentiation has been 
shown to be mediated through the mitogen activated protein kinase (MAPK) cascade 
(Fujita et al.’ 2002，Nakade et al., 1999, Suzuki et al.’ 2002, Xiao et al., 2000). The 
inputs leading to MAPK activation in osteoblastic cells can be mediated through the 
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cyclic AMP (Fujita et al., 2002). Once activated, MAPK has been shown to 
phosphorylate osteoblast-specific proteins, including osteocalcin (Xiao et al, 2000). 
MAPKs are well known to play an essential role in controlling cell proliferation and 
differentiation (Johnson and Vaillancourt, 1994，Seger and Krebs, 1995, Zhang and 
Liu, 2002). In addition, Suzuki et al. (2002) reported that activation of ERK would 
play an important role in osteoblast proliferation. Recent findings also revealed that ' 
activation of the MAPK p38 is required for osteoblast differentiation, and p38 
activation induces the expression of differentiation markers, such as ALPase and 
mineral deposition (Gallea et al.’ 2001，Guicheux et al., 2003, Hu et al, 2003, Kakita 
et al., 2004, Sowa et al., 2002). Clearly, the role of the MAPK pathway in 
melatonin-induced osteoblast differentiation might be an important hint toward the 
abnormal response in Group B toward melatonin. 
Insight into the mechanisms by which melatonin promotes osteoblast proliferation 
and differentiation can be implicated partly from recent reports on the melatonin 
signaling pathways. Moreover for the promoting effect of differentiation in bone 
cells, Roth et al. (1999) demonstrated that the transmembrane receptor might initiate 
the actions of melatonin in osteoblasts via signaling through the Gi protein. As the 
putative orphan receptor is regulated by cyclic AMP (Baler et al., 1996), the binding 
of melatonin to its transmembrane receptor will result in changes in the levels of 
activity of the nuclear transcription factor in altering the expression of bone 
sialoprotein and differentiation. As it is shown clearly in the study of Satomura et 
al. (2007), the inhibition of cyclic AMP could enhance osteoblasts to proliferate and 
differentiate under the same melatonin concentrations. Similar findings on lower 
cyclic AMP accumulation resulting in higher cell proliferation and differentiation of 
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other cell types (Mallat et al., 1998，Tsuboi et al., 1996，Watson, 1976) have been 
reported. Hence, these findings further suggested that the abnormality in Group B 
of the AIS osteoblasts might be related directly to the accumulation in cyclic AMP as 
reported in recently (Azeddine et al, 2007, Moreau et al” 2004). 
Detail micro-architecture of normal bone show the presence of bone-forming 
osteoblasts and bone-resorping osteoclasts (Boskey and Posner，1984, Felsenberg and 
Boonen, 2005，Parfitt, 1984). Bone resorption is much faster than bone formation. 
The area of bone can be resorbed in 2-3 weeks but it takes at least three months to 
rebuild it (Harada and Rodan, 2003). Osteoblasts have a very important role in 
creating and maintaining skeletal architecture and are responsible for the deposition 
of bone matrix and the regulation of osteoclasts activity (Fonseca et al., 2005). 
Along the osteoblastic differentiate, they acquire the ability to secrete bone matrix 
(Gori et al, 2000). Both osteoblast proliferation and differentiation are controlled 
by the cyclic AMP signaling pathway. In the previous studies, parathyroid 
hormone (PTH) modulates proliferation and differentiation of osteoblasts through the 
cyclic AMP-mediated pathway (Partridge et al., 1994, Siddhanti and Quarles, 1994). 
Moreover, cyclic AMP functional response elements have been reported in promoter 
regions of osteoblast associated genes (Pearman et al., 1996, Povinelli et al., 1992, 
Towler and Rodan, 1995). In the mechanism of matrix mineralization, a series of 
events occurs as cells undergo differentiation (Stein et al, 1996). Proliferation 
declines before the onset of differentiation, and various osteoblastic marker genes, 
involved in extracellular matrix development and mineralization, are expressed. 
These include collagen type I，expressed maximally during proliferation and declines 
progressively, while ALPase and matrix GLA protein (MGP) expression start low 
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and peak during the matrix development/maturation stage. Other bone markers, 
osteopontin and osteocalcin, expressed would increase drastically during matrix 
mineralization (Stein et al., 1996). However, the complex process of matrix 
mineralization in osteoblasts still remains unclear. Much evidence points to control 
of formation and maturation of extracellular matrix, providing an environment that 
facilitates mineral deposition (Robey, 1996，Stein et al.’ 1996). Based on our data, 
the AIS osteoblasts demonstrated two different responses toward melatonin. Though 
a small sample size, Group B was found to have a lower BMD than Group A, 
possibly a result of the inhibitory response to melatonin. Similar to Moreau et al. 
finding (2004), the different responses in osteoblasts from AIS patients toward 
melatonin would most likely be a primary cellular functional defect involved in AIS, 
rather than a consequential secondary response from the spinal deformity. This 
could imply that the melatonin signaling pathway dysfunction might be the source of 
problem in certain subgroup of AIS patients. 
For ethical reason, bone biopsies from normal adolescent controls is often very 
difficult to obtain even more so for girls than boys. In the present study, the age of 
the control was slightly older than the AIS patients. As mentioned by few authors 
(Cardinali et al., 2008, Satomura et al.’ 2007), an increase in age could be associated 
with decrease in expression of melatonin receptors. Therefore, it is speculated that 
the difference might be even more significant if the controls were of similar age. 
Another possible limitation of the present study is the sex difference between the 
normal control and the AIS subjects. Although there are two female osteoblast 
samples in the normal controls, the remaining seven osteoblast samples were from 
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male subjects. While for all the AIS osteoblasts, they were isolated from female 
patients only. To our knowledge, there might be a fluctuation in the levels of sex 
hormones affecting bone metabolism in the patients, such as estrogens. The levels 
of these hormones are highest during the pubertal stage, especially in females. 
However, this study was conducted in vitro that was under a controlled culture 
environment without the influence of sex hormones to the osteoblasts from male and 
female. Hence, in general, the hormone fluctuation between genders would be 
minimal in this cellular study. Other studies have also demonstrated a similar effect 
of melatonin on human osteoblasts from samples of male and female (Azeddine et al, 
2007, Moreau et al, 2004，Satomura et al, 2007). Therefore, it is reasonable to 
have the comparison between the present normal controls and AIS patients. 
In this study, it is clearly demonstrated the abnormal response of AIS osteoblasts to 
melatonin. Most importantly, there was heterogeneous response of osteoblasts from 
AIS patients to proliferation and differentiation when melatonin is added. One of 
the groups (group A) demonstrated a promoted response toward proliferation and 
differentiation with the addition of melatonin. While the other group (group B), it 
showed inhibition in proliferation and differentiation with the addition of melatonin. 
From previous studies, the polymorphism of MT2 to the occurrence of AIS might be 
a hint toward the abnormality between the two groups of AIS osteoblasts. Thus, it 
would be highly speculated that there might be related to the melatonin receptors in 
these AIS osteoblasts. 
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Table 4.1. Clinical data of patients with AIS 
Case Diagnosis Curve Pattern Gender Age at Cobb Risser Family 
no. Surgery Angle Sign History 
(yrs) (。） (Yes/No) 
Al MS R/L Double curve F iTs 80-46 2 Y ^ 
A2 AIS R/L Double curve F 17^ 53-58 4 ^ 
A3 AIS R/L Double curve F 90-63 4 
A4 AIS R/L Double curve F K d 56-31 4 ^ 
A5 AIS R/L Double curve F 12^ 31-64 2 
A6 AIS L/R/L Triple curve F 1 6 . 2 3 7 - 6 7 - 4 2 5 No 一 — 
A7 AIS R/L Double curve F ^ 66-70 5 Y ^ 
A8 AIS R/L Double curve F 36-75 1 Y ^ 
A9 AIS R/L Double curve F 14^ 6 64-60 4 ^ 
AlO AIS L/R/L Triple curve F 14^ 33-77-66 3 ^ 
All AIS R thoracic curve F ^ 5 ^ 
A12 AIS R/L Double curve F 172 31-54 5 Y ^ 
A13 AIS L/R/L Triple curve F 30-72-60 3 ^ 
AIS = adolescent idiopathic scoliosis; R = right; L = left. 
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Table 4.2. Clinical data of control patients 
Case Type of Surgery where Curve Gender Age at Family 
No. intraoperative bone Pattern Surgery History 
biopsies were obtained (yrs) (Yes/No) 
N1 ACL Reconstruction Nil M l l s 
N2 Musculoskeletal Tumor Nil F NA 
19.5 
Surgery 
"m ACL Reconstruction W\ M ^ 
“ m ACL Reconstruction M M ^ 
“ ^ ACL Reconstruction m F ^ 
“ m ACL Reconstruction M K l ^ 
W ACL Reconstruction M ^ 
—~m ACL Reconstruction M ^ 
N9 Musculoskeletal Tumor Nil M NA 
14.8 
Surgery 
ACL = Anterior cruciate ligaments; NA = Not applicable 






Figure 4.1. Isolation of human osteoblasts from bone biopsies. Bone pieces 
from normal and AIS patients were collected and isolated from orthopedic surgeries. 
Unwanted tissues and blood were removed and the bone pieces were cleaned. 
Trabecular bone pieces were cultured in alpha-modified Eagle's Medium 
supplemented with 10% FBS, 1% PNS and D-valine for the migration of osteoblasts. 
- 9 3 -
H H H k 
Figure 4.2. Typical microphotograph of normal human osteoblasts isolated in 
this study. (A) Osteoblastic cells were isolated from bone pieces after culture (xlOO). 
(B) After culture in osteogenic medium for 4 days, the cells showed the presence of 
alkaline phosphatase. ALP activity was assessed by NBT/BCIP staining. Cells 
that were stained purple indicate a positive pool, as denoted above (lOOx). 
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•國 
Figure 4.3. Typical microphotograph of human AIS osteoblasts isolated in this 
study. (A) Osteoblastic cells were isolated from bone pieces after culture (xlOO). (B) 
After culture in osteogenic medium for 4 days, the cells showed the presence of 
alkaline phosphatase. ALP activity was assessed by NBT/BCIP staining. Cells 
stained purple indicate a positive pool, as denoted above (lOOx). 
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Figure 4.4. Effect of melatonin on the viable cell numbers of normal human 
and AIS osteoblasts. The effects of melatonin on cell viability were determined by 
MTT cell viability assay after 3 days of daily melatonin treatments. 
a. Student t-test; p<0.05 when compared against vehicle 
b. Student t-test; p<0.01 when compared against vehicle 
• Independent Student t-test; p<0.05 when Control vs AIS 
• • Independent Student t-test; p<0.01 when Control vs AIS 
- 9 6 -
I • Normal (n=9) • AIS (n=13) | 
180 a-
160 J 
•t 140 ； —— 
1 1 2 0 - r f r ^ i i 
『 丨 H m 
Vehicle 10-9 10-5 10-4 
Melatonin Concentration (M) 
Figure 4.5. Effect of melatonin on the ALPase activity of normal human and 
AIS osteoblasts. The effects of melatonin on ALPase activity were determined 
after 3 days of daily melatonin treatments, with normalization by MTT viability 
assay. 
a. Student t-test; p<0.05 when compared against vehicle 
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Figure 4.6. Distribution of the viable osteoblast cell numbers in controls and AIS 
at physiological concentration of melatonin (lO'^M). The normal human 
osteoblasts showed enhancement on cell viability when physicological concentration 
of melatonin was added. While the AIS osteoblasts, three of the samples showed 
enhancement on cell numbers when melatonin was added. However, the remaining 
10 AIS osteoblasts showed inhibition at physiological concentrations of melatonin. 
- 9 8 -
I • Normal (n=9) • Group A (n=3) a Group B (n=1Q) | 
180 
IDU — ** 雌 i* 
= 1 4 0 
丨! swn 
Vehicle 10-9 10-5 10-4 
Melatonin Concentration (M) 
Figure 4.7. Effect of melatonin on the viable cell numbers of normal human 
and the two groups of AIS osteoblasts. The effect of melatonin on cell viability 
was determined by MTT cell viability assay after 3 days of daily melatonin 
treatments. 
a. Student t-test; p<0.05 when compared against vehicle 
b. Student t-test; p<0.01 when compared against vehicle 
* Post Hoc Test (LSD); p<0.05 when Control vs Group B 
** Post Hoc Test (LSD); p<0.01 when Control vs Group B 
# Post Hoc Test (LSD); p<0.05 when Group A vs Group B 
M Post Hoc Test (LSD); p<0.01 when Group A vs Group B 
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Figure 4.8. Effect of melatonin on ALPase activity in normal human and the 
two groups of AIS osteoblasts. The effects of melatonin on ALPase activity were 
determined after 3 days of daily melatonin treatments, with normalization by MTT 
viability assay. 
a. Student t-test; p<0.05 when compared against vehicle 
• Post Hoc Test (LSD); p<0.05 when Control vs Group B 
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Melatonin signaling pathway dysfunctions have been reported in osteoblasts derived 
from selected group of severe AIS patients (Azeddine et al.’ 2007, Moreau et al, 
2004). In Chapter 4, it has been also demonstrated the presence of abnormal 
response of osteoblasts to melatonin effect on proliferation and differentiation in 
subgroups of the AIS. There were two distinct responses from the AIS osteoblasts 
toward melatonin. One was similar to the normal osteoblasts enhancing effects, 
namely as Group A. Another was Group B where melatonin was shown to have 
inhibitory effect on both osteoblasts proliferation (cell viability) and differentiation 
(ALPase activity). To account for the observed melatonin pathway dysfunction, it 
is speculated that the abnormality could be related to a quantitative or qualitative 
variation in the melatonin receptors. Reports have indicated that melatonin 
receptors could be regulated homologously or heterologously, or by other stimuli 
such as light or estradiol (Witt-Enderby et al.’ 2003). It was also shown that 
G-protein uncoupling, receptor down-regulation, internalization and phosphorylation 
might be part of the mechanisms for melatonin receptor regulation (Witt-Enderby et 
al., 2003). In the present study, the nature of melatonin receptors in these AIS 
osteoblasts was evaluated. This might help to provide further understanding and 
explanation of the observed heterogeneous responses of the AIS osteoblasts to 
melatonin. 
Three types of mammalian melatonin receptors, MTl, MT2 and MT3, have been 
identified (Witt-Enderby et al., 2003). However, MT3 receptor has only been 
identified in avians and rodents, but have not been identified in humans (Nosjean et 
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ai, 2001, Reppert, 1997). The two human melatonin receptors, MTl and MT2, are 
membrane-associated G-protein-coupled receptor families, and belonging to the 
rhodopsin superfamily (Morgan et al., 1989, Reppert, 1997, Reppert et al., 1995, 
Reppert et al., 1994，Rivara et al, 2005，von Gall et al.’ 2002). Both MTl and 
MT2 have been suggested to play a role in bone remodeling (Dubocovich et al., 2001, 
Reppert et al., 1995, Reppert et al., 1994). Although active expressions of these 2 
receptors can also be found in the retina (Fujieda et al., 1999, Meyer et al., 2002, 
Savaskan et al, 2002) and brain (Kong et al., 2008, Uz et al., 2005), it is also 
distributed across many other tissues (Achong et al., 2003，Dillon et al, 2002, 
Lanoix et al.’ 2006，Naji et al.’ 2004). In general, the signaling pathway mechanism 
after the activation of either MTl or MT2 receptors in osteoblasts could result in the 
inhibition of adenylate cyclase activity (von Gall et al.’ 2002), which in turn inhibit 
forskolin-induced cyclic AMP formation, with a subsequent decrease in activated 
protein kinase A (Vanecek, 1998). This signal transduction mechanism is the best 
recognized pathway. However there are speculations on other possible 
transductions involved in different tissues. For example, in HEK293 cells, 
melatonin acting through MTl receptors downregulates the activity of adenylate 
cyclase, though MTl receptor can also activate upregulate phospholipase C-(3 in 
HEK293 cells (Brydon et al., 1999). Through the MT2 receptor of the HEK293 
cells, melatonin can inhibit soluble guanylate cyclase as well (Petit et al, 1999). 
Depending on the type of cell, melatonin may regulate different secondary 
messengers within the same signal transduction pathway (New et al., 2003). 
In addition to the receptor diversity, Moreau et al. (2004) found dysfunction of 
melatonin signaling pathway in osteoblasts derived from AIS patients. The addition 
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of melatonin to osteoblasts isolated from a selected group of AIS patients failed to 
inhibit the forskolin-stimulated cyclic AMP. The degree of inhibitions can be 
further classified into 3 distinct groups based on the functional response (Moreau et 
al., 2004). In regards to the possible dysfunction of melatonin signaling pathway, 
the Gi protein coupling was thought to be dysfunctional in some AIS patients 
(Letellier et al, 2008, Moreau et al, 2004). In another study at our center, we 
found that melatonin IB polymorphism was associated with the occurrence of AIS 
(Qiu et al., 2007a). In this study, the AIS patients demonstrated a majority with the 
phenotype of TC (42.8%) and CC (50.6%)，with a higher C allele expression (72%) 
than T allele (28%). However, the MT2 gene was not associated with curve severity. 
It was suggested that MT2 might be a disease predisposition gene. 
Therefore, with the assumption that AIS patients have systemic problem with the 
melatonin signaling pathway, the present study aims to investigate the expression of 
the melatonin receptors, MTl and MT2, in human AIS osteoblasts which to the best 
of our knowledge has never been properly studied. 
5.2. Methodology 
5.2.1. Osteoblast Samples 
The samples of normal control and AIS osteoblasts were the same as described in the 
previous chapter (Chapter 4). Methods of collection and isolation are explained in 
details in Chapter 4.2. 
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5.2.2. Protein Expression of Melatonin Receptors in AIS Osteoblasts 
To investigate the presence of the melatonin receptors in AIS osteoblasts，the protein 
expression of melatonin receptors were evaluated semi-quantitatively by Western 
blotting and compared with normal controls. 
5.2.2.1. Materials and Reagents 
Radioimmunoprccipitation assay (RIPA) Buffer 
The following including 1.8 g NaCl (Merck & Co., Darmstadt, Germany), 1.0 g 
deoxycholic acid (Sigma, St丄ouis, USA), 2.0 ml NP-40 (Fluka, Steinheim, 
Switzerland), 1 ml 20% SDS (Amresco, Solon, USA), and 6.7 ml 1.5M Tris-HCl (pH 
8.0) (Sigma, St.Louis, USA) was dissolved in 200 ml distilled water. 
2x Sodium Dodecvl Sulfate (SDS) Gel Loading Buffer 
Bromophenol blue (4 mg) (Merck & Co.，Darmstadt, Germany) was dissolved in 1.6 
ml IM Tris-HCl (pH 6.8) (Sigma, St丄ouis, USA), 4 ml 10% SDS (Amresco, Solon, 
USA), 2 ml glycerol (Amresco, Solon, USA), 1 ml p-mercaptoethanol (Merck & Co., 
Darmstadt, Germany) and 1.4 ml deionized water. The solution was mixed gently 
and the final volume made up to 10 ml. 
4% Stacking Gel 
0.49 ml of 30% acrylamide solution (containing 0.3 g/ml acrylamide and 8 g/ml ofN, 
N'-methylene bisacrylamide) (GE Healthcare, Bucks, UK), 0.97 ml O.IM Tris-HCl 
(pH 6.8) (Sigma, St.Louis, USA), 35 i^l 10% SDS (Amresco, Solon, USA) and 1.96 
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ml of deionized water were mixed gently. Prior to loading the gel onto the cask, 4 
|il TEMED (Merck & Co., Darmstadt, Germany) and 14 |il 10% ammonium 
persulfate (Sigma, St.Louis, USA) were added to the mixture. 
12% Separating Gel 
3.5 ml of 30% acrylamide solution (containing 0.3 g/ml aery lam ide and 8 g/ml of N, 
N'-methylene bisacrylamide) (GE Healthcare, Bucks, UK), 3.3 ml IM Tris-HCl (pH 
8.8) (Sigma, St丄ouis，USA), 87.5 \i\ 10% SDS (Amresco, Solon, USA) and 1.9 ml 
of deionized water were mixed gently. Prior to loading the gel onto the cask, 4 |il 
tetramethylethylenediamine (TEMED) (Merck & Co.，Darmstadt, Germany) and 35 
[i\ 10% ammonium persulfate (APS) (Sigma, St.Louis, USA) were added to the 
mixture. 
SDS Running Buffer 
The following including 3.0 g 0.25M Tris Base (Sigma, St丄ouis，USA), 14.4 g 
1.92M glycine (Amresco, Solon, USA) and 1.0 g 1% SDS (Amresco, Solon, USA) 
were dissolved into 800 ml deionized water. The solution was mixed gently and the 
pH was adjusted to 8.3. The final volume was made up to 1000 ml with deionized 
water. 
Tris-Buffered Saline with Tween-20 (TBST) 
The following including 8.8 g NaCl (Merck & Co.，Darmstadt, Germany), 0.2 g KCl 
(Merck & Co.，Darmstadt, Germany) and 3 g Tris base (Amresco, Solon, USA) were 
dissolved in 800 ml distilled water. The solution was mixed gently and 0.5 ml 
Tween-20 (Amresco, Solon, USA) was added. The pH was adjusted to 7.4 and the 
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final volume made up to 1000 ml with distilled water. The solution was sterilized 
and stored at 4�C. 
5% Skimmed Milk 
Skimmed milk (5.0 g) was dissolved in 100ml TBST. The diluted skimmed milk 
was mixed gently and stored at 4°C. All the primary and secondary antibodies were 
diluted with 5% skimmed milk at different dilution factor shown below: 
Primary Antibody 
Dilution range was determined by serial concentrations of the antibody: 
Goat IGg anti-human MTl receptor (Santa Cruz, Santa Cruz, USA) (Dilution: 1:500) 
Goat IGg anti-human MT2 receptor (Santa Cruz, Santa Cruz, USA) (Dilution: 1:200) 
Goat IGg anti-human Actin (Santa Cruz, Santa Cruz, USA) (Dilution: 1:500) 
Secondary Antibody 
Dilution range was determined by serial concentrations of the antibody: 
Donkey anti-goat IgG (Santa Cruz, Santa Cruz, USA) (Dilution: 1:500) 
Stripping Buffer 
Tris-HCl (12.5 g) (pH 6.8, 0.5M) (Sigma, St.Louis, USA) in 20 ml 10% SDS 
(Amresco, Solon, USA) and 67.5 ml distilled water were mixed gently and, in a 
fumehood, 0.8 ml B-mercaptoethano 1 (Merck & Co., Darmstadt, Germany) was 
added into the solution. 
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5.2.2.2. Western Blotting 
For protein extraction, the cells were seeded at a cell density of 1x10^ cells in a 150 
cm^ flask (Corning, Corning, USA) and cultured in a-MEM containing 10% FBS. 
Upon reaching confluence, the cells were cultured for 3 more days. Then, the cells 
were trypsinized and lysed in RIPA buffer containing 1 mM protease inhibitor 
cocktail (Sigma, St.Louis, USA) for 30 minutes. The mixture was centrifuged at 
14,000 rpm for 10 minutes at 4°C. The supernatant was collected for protein 
detection. 
For Western blotting, approximately 16 \i\ of the prepared supernatant was taken out 
and mixed with an equal volume of 2x SDS gel loading buffer. The samples were 
placed in a boiling water bath for 5 minutes. After sonication, the samples were 
centrifuged at 14，000rpm for 7 minutes. The supernatant (25 |ig)，in 15ul, was 
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (BioRad, Hercules, USA) using 12% separating gel and 4% stacking 
gel for 45 minutes at 200V. The gel was removed from the tank and electroblotted 
onto a methanol-activated nitrocellulose membrane (Hybond-ECL; GE Healthcare, 
Bucks, UK) by using a semi-dry method for 30 minutes at 400 mA. After semi-dry 
transference, the membrane was washed three times with TBST buffer and blocked 
with 5% skimmed milk for I hour at 4°C. Thereafter, it was probed with the 
selected goat anti-human primary antibodies overnight at 4®C. The membrane was 
washed three times with TBST buffer and incubated with horseradish 
peroxidase-conj ugated donkey anti-goat secondary antibody for 1 hour at room 
temperature. After three washes, the immunocomplex was visualized using ECL 
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Western Blotting Detection Reagents (GE Healthcare, Bucks, UK) and ECL 
mini-Camera (Alphalmager 2200 Imaging System). 
After analyzing the first primary antibody, the same membrane was rinsed with 
TBST buffer and the antibodies were stripped away by stripping buffer for 30 
minutes. Then, it was incubated with anti-actin antibody for 1 hour at room 
temperature as reference protein. As before, after conjugating with a secondary 
antibody, it was visualized using ECL Western Blotting Detection Reagents (GE 
Healthcare, Bucks, UK) and ECL mini-Camera (Alphalmager 2200 Imaging System). 
An affinity-isolated antigen-specific antibody directed against the actin protein 
(Santa Cruz, Santa Cruz, USA) was used as a reference protein for 
semi-quantification of the Western blots. Semi-quantification of the bands was 
done by an image analytical program, ImageJ (Version 1.37，USA). All results 
were confirmed in duplications. 
5.2.3. Genotyping of MTl receptors by Restriction Fragment Length 
Polymorphism (RFLP) 
The genotyping of MT2 receptors by RFLP was performed as described previously 
by Qiu et al (2007a). This was to determine whether there is any difference in the 
MT2 receptor polymorphism in the AIS patients from this study. In brief, total 
peripheral DNA was isolated from the 3 ml blood samples of AIS patients using 
DNA extraction kit (Amersham, Buckinghamshire, UK) according to the 





Genomic deoxyribonucleic acid (DNA) amplification was performed using a 
polymerase chain reaction (PCR) with 12.5 |il reaction mixtures, containing 0.5 
Units of Taq polymerase, 10 mmol/L of each primer and 2 mmol/L MgC^. A 
typical 35 amplification cycles, consisted of 30 seconds, at 96°C, 45 seconds at 
annealing temperature and 30 seconds at 72°C, was used. The final elongation step 
consisted of 7 minutes at 72°C. For the restriction enzyme digestion, PCR product 
was subjected to 3 to 5 Units of the required enzyme, in the presence of the 
accompanying buffer, was incubated overnight. The restricted PCR products were 
visualized by electrophoresis in 4% agarose gel. Validation was performed by 
duplicating the samples. 
5.2.4. Clinical Evaluations of the AIS Patients 
The anthropometric and BMD measurments of the AIS patients were the same as 
described in the previous chapter (Chapter 3). Comparison was then made with 
matched controls data (z-score) from the normal population. Detailed procedures 
on the measurments are explained in details in Chapter 3.2. 
5.2.5. Data Analysis 
All data were expressed as mean 士 S.D. Statistical significance of the difference 
between the band intensity of the receptors from Western blotting was analyzed 
between the control and the three groups by ANOVA. The difference was 
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considered significant when p < 0.05. SPSS software (version 11; SPSS, Inc., 
Chicago, IL) was used for statistical analysis. 
5.3. Results 
5.3.1. Semi-quantification of Melatonin Receptors in AIS Osteoblasts 
In Figure 5.1 and 5.2，MTl receptors were found in osteoblasts isolated from AIS 
patients and normal controls. As for MT2 receptor expressions, it was expressed in 
all the normal controls (Figure 5.1). However, only 69% of AIS subjects showed 
expressions of MT2 receptor from their osteoblasts (Figure 5.2). With further 
analysis of the Western blotting according to the subgroups suggested in Chapter 4， 
all the subjects in Group A showed observable band of MT2 expression. However, 
in Group B, only 60% of the patients showed the expression of MT2 receptor on 
their osteoblasts. Therefore, the Group B subjects could be divided into 2 groups, 
according to the presence of MT2 expression on osteoblasts as Group B1 and B2, 
namely. 
In Figure 5.3，it showed that there was no significant difference on the MTl receptor 
expressions between the normal osteoblasts and with Group A (p=0.236), Group B1 
(p=0.977) and Group B2 (p=0.068). There was no significant difference between 
the MT2 receptor expression of normal controls with Group A (p=0.202) and Group 
B1 (p=0.138). In comparing the receptor expression intensity between different 
AIS subgroups, there was no difference between the MTl expressions in Group A 
with Group B1 (p=0.406) and Group B2 (p=0.352). The MT2 expression between 
Group A and B1 was similar (p=0.996). 
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5.3.2. RFLP 
Figure 5.4 shows the gel image of all the genotype results of MT2 receptor of the 
thirteen AIS subjects. The distribution is summarized in Table 5.1. In Group A 
(n=3), 67% of the subjects (2 out of 3 subjects) showed the genotype expression of 
CT, while the only 33% of the subjects showed TT (1 out of 3 subjects). In Group 
B (n=10), 60% of them demonstrated genotype expression of CT (6 out of 10 
subjects). The remaining showed 30% of the subjects (3 out of 10 subjects) 
carrying the genotype ofTT, while 10% was CC (1 out of 10 subjects). 
5.3.3. Functional Response Between the Different AIS Groups 
Figure 5.5 shows the effect on proliferation between the three different groups of 
AIS osteoblasts toward melatonin. The osteoblasts from the AIS patients were 
divided into three groups based on the classification on Chapter 4 and the presence of 
MT2 receptors. In the first group (Group A; Figure 5.5)，melatonin treatment 
enhanced the number of osteoblasts, similar to the normal control, at all 
concentrations (10" ,^ 10"^  and 10.4 M). The promotion was significant at 10"^  M 
(p=0.021). However, the enhancement of osteoblast proliferation at melatonin 
concentrations 10"^  M (p=0.109) and 10"^  M (p=0.263) was not statistically 
significant. The non-significant association between these two doses of melatonin 
might be accounted by the large standard deviations in the small sample size (n=3). 
Both groups in Group B (Group B1 and Group B2, Figure 5.5) showed an inhibition 
on the number of osteoblasts to effect of melatonin. The inhibition of Group B1 
was statistically significant at all concentrations of 10'^  (p=0.039) and 10.4 M 
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(p二0.039). For Group B2, the inhibition was not significant at concentrations of 
melatonin (p>0.05). In comparing between the normal controls and Group B1 and 
B2, there were significant differences in the number of osteoblasts at all melatonin 
concentrations (p<O.Ol). There was no significant difference between the number 
of viable osteoblasts in Group A and normal controls at melatonin concentrations of 
10-9 (p二0.472)，10-5 (p二0.305) ^^^ iq-^m (p=0.995). In comparing Group A and 
Group Bl, there were significant differences in the number of osteoblasts at 
melatonin concentrations of 10"^  (p=0.018) and 10'^  (p=0.001). However, there was 
no significant difference at the melatonin concentrations of 10.4 (p=0.084). While 
similarly in the comparison between Group A and Group B2, there was significant 
difference on the effect of melatonin toward the number of osteoblasts at all 
concentrations of 10"^  (p=0.045), 10"^  (p=0.002) and 10"^  (p=0.05). Comparing 
between the two groups in Group B, there was no significant difference on any of the 
melatonin concentrations (p>0.05). 
Figure 5.6 shows the effect of melatonin on ALPase activity between the three 
different groups of AIS osteoblasts. With the same classification mentioned above, 
the AIS osteoblasts displayed 3 types of response to various concentrations of 
melatonin (Figure 5.6). In Group A (Figure 5.6)，melatonin treatment promoted 
ALPase activity, similar to the normal control, at all concentrations (10"^ 10"^  and 
10"^  M). However, the enhancement of ALPase activity in Group A was not 
statistically significant at any of the melatonin concentrations (p>0.05). For the 
Group Bl (Figure 5.6)，it showed an inhibition on the ALPase activity at all 
concentrations of melatonin, while for Group B2, it showed an enhancement of 
ALPase activity. However, there was similar ALPase activity in Group Bl and 
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Group B2 (p>0.05). In comparing between the normal controls and Group Bl, 
there were significant differences in ALPase activity at the melatonin concentrations 
of (p=0.017)，but not at the melatonin concentrations 10'^  M (p=0.136) and 
10-5 M (p=0.l21). In the comparison between the normal controls and Group B2, 
no significant difference was shown between the two groups in ALPase activity 
(p>0.05). Similarly, there was no significant difference between the ALPase 
activity in Group A and normal controls (p>0.05). In comparing Group A and the 
two groups in Group B (Group Bl and Group B2), there was no significant 
difference in the melatonin effect on ALPase activity (p>0.05). There was no 
significant differences of ALPase activity in response to melatonin between the two 
subgroups in Group B (p>0.05). 
5.3.4. Correlation of the Clinical Phenotypes with the Different AIS 
Subgroups 
Table 5.2 shows the results of body weight, height, corrected height, BMI, arm span 
and BMD of the three AIS groups obtained from the Chapter 3. The AIS patients in 
Group B2 showed a longer arm span, body weight, height and BMI than those of 
Group A and Group B1. Also, the dominant and non-dominant sides of the bilateral 
femoral neck BMD of Group B2 were higher than Group A and Group B1. When 
adjusted with the age-matched normal community, Group B2 showed a longer arm 
span, body weight and BMI when compared with Group A and Group Bl. 
Similarly on BMD, the dominant and non-dominant sides of the bilateral femoral 
neck of Group B2 were higher than Group A and Group Bl. The midshaft apparent 
BMD was lower in the AIS patients of Group B than those in Group A. While, the 
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other parameters, they all seemed to be similar between the three groups. However, 
none of the comparisons was significant. The lack of significance might be due to 
the small sample size. In Table 4.4, the prevalence of having a family history with 
scoliosis is 75% in Group B2 (3 out of 4 subjects), while Group B1 and Group A 
have a prevalence of 17% (1 out of 6 subjects) and 0% (0 out of 3 subjects), 
respectively. 
5.4. Discussion 
In the present study, it was shown that MTl receptor protein expression was 
observed in all the AIS subjects. According to the grouping in Chapter 4, it was 
shown that all Group A subjects have MT2 expression, while only 60% of the 
subjects in Group B showed MT2 expression. The genotypes of Group A subject 
were TC (2/3) and CC (1/3). For the Group B subjects with MT2 expression，the 
genotypes were TC (4/6)，CC (1/6) and TT (1/6). The subjects without MT2 
receptor protein expression allowed further subgrouping into Group B1 and B2, 
namely. The Group B2 patients without MT2 receptor response were found to have 
a longer arm span than the other two groups of AIS subjects. In addition, the Group 
B2 patients have higher prevalence rate of positive family history of AIS. Although 
the result did not reveal direct relationship with the BMD level, the finding might 
reflect possible association of melatonin receptor abnormality with disproportional 
endochondral ossification and abnormal bone growth and longer arm span in AIS 
patients. 
As MT2 polymorphism was associated with the occurrence of AIS (Qiu et al., 
2007a), the result (Table 5.1 and Figure 5.4) showed 61.5% (8 out of 13 subjects) of 
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the AIS patients having the majority of the genotype TC. Only 7.7% (1 out of 13 
subjects) expressed a rare TT genotype in Group Bl，while 30.8% (4 out of 13 
subjects) showed CC genotype expression. The frequency of C allele of this single 
nucleotide polymorphism (SNP) located in the promoter was 61.5%, while the T 
allele was 38.5%. This result matched with the reported findings of the AIS 
patients having a majority at the C allele and the genotype of CC and TC (Qiu et al., 
2007a). However, the small sample size has to be taken into account. As from the 
report from Qiu et al. (2007a), the majority of the AIS patients carrying genotype CC 
(50.6%) than genotype TC (42.8%). In that study, the majority of the C allele was 
72% in the AIS subjects, while the T allele was 28%. 
From the previous chapter, Group B of AIS osteoblasts demonstrated a generalized 
inhibitory response in proliferation and differentiation to melatonin. However, in 
this study, not all the Group B showed similar MT2 expression. Even though 
Group B2 has no MT2 phenotype by Western blotting, melatonin induced inhibitory 
response in proliferation and differentiation was still found. By genotyping, MT2 
receptor gene was also found in Group B2 AIS osteoblasts. Hence, it is speculated 
that there might be problem with either the gene translation or the translocation of 
the MT2 receptor to the membrane in the Group B2 osteoblasts. The abnormal 
MT2 receptor is likely to result in impaired response toward melatonin. 
With the new classification, the proliferative response of osteoblasts to melatonin 
was further divided into three groups of AIS osteoblasts. In Figure 5.5 and 5.6’ the 
proliferative and differentiation response of the three groups of AIS osteoblasts 
toward melatonin was summarized. Group A showed an enhancement in cell 
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numbers and ALPase activity with serial concentrations of melatonin, similar to the 
pattern of normal controls. While for Group Bl, it showed inhibitory response in 
both proliferation and differentiation to melatonin. As for Group B2, it showed 
inhibition in proliferation to melatonin though a lesser degree than Group Bl. In 
contast to Group Bl, minimal enhancement on the ALPase activity was found 
instead of inhibition. This observation is similar to the finding of Moreau et al 
(Azeddine et al.’ 2007,，2004)，who reported 3 distinct groups of AIS osteoblasts 
based on their responsiveness to melatonin in the cyclic AMP assay. As it is shown 
in the study of Satomura et al (2007), the inhibition of cyclic AMP would enhance 
osteoblasts to proliferate under the same melatonin concentrations. Similar findings 
on lower cyclic AMP accumulation resulting in higher cell proliferation in other cell 
types (Mallat et al.’ 1998, Tsuboi et al, 1996, Watson, 1976) have been reported. 
Hence, the abnormal functional response to melatonin might imply a possible 
dysfunction in the melatonin signaling pathway. However, it may still be too early 
to directly compare our results in the proliferation assay with the one used by 
Moreau et al. (cyclic AMP assay). As in our cellular model, melatonin can cross 
the cytoplasmic membrane in the viable cell to act in the cytosol with MT3 receptor 
and translocate in the nucleus through interactions with orphan nuclear receptor. 
While in Moreau's study, the effect from the nucleus is neglected for the cell is lysed 
for determination on the cyclic AMP accumulation. Moreover, in the current study 
assessment of cyclic AMP was not included. Further study would be needed to 
compare and correlate with the response shown in Moreau et al.,s study (Azeddine et 
al, 2007，，2004). 
With this assumption, multiple studies have identified different loci of susceptibility 
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(Chan et al, 2002, Salehi et al., 2002，Wise et al., 2000). Similar to Moreau et al. 
finding (Azeddine et al., 2007，，2004)，the different responses in osteoblasts from 
AIS patients to melatonin would most likely to be a cell autonomous defect rather 
than a consequential response from the spinal deformity. The author, Moreau at al.’ 
commented that abnormality in melatonin signaling pathway of this selected group of 
AIS could be due to the G protein coupling disturbance (Letellier et al., 2008, 
Moreau et al., 2004). However, the result of Western blot in our study opened up 
another explanation that the loss of MT2 receptor function might also play an 
important role in explaining the abnormality observed in Group B2. 
To investigate the effect of MT2 on the signaling process in the cell, luzindole is a 
commonly used MT2 receptor antagonist (Dubocovich et al., 1998, Satomura et al, 
2007，Scares et al, 2003). In a study conducted by Sanchez-Hidalago et al. (2007), 
they investigated whether melatonin can inhibit fatty acid-induced triglyceride (TG) 
accumulation in ROS 17/2.8 cells, a rat osteosarcoma cell line. In a part of their 
study, luzindole was added in an attempt to elucidate the mechanism of action by 
which melatonin can influence TG accumulation. The result showed a significant 
increase in TG accumulation. The increase in TG accumulation, which antagonize 
the osteoblastic pathway (Ahdjoudj et al.’ 2001, Diascro et al., 1998), was shown to 
inhibit the stimulatory effect of melatonin on the osteosarcoma cell line to proliferate 
and differentiate. Radio et al. (2006), showed that melatonin, acting through MT2 
melatonin receptors could enhance ALPase activity to osteogenic media alone in 
mesenchymal stem cells. With MT2 antagonists, 4-phenyl-2-propionamidotetralin 
(4-P-PDOT) and luzindole, the ALPase activity of the stem cells in osteogenic 
medium and melatonin was inhibited. These results showed that MT2 receptor 
-118 -
could play an important role in influencing osteoblasts proliferation and 
differentiation. 
The anthropometric data of the 4 Group B2 AIS patients with abnormality of MT2 
receptor expression revealed significantly longer arm span, taller in height, heavier 
body weight and higher BMI than all the other AIS patients in Group A and Group 
Bl. After adjusted for age and compared with normal adolescents (Table 5.3), an 
even longer arm span and higher BMI difference in Group B2 than Group Bl and 
Group A AIS could be seen. This could imply that the abnormal expression of MT2 
receptors might have a direct effect on the endochondral ossification in the AIS 
patients. In addition, the Group B2 patients seemed to have a higher prevalence in 
familial history (Table 5.4). The rate of having first degree family members with 
scoliosis in Group B2 was 75%, which was much higher than the other two groups. 
It is likely that AIS patients with long arm span might have a higher prevalence of 
positive family history. 
Group B2 was found to have higher mean body mass index and a higher BMD at 
both femoral necks than the other two groups of AIS. Also, with age-adjusted 
comparison with the normal community (Table 5.3), BMD of the dominant and 
non-dominant femoral neck were higher in Group B2 than Group A and Group Bl . 
Previous studies have demonstrated that body mass and bone mass are directly 
related, and many studies have shown a positive association of BMD with body mass 
(Felson et al” 1993，Glauber et al, 1995，Khosla et al.’ 1996, Lim et al., 2004, 
Lindsay et al., 1992, Stewart et al., 2002). Although mechanical loading may 
contribute to this, other factors have been reported to be involved, such as estrogens 
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(Olson et al.’ 2008, Yu et al., 2002) and leptin (Cock and Auwerx, 2003). As 
estrogens are known to play a role toward bone formation (Olson et al, 2008, Yu et 
al., 2002), the effect of melatonin on bone formation might not be direct. Indirect 
actions can be induced by secretion of growth hormone (Forsling et al, 1999) and 
Cortisol (Cagnacci et al., 1995, Kostoglou-Athanassiou et al., 1998)， or 
down-regulation of the receptor activator of NF-kappaB ligand (RANKL)-mediated 
osteoclast formation/activation (Koyama et al, 2002) stimulated by melatonin. 
Recent studies suggest that estrogens suppress the synthesis of AA-NAT protein 
(Hayashi and Okatani, 1999，Weiss and Crayton, 1970), the rate-limiting enzyme in 
the synthetic pathway of melatonin (Illnerova et al, 1983，Klein et al, 1971). 
Further study on estrogens level of these AIS subjects could be helpful. In in vitro 
study, melatonin may enhance bone formation by suppressing osteoclasts (Koyama 
et al., 2002, Suzuki and Hattori, 2002) through free radical scavenging properties or 
enhancing osteoblast activity (Radio et al, 2006, Roth et al, 1999) through specific 
melatonin receptors (Moreau et al., 2004，Radio et al, 2006). A previous study 
using goldfish scales had found significant decrease on the tartrate-resistant acid 
phosphatase, a biomarker of osteoclast activity, after incubating with melatonin 
(Suzuki and Hattori, 2002). Thus, further signifying possibilities that other 
melatonin-mediated mechanisms might be involved in bone mineralization (Roth et 
al., 1999, Satomura et al, 2007). 
Although the cellular response in Group A showed similar response to the normal 
controls, the AIS patients still showed abnormal phenotypic expression of a longer 
arm span and lower BMD than the normal controls. This may indicate a different 
etiology involved on the scoliosis occurrence in this group of AIS. This is likely 
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that the AIS patients consist of a heterogenous population with different etiologies. 
With this, it may help to explain why osteopenia does not occur in all AIS patients. 
Most importantly, this study provided another important piece of evidence on the role 
of melatonin in the etiopathogenesis of AIS. 
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Control N1 N2 N3 N4 N5 N6 N7 N8 N9 
MTl 1 _ • . 一 3 7 kDa 
I • ' 
MT2 4-. i c x ^ 
一， 、， ‘ ^^ • — "KIN , ^ 36 kDa 
Aetm . - I I I 1 一 _ _ _ 編 40 kDa 
Figure 5.1. Expression of MT receptors in normal human osteoblasts. The 
cells isolated from 9 normal controls were cultured until they reached confluence. 
The cells were lysed and examined for the expression of MTl and MT2 protein 
receptor expressions by Western blot analysis. All the normal osteoblasts showed 
the presence of MTl and MT2 receptor expressions. 
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Group Bl A B2 A Bl Bl B2 B2 
AIS “ A 2 A 3 A 4 A 5 “ A 6 ~ A 7 A 8 
MTl 一 一 一 < r 37 kDa 
MT2 _ • � ^ 3 6 kDa 
Aetin —,丨丨！ . , . ^ . ^ j ^ g < r 40 kDa 
Group A Bl Bl B2 Bl 
AIS A9 ~ A U ~ A T 2 A 1 3 
MTl ^mrn^ 一 < - 37 kDa 
MT2 _ - — • 36 kDa 
Aetin _ •_ — • 40 kDa 
Figure 5.2. Expression of MT receptors in AIS osteoblasts. The cells isolated 
from 13 AIS patients were cultured until they reached confluence. The cells were 
lysed and examined for the expression of MTl and MT2 protein receptor expressions 
by Western blot analysis. MTl receptor expression was detected in all AIS 
osteoblasts. However, in the MT2 receptors, only 9 (Group A and Group Bl) out of 
13 AIS osteoblasts showed MT2 receptor expression. 4 subjects (Group B2) did 
not reveal any MT2 receptors expression. 
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• I 0.8 - 4 — ]= 
M T 1 M T 2 
T v p e o f M e l a t o n i n F R 8 C 6 p t o r 
Figure 5.3. Semi-quantification of melatonin receptor (MTl and MT2) levels 
by Western blot. (No significant difference between groups). 
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Figure 5.4. The expression of MT2 gene polymorphism in osteoblasts from 
AIS patients. Peripheral bloods were collected from 13 severe AIS patients. 
DNA was isolated from the blood and restriction fragment length polymorphism was 
performed. The tagSNP used was rs4753426, cut with the enzyme Haelll. The 
PGR products were separated and visualized on a 4% agarose gel. 
Labels: -ve: Negative Control, +ve: Positive Control. 
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Table 5.1. The Genotype of the SNP rs4753426 in the MT2 Gene of the 13 AIS 
patients. 
Normal (n=304)* Group A (n= 10) Group B (n=10) 
Rs4753426 " n % " n % " n % 
Genotype 
T f ^ t W o 0 0% i 10.0% 
~TC 151 49.7% 2 66.7% 6 60.0% 
~CC m 42.4% i 33.30% 3 30.0% 
MT2, melatonin receptor IB; AIS, adolescent idiopathic scoliosis. 
•Normal referenced from Qiu et al 2007 (2007a) 
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Normal (n=9) - « - G r o u p A (n=3) Group B1 (n=6) ^ Group B2 (n=4) | 
a2, ci, d2 a2,bi,d2 a2,ci’d2 
I 130 f2.g2. hi.ii P . g2 h2 i2 ^ 
O 120 T 
^ 干 
% 憎 ^ ^ ^ [ J ： ^ ^ 一 . “ — — 
. 1 0 0 - f ii 
^ 90 i f 
80 1 1 1 i 
Vehicle 10-9 10-5 10-4 
Melatonin Concentration (M) 
Figure 5.5. Effect of melatonin on the viable cell numbers of normal human and 
the 3 subgroups of AIS osteoblasts. The effects of melatonin on cell viability 
were determined after 3 days of daily treatments. 
Student t-test; a': p<0.05, a^: p<0.01, when compared Control against vehicle 
Student t-test; b^: p<0.05, b^: p<0.01, when compared Group A against vehicle 
Student t-test; c^ p<0.05, c^: p<0‘01，when compared Group Bl against vehicle 
Student t-test; d^: p<0.05, d^: p<0.01, when compared Group B2 against vehicle 
Post Hoc Test (LSD); ft p<0.01, when Control vs Group Bl 
Post Hoc Test (LSD); g^ ： pO.Ol, when Control vs Group B2 
Post Hoc Test (LSD); h'： p<0.05，h^: p<0.01, when Group A vs Group Bl 
Post Hoc Test (LSD); p<0.05，P： p<0.01, when Group A vs Group Bl 
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• Normal (n=9) • Group A (n=3) 0 Group B1 (n=6) 0 Group B2 (n=4) 
180 ^ ^ 
i imr t 'M 
Vehicle 10.9 10.5 10.4 
Melatonin Concentration (M) 
Figure 5.6. Effect of melatonin on ALPase activity in normal human and the 3 
subgroups of AIS osteoblasts. The effects of melatonin on ALPase activity were 
determined after 3 days of daily treatments. 
a. Student t-test; p<0.05 when compared normal control against vehicle 
枯 Post Hoc Test (LSD); p<0.05 when Control vs Group B1 
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Table 5.2. Clinical Characteristics between the Three Groups of AIS Patients 
Group A Group B1 Group B2 p-
Mean 士 SD Mean 士 SD Mean 士 SD value 
(n=3) (n=6) (n=4) (a) 
Age at surgery (yrs) 15.03 士 2.30 14.58 ±1.51 15.55 ±2.44 0.784 
Arm span (cm) 158.83 士 5.53 159.94 ±6.29 167.07 ±5.09 0.153 
~ B o d y Weight (kg) 45.67 士 6.36 45.40 士 4.55 51.95 ±8.82 0.330 
Body Height (cm) 157.20 ±5.32 156.56 ±4.89 159.62 士 4.69 0.649 
一^rected Body 158.87 士 5.36 158.56 ±4.92 161.40 ±4.64 0.675 
Height (cm) 
BMI (kg/m') 18.03 ± 1.36 17.82± 1.97 18.52±2.15 0.860 
a: The p value indicated any inter-group difference by One-way ANOVA. 
Statistical significance at p<0.05 
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Table 5.3. Z-Score Comparison on the Anthropometry and Bone Geometry 
Between the Three Groups of AIS Patients 
Group A Group B1 Group B2 p-
Mean 士 SD Mean 士 SD Mean 士 SD value 
(n=3) (n=6) (n=4) (a) 
Arm span (cm) 0.25 ±0.90 0.44 ± 0.93 1.40 ±0.65* 0.185 
“ B o d y Weight (kg) -0.45 ± 1.20 -0.45 ± 0.67 0.51 ± 1.37 0.385 
“ B o d y Height (cm) -0.11 ±1.17 0.91 ±2.81 0.27 ± 0.89 0.775 
Corrected Body 0.45 ± 1.21 1.81 ±2.98 0.97 ±0.84 0.672 
Height (cm) 
BMI (kg/m^) -0.75 士 0.78 -0.83 士 0.90 -0.55 ± 1.03 0.898 
Non-dominant -0.51 士 1.16 -0.77 ± 0.64 -0.26 ± 1.07 0.716 
Femoral Neck BMD 
(g/cm') 
"Dominant Femoral -0.28 ±0.71 -0.82 ±0.61* -0.10 ±0.73 0.295 
Neck BMD ( g W ) 
Femoral Neck -0.16 ±0.85 -0.77 ± 0.62 -0.38 ±0.84 0.537 
(Convex) BMD 
( g W ) 
Femoral Neck -0.63 ± 1.02 -0.83 ± 0.62* 0.02 ± 0.92 0.342 
(Concave) BMD 
( g W ) 
“ i ^ d s h a f t Cortical 0.21 ±0.40 -0.50 ± 0.74 -0.21 ± 1.94 0.746 
BMD (g/cm^) 
“Midshaf t Apparent 0.11 ±0.43 -0.62 ± 1.00 -0.03 士 1.70 0.655 
BMD ( g W ) 
a: The p value indicated any inter-group difference by One-way ANOVA. 
Statistical significance at p<0.05 
*: One sample t-test: p<0.05 when AIS vs Normal Population 
*•： One sample t-test: p<O.Ol when AIS vs Normal Population 
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Table 5.4. Familial Occurrence in the Three Groups of AIS Patients 
Group A Group B1 Group B2 
(n=3) (n=6) (n=4) 
Rate of Occurrence 0 % (0/3) 17% (1/6) 75 % ( 3 / 4 ) “ 
-131 -
Chapter 6 Summary and Conclusion 
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6.1. Summary and Discussion 
This series of study confirmed the presence of abnormal responses of AIS osteoblasts 
to melatonin. The present study aimed to investigate the response of cellular 
activities of osteoblasts from severe AIS girls under the influence of melatonin in 
different concentrations. The objectives were 1) to study the anthropometric 
parameters and the bone mineral status of severe AIS girls when compared with 
control subjects; 2) to document the response of the cellular proliferation and 
differentiation of osteoblasts from AIS subjects to melatonin at different dosage 3) to 
study the expression of the melatonin receptors (MTl and MT2) in normal human 
and AIS osteoblasts. It was demonstrated that the severe AIS girls had longer arm 
span and lower BMD of femoral neck in general. There was no significant 
difference on the enhancement on proliferation and differentiation to melatonin. By 
comparing between normal controls and AIS osteoblasts, there were significant 
differences in all concentrations of melatonin, and marginal for high dosage in 
differentiation. For the anthropometric measurements and BMD of severe AIS girls 
and healthy controls, the results showed that the severe AIS girls have a significantly 
longer arm span and lower body mass index than the normal controls. BMD of the 
femoral neck in the severe AIS girls were significantly lower than that of the normal 
controls. 
However, with a more detail analysis, it could be grouped into 2 subgroups of AIS 
patients based on the response to physiological dosage of melatonin on cell 
proliferation. One group (Group A) was similar to the normal control subjects that 
both proliferation (Figure 4.6) and differentiation (Figure 4.7) of osteoblasts were 
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enhanced when melatonin was added. On the contrary, the osteoblasts of the other 
group (Group B) showed an inhibitory effect of melatonin on cell proliferation 
(Figure 4.6) and cell differentiation (Figure 4.7). With further investigation on the 
expression of melatonin receptors in those AIS subjects, it was shown by Western 
blotting that melatonin receptor MT2 was not expressed in 4 out of 10 subjects in 
Group B. This helps to further subgroup the Group B into those with (Group Bl) 
and without (Group B2) MT2 expression. With the limited number of subjects 
studied in the present study, the anthropometric data of the 4 AIS patients in Group 
B2 showed significant longer arm span, heavier body weight and higher BMI than all 
the other AIS patients in Group A and Group Bl. Although all the AIS 
demonstrated a lower BMD than the normal community. Group B2 have a higher 
BMD of bilateral femoral neck than the other two subgroups of AIS. 
With the 3 subgroupings，the response of the osteoblasts in proliferation and 
differentiation to melatonin was re-analyzed (Chapter 5). Group A showed an 
enhancement in cell proliferation and ALPase activity with different concentrations 
of melatonin, similar to the pattern of normal controls (Figure 4.4). Group Bl 
showed inhibitory response in proliferation and differentiation to melatonin. Group 
B2 showed inhibition in proliferation to melatonin. However, the degree of 
inhibition by melatonin is less than Group Bl. In contrast to Group Bl, Group B2 
showed minimal enhancement on the ALPase activity with addition of melatonin. 
This observation was similar to the finding of Moreau et al., who reported 3 distinct 
groups of AIS osteoblasts based on their responsiveness to melatonin using cyclic 
AMP assessment. The study of Satomura et al. showed that inhibition of cyclic 
AMP could enhance proliferation of osteoblasts with the same melatonin 
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concentrations. This finding supported our speculation that the three subgroups 
might have similar responses in the cyclic AMP accumulation as shown in Moreau et 
al. study. The abnormal functional response to melatonin may in fact be due to the 
impaired melatonin signaling pathway. 
In the phenotypic expression of the subgroups, the anthropometry of the AIS girls 
(Group A, B1 and B2) showed longer arm span, lower body mass index and lower 
BMD than the average adolescent girls. The 4 Group B2 AIS patients with low 
MT2 receptor expression were found to have significant longer arm span, heavier 
body weight and higher BMI than the other AIS patients in Group A and Group Bl. 
This implies that the MT2 abnormality might have a direct effect on the 
endochondral ossification in the AIS patients. Also, the BMD at dominant and 
non-dominant sides of the bilateral femoral neck were smaller in Group B than 
Group A. This may indicates a possible difference on the bone material property in 
Group B. In addition, Group B2 patients also had higher prevalence of positive 
familial history (75%) than Group A (0%) and Group Bl (25%). The major 
comparison between the three AIS subgroups is summarized in Table 6.1. 
In summary, this study provides important evidence on the hetereogenity of the AIS 
population in response to melatonin. One of the groups (Group A) showed 
enhancement in proliferation and differentiation to melatonin, while the other 
showed inhibition (Group B). With the MT2 receptor analysis, it can further 
subgroup the Group B into those with (Group Bl) and without (Group B2) the 
presence of MT2 receptor. Based on the previous findings on the dysfunction of the 
melatonin signaling pathway, the three groups of AIS osteoblasts from our study 
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might demonstrate similar responses with the groups mentioned in those studies. 
Also, these three subgroups of AIS patients showed heterogeneous difference in the 
anthropometric measurement and bone mineral status. Although the AIS patients 
showed a longer arm span and lower BMI than the controls, Group B2 has the 
longest arm span and lowest BMI among the three groups of AIS patients. This 
finding correspond to multiple reports of AIS patients of being more slender and 
leaner than normal healthy controls. Similarly, the AIS patients showed low BMD 
when compared with the normal populations. However, the AIS patients in Group 
B2 showed a higher BMD at the dominant and non-dominant side of the bilateral 
femoral neck than the other two groups. Group B1 had the lowest BMD among the 
three groups of AIS patients. This may imply that the bone material property in 
these three groups might be different. The observations might help to explain why 
only 30% of the AIS patients were clinically reported to have osteopenia. Although 
the cellular response in Group A showed similar response to the normal controls, the 
AIS patients still showed abnormal phenotypic expression of a longer arm span and 
lower BMD than the normal controls. This may indicate that AIS is likely to be a 
heterogeneous condition with different etiologies and that the occurrence and 
progression could be affected by different combination of factors intrinsically and 
extrinsically. Most importantly, the series of studies reported in this thesis has helped 
to provide better understanding of the role of melatonin in the etiopathogenesis of 
AIS. 
6.2. Limitations and Further Studies 
There are a number of limitations in the present studies. From the results, the 
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disturbance in endochondral ossification of the severe AIS subjects is reflected in 
longer arm span and lower BMI. However, this study has not analyzed the possible 
bone markers and hormonal changes affecting endochondral ossification and 
membranous ossification of the severe AIS subjects. 
In the study on BMD, both femoral necks showed significantly lower BMD than 
normal controls. Although difference in the BMD of the cortical radius of the 
midshaft was not significant, the numerical value of the AIS patients was lower than 
the control. The results indicated a possible abnormality in the property of bone 
material in the AIS patients. The biomechanical property, material property and the 
microarchitectural properties have not been studied in this series. 
In the vitro assessment, the age spectrum of the control was older than the AIS 
patients. As mentioned by few authors, an increase in age could account for the 
decrease in expression of melatonin receptors although the effect would be unlikely 
to affect the results in a negative way. As mentioned before, for practical and 
ethical reasons, the gender of the normal control consisted of a mixture of male and 
female patients. While for the AIS osteoblasts, they were all isolated from female 
patients. The fluctuation of the levels of hormones affecting bone metabolism, such 
as estrogen, is at the highest during the pubertal stage, especially in females. 
However, as the study was at the cellular level, the level of hormones, besides 
melatonin, was adjusted by the culture medium to be similar for all the osteoblasts, 
both male and female, used in this study. 
For the assessment of cellular proliferation, MTT assay only detects the number of 
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viable cells. Hence, a better approach for detecting proliferation would be by 
thymidine uptake by the cells. However, as this assessment is radioactive, there 
was a concern involved on using radiation in the current study. Also, assessments 
on the possible gene expressions of bone markers should be further assessed in future 
studies. As melatonin is incorporated to two different responses in AIS osteoblasts, 
there might be changes on the expressions of different bone markers (e.g. 
Osteopontin, osteocalcin). For the semi-quantification of melatonin receptors, the 
lack of MT2 response in some of the AIS osteoblasts of group B might be due to 
structural difference (mutations) of melatonin receptors thus affecting the binding 
affinity toward melatonin resulting in the abnormal functional responses. Future 
studies on correlating cyclic AMP assay with MT2 receptors might help to further 
delineate the actual defect or dysfunction in the melatonin signaling pathway. 
Overall, as this study was the beginning of a a small scale pilot investigation on the 
effect of melatonin on AIS osteoblasts, larger sample series in future could allow 
more indepth studies to better document the different responses of the osteoblasts to 
melatonin and their association with the abnormal phenotypes observed in AIS 
patients. 
6.3. Conclusion 
Overall, this is the first report on the abnormal cellular responses of AIS osteoblasts 
to melatonin. In general, there was no significant response on proliferation and 
differentiation in the AIS osteoblasts to melatonin. For the anthropometric 
measurements and BMD of severe AIS girls and healthy controls, the results showed 
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that the severe AIS girls have a significantly longer arm span and lower body mass 
index than the normal controls. Based on the responses toward melatonin, the AIS 
osteoblasts were divided into three groups. The groups of AIS osteoblasts (Group 1 
and Group 2)，with inhibitory functional responses toward melatonin, have shown 
disturbance on the phenotypic expression in the AIS patients, such as abnormal 
anthropometry and lower bone mineral status. With regards to the dysfunction of 
the melatonin signaling pathway, Group B2 without MT2 expression may play a role 
toward the abnormal bone growth of having longer arm span. From this study, it is 
likely that AIS patients are, in actual fact, a heterogenous group with different 
etiologies. Nevertheless, this study is a good step forward in providing additional 
interesting observations and understanding of the role of melatonin in the 
etiopathogenesis of AIS. However, further studies would be needed to determine 
the possible mechanisms involved in the heterogeneous responses to melatonin of 
AIS osteoblasts, and their association with abnormal bone growth and phenotypes in 
AIS patients. 
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Table 6.1. Summary on major characteristics between the 3 groups of AIS 
osteoblasts in this study. 
Group A Group B1 Group B2 
(n=3) (n=6) (n=4) 
Genetics 
” S u b j e c t s with CC 1/3 m 2/1 
genotype 
% of Family History oWo 16.6% 75.0% 
with Scoliosis 
Protein Expression 
Presence of MTl Yes Yes Yes 
Presence of MT2 ^ ^ ^ 
Functional Characteristics 
Effect of Melatonin Enhancement, Inhibition No response 
n 匸 similar to 
on Proliferation 隱 a l controls 
Effect of Melatonin Enhancement, Inhibition No response 
. ‘. similar to 
on Differentiation ^ o 隱 1 
Phenotypic Characteristics 
Arm span # Shortest Moderate Longest* 
BMI # Moderate* Lowest* Highest 
Bilateral Femoral Moderate Lowest* Highest 
Neck BMD # 
•Significant difference against the normal population 
# Compared between the 3 subgroups 
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Department of Orthopaedics & Traumatology 
^ ^ ^ ^ The Chinese University of Hong Kong 
青少年特發性脊柱側研究計劃 
Adolescent Idiopathic Scoliosis Research Study 
麥典者須知 
？aticqt 丨 nfom 沾 Qn 
s的： 
Objective: 
逸 過 身 效 測 董 、 骨 賀 密 度 、 基 因 测 试 _ 、 及 生 物 化 學 漸 試 , 針 青 少 年 特 發 性 脊 枉 側 變 作 弃 
廉 的 科 學 研 究 • 
一 — ‘ T h i t f O ^ Banc mineral denaity measiuemat. ^enedc analysis, blochemtcal aMlys i sTand^y measurement to 
study the edalogy of Adolasceat Idiopathic Sqoliosii 
• 研 究 计 《 内 容 ： 此 研 究 计 制 為 時 2 年 . 
Coateat of the Study: T h i s Study las ts f o r . 2 years . 
‘研究小組將會進^ 以^下检查： 
Research group will carry out the fbllowing measurement: ‘ 
身雄测量 
Body anthropometric mensureinsnt 
肢 t t的骨賀密度（浪意：作骨質密;M t * •如已懷华• J f e 在最後一次期 f e 计之 2 8 天後’接受 -光 
-骨*赛度儀•可缴t?丨致梟兄崎形 
Bone minoral density measuronvint oflong bones. (Possible risk of ndbtkm induced nalfbrowtion to the cmbcyo/fctuj aftci 28 I days foUow{fig ih« oiutt of Um last nenicntil period) 
因(解紅取10毫升AJft作到試） 
Genetic analysis (lOmL venous blood U ukcn for the analysts) 
生物4匕學测試（Jlf锖麥加者提供虎tf A t樣本作 
Dkochecoical Analysis (?vtidpuits are request to provitk sJdn sod boM lunpU tor wudysis) 
、封象： 
Participants: 
1 . 年 齡 十 二 崴 成 以 上 青 少 年 女 性 
10 to 16 years of age female 
. 2 • 年 齡 十 二 我 或 以 上 患 有 特 發 性 脊 枉 少 年 女 性 
10 to 16 years of age fiuxute with AdcAesceat Idiopathic Scoliosis 
備 t t : 
Note: 
所 有 資 料 只 作 研 究 用 速 ， 絕 對 保 密 
An the infonnadon collocted wffl be stricHy used for resemch purposes only and wQl b« kepi confidcntul by the 
researcfaen, 
计 射 負 责 人 ： 
香 * 中 文 大 學 场 形 外 科 及 釗 舟 學 系 教授 
Depaitment of Orthopaedics & Traunutology, O J H K Prof. ICY Cheng 
• 
• . i .A...H.. I 
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• 番港中文A學辞形外科及創係學系 . 
- D e p a r t m e n t of Orthopaedics Traumatology J O -
The Chinese University of Hong Kong 
一 . • • 峰 ••• — • • •• - • —— - •‘£ ‘— 
务 少 年 特 發 性 脊 枉 側 脅 研 究 计 劃 
Adolescence Idiopathic Scol ios is Research Study 
參 加 老 同 棄 書 
Consent Form 
下速簽名者（P a r t i c i p a n t Detail) 
社名 ( N a m e ) 身份进说碟（H K I D No. ) 編號（C o d e ) 
我 在 此 聲 明 自 拥 麥 加 青 少 年 特 發 性 脊 枉 例 来 研 究 計 劃 ： 
I dectaie that I consent voluntarily to ulce part in (he Adolescence Idiopathic Scoliosis Research Study: 
” • " ‘ 
- I fully understand oad volunCQrily join the ttswch study. 
2.我明白此计劃是怎樣進行的•... ’ -
• I fiilly undersund the details of the study including its aims, methods and u5c of date. 
3 . 我 有 權 出 有 關 此 计 拥 的 各 種 f U J 題 • 而 且 我 所 提 出 的 問 題 會 得 到 完 煤 的 解 答 
I h簏VC the right lo ask any question about ihe study and have satisfactory answer for the 
‘reiearchen/doceofs. 
4 . 我 明 白 有 权 隨 時 退 出 此 计 H , 我 亦 明 白 » 後 人 員 有 權 決 定 我 不 適 S 完 成 此 計 劃 而 
« 要 伴 i , 並 不 會 影 年 正 常 的 》 療 照 顧 • 
I understand that I have the tight to wilhdfaw from the study aad the healthcare pcrsonncl/rcsearchers also 
hive tho right to ask my withdrawal due to inappropriate continuation of tho study wiihout affccring normal . 
medical care. 
5 . 我 提 供 的 資 料 华 碟 無 供 ， 並 有 可 能 用 作 》 學 研 究 用 途 • 
All the inforaiadon provided by me is correct and wilt be used for research purposes • 
6 . 我 饭 明 我 已 般 完 全 味 解 這 份 同 意 書 的 内 容 • 
I •cJniowledge that [ undustand Ihe conlonts of this consent form. 
7 . 如 有 任 何 問 《 •可於辦工詩 M 内政電 2 6 3 2 - 3 3 0 9 . 南楊先生查恂• 
If you h»ve any queation, ptea«e contact Mr. Yeung at 2632-2745 during office hour. 
麥加者（P a r t i c i p a n t ) 革 " f t / f e獲人 ( P a r e n t / G u a r d i a n ) 
^ ^ (Signature) 簽名(Sigiwture) 
. • • 
效名(Namo) I 姓名(Name) 
tttt明上迷自颜者完全了解他们所•加的计« ‘ 並 秦 示 同 意 書 正 碟 無 
工 作 • 姓 名 ： 日期： . 
(Rweaicher Name) (Dote) 
. • • • 
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Appeddix III 
n • • • • -
• • “： 
. _ 香 港 中 文 大 學 • 
——续形外科及創傷學系 . ^ 
II 0 W M M 
青 少 年 特 發 性 脊 枉 側 呀 研 究 計 劃 
生 物 化 學 测 試 及 活 組 蛾 檢 查 
麥 加 者 同 意 書 
姓名： 性別： 
身份 l i /護妹就场 出生B斯： 年 月 曰 
舆因特發性脊柱例，，領接受脊推融合手術•手術曰期身 J•.锋棄辨 . . • J I *复本 
所涉及研究是有M骨質生長及活組織检查，我已明白這次研究的B的是•為了解特發性脊 
柱側 *的起因• 
A 同责 /不同念 * g生在手術過&中取出： 
0 «骨 / »骨中一片 0 . 5立方毫米的小骨片 * • 
0 0.5平方毫米皮膚• 
經解釋後，我明白到取小骨片及皮膚對手術'沒有彩亦不會是生其他的併發症• 
. 父母 / K獲人 * 
S i 姓名 
I h i ’曰期（日/月/年)~ 
研究人风 
^ 曰期(日/月/年） — 
險不遍用 * 




Department of Orthopaedics & Traumatology •'崎驗,^  
^ ^ ^ ^ The Chinese University of Hong Kong -
Adolescent Idiopathic Scoliosis Research Study 
Consent form for Bone Metabolism Study and Boae Biopsy 
Patient Name: Sex: 
HKID/Passport No.': Date of Birth: D M Y 
I am affected by idiopathic scoliosis and will undergo posterior spinal fusion with 
implantation and autologous bone graft oa the designated date. A study of bone growth in 
adolescent idiopathic scoliosis will be carried out. An antibiotic will be given by the doctor 
before the surgery. Hereby I consent / do not consent* lhat I take tetracycline according to the 
- d o c t o r instruction. I consent / do not consent* during the surgery a block of 0.5cm' bone 
biopsy from the bone graft site will be used for research in Idiopathic Scoliosis. While read 
the padent information sheet, I understand that Dr. ； (Name of 
Doctor) had explained to me that the possible effects of tetracycline and the bone specimen 
taken for examination would not affect the result of the operation, nor dues it add any further 
problem to harvest of bone graft. It would not cause any extra complications. 
Patient Parent / Guardiag* 
Name in block Name in block 
Signature Signature Date (dd/rom/yy)“ 
Name in block 
Signature Date (dd/nun/yy) 
, P l e a s e delete if tnapfdicabhs 
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